Document:

Supply Agreement, dated July 12, 2007

 Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information
subject to the confidentiality request. Omissions are designated as “***”. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. 
 Exhibit 10.1 
 SUPPLY AGREEMENT 
 THIS SUPPLY AGREEMENT (hereinafter “Supply Agreement”) is made this 12 day of July, 2007 (the “Effective Date”) by and between Abbott
GmbH & Co. KG, having a place of business at Max-Planck Ring 2, 65205 Wiesbaden, Germany and a facility at Knollstrasse 50, 67061 Ludwigshafen, Germany (hereinafter “Abbott”), and Barrier Therapeutics, Inc., having a place
of business at Suite 3200, 600 College Road East, Princeton NJ 08540, USA (hereinafter “Barrier”). 
 WHEREAS Abbott and Barrier have
entered into a Development and Supply Agreement dated 16 May 2002 with respect to the development of Bulk Product and Finished Product as defined therein (hereinafter “Development and Supply Agreement”); and 
 WHEREAS Article V of the Development and Supply Agreement stipulates that the parties will enter into a supply agreement as soon as reasonably possible after
Barrier submits the first New Drug Application for the Finished Product to a Regulatory Agency; and 
 WHEREAS Abbott and Barrier now wish to enter
into this Supply Agreement for Bulk Product. 
 NOW THEREFORE the parties agree as follows: 
 Article I 
 Definitions 
  

	1.1	 Affiliate means any person or business entity which directly or indirectly controls, is controlled by, or is under common control with a party to this Supply
Agreement. A business entity shall be deemed to “control” another business entity, if it owns directly or indirectly, more than fifty percent (50%) of the outstanding voting securities, capital stock, or other comparable equity or
ownership interest of such business entity, or exercises equivalent influence over such entity. If the laws of the jurisdiction in which such entity operates prohibit ownership by a party of fifty 

  

 1 

	 	 
percent (50%) or more, “control” shall be deemed to exist at the maximum level of ownership allowed by such jurisdiction.

  

	1.2	Bulk Product means Drug Substance formulated by Abbott using its MeltrexTM Technology according to the terms of this Supply Agreement. 

  

	1.3	Delimitation of Responsibilities Agreement means an agreement approved by both parties that defines the responsibilities related to quality, compliance, regulatory, and
manufacturing to assure the Bulk Product is manufactured according to all applicable regulations and guidelines. 

  

	1.4	Drug Substance means the antifungal compound itraconazole, alone or as a premix (“Triaset”). 

  

	1.5	Finished Product means the final tablets made by milling and compressing Bulk Product according to the terms of this Supply Agreement and suitable for marketing and sale.

  

	1.6	MeltrexTM Technology means any and all know-how, proprietary data, patents and patent applications owned or controlled by Abbott or any of its Affiliates relating to the
formulation and shaping of pharmaceutical products by melt-extrusion. 

  

	1.7	NDA means the first new drug application filed with the United States Food and Drug Administration or appropriate foreign equivalent Regulatory Agencies.

  

	1.8	Net Sales means the amount billed by Barrier or an Affiliate or sublicensee of Barrier for sales of Finished Product to a third party (including without limitation third
party distributors and wholesalers) less: (a) discounts, including cash discounts, discounts to managed care or similar organizations or government organizations, rebates paid, credited, accrued or actually taken, including government rebates
such as Medicaid chargebacks or rebates, and retroactive price reductions or allowances actually allowed or granted from the billed amount, and commercially reasonable and customary fees paid to distributors (other than to a distributor that is an
Affiliate of Barrier), (b) credits or allowances actually granted upon claims, rejections or returns of such sales of Finished Products, including recalls, regardless of Barrier requesting such recalls, (c) freight, postage, shipping and
insurance charges paid for delivery of such Finished Product, to the extent billed separately on the invoice and paid by the buyer, and (d) taxes, duties or other governmental charges levied on or measured by the billing amount when included in
billing, as adjusted for rebates, charge-backs and refunds and (e) provisions for 

  

 2 

	 	 
actual uncollectible accounts determined in accordance with U.S. generally accepted accounting practices, consistently applied to all products of Barrier.

  

	1.9	Regulatory Agencies means the regulatory authorities having jurisdiction over the clinical testing, manufacture, marketing and sale of Finished Product.

  

	1.10	Replacement Value means, with respect to Drug Substance and/or hydroxypropylmethylcellulose (hereinafter “HPMC”), the out of pocket cost incurred by Barrier
in connection with the purchase and delivery to Abbott of such Drug Substance and/or HPMC. 

  

	1.11	Specifications means the specifications for Drug Substance and Bulk Product as set forth in the NDA and attached hereto as Appendix 2 in accordance with Article 3.1, as may
be amended or supplemented from time to time upon the written agreement of both parties or as required by Regulatory Agencies. 

  

	1.12	Supply Price for Bulk Product shall mean the prices as set out in Appendix 1 hereto. 

 Article II 
 Supply of Bulk Product 
  

	2.1	Barrier hereby appoints Abbott as its exclusive supplier for Barrier’s and any Barrier designee’s or sublicensee’s entire requirements of Bulk Product.

  

	2.2	Abbott shall manufacture Bulk Product in its facilities exclusively for supply to Barrier or Barrier’s designees or sublicensees. 

  

	2.3	Abbott shall ship Bulk Product, together with agreed upon documentation, to Barrier or such designee or sublicensee of Barrier as Barrier specifies with each order. Title and risk
of loss in Bulk Product shall pass to Barrier when each shipment leaves Abbott’s premises. The Bulk Product shall be delivered on the basis Ex Works (Incoterms 2000) Abbott’s manufacturing facility, Ludwigshafen, Germany. Shipment shall be
via carrier designated by Barrier. 

  

	2.4	 Not later than thirty (30) days prior to Barrier targeted filing of its first NDA with a Regulatory Agency for approval of Finished Product, Barrier will
provide Abbott with its current demand forecast for use of capacity analysis. Within ninety (90) days following Barrier’s launch of the Finished Product following the first NDA approval by a Regulatory Agency, Abbott will determine if it
will 

  

 3 

	 	 
continue to supply Bulk Product or will work with Barrier on an alternative source for Bulk Product in the event that Abbott is unable or unwilling to
fulfill Barrier’s requirements for Bulk Product. Abbott may determine whether it wishes to supply Bulk Product but it reserves the right to sub-contract manufacture thereof. Abbott will be liable for the performance of any responsibilities so
sub-contracted as if they had been performed by Abbott. 

  

	2.5	In the event that an alternative source for Bulk Product is required, Abbott hereby covenants and agrees that it will use commercially reasonable efforts to assist Barrier to
establish its own manufacturing for Bulk Product prior to the termination of this Supply Agreement in order to enable Barrier or its designee to manufacture Bulk Product upon the termination of this Supply Agreement without interruption of supply;
provided, however, that Abbott will not be obliged to assist Barrier in developing a manufacturing process which differs in any manner from the process or procedures that Abbott or Abbott’s Affiliates utilize in their manufacture
of the Bulk Product. The parties will develop a procedure and timetable under which Abbott will transfer the manufacturing instructions, the technical information and the manufacturing of the Bulk Product to Barrier (the “Transfer
Programme”). As part of the Transfer Programme, Abbott will make available its manufacturing personnel, at no additional cost to Barrier, [***] to provide technical assistance and training regarding Barrier’s manufacture of
the Bulk Product and any other matters included in the Transfer Programme. Abbott will provide Barrier such other support services as may be agreed upon between the parties, provided, however, that any excess time spent by Abbott or
Abbott’s Affiliates personnel for the purpose of assisting Barrier or Barrier’s Affiliates, [***]. Notwithstanding the foregoing, Abbott will be entitled to decline to provide support services to Barrier or Barrier’s Affiliates
[***]. Barrier will reimburse Abbott (against presentation of verifiable invoices) for reasonable costs of travel and lodging incurred by Abbott personnel in the course of travel for the purpose of providing the cooperation or assistance
requested by Barrier pursuant to this Article 2.5. 

  

 4 

 Article III 
 Specifications for Bulk Product 
  

	3.1	Abbott will manufacture Bulk Product in accordance with current Good Manufacturing Practices (“GMP”), including the requirements of the Food and Drug
Administration of the United States and EU/ICH Guidelines, and, where applicable, JP guidelines, and in accordance with the Specifications for the Bulk Product which will be agreed upon by the parties prior to the submission of the first NDA to a
Regulatory Agency and thereupon will be attached hereto as Appendix 2. Such Specifications may be amended or supplemented from time to time upon the written agreement of both parties or as required by the FDA or other comparable Regulatory Agencies
outside the United States. 

 (a) Abbott will bear the expense of any changes to the manufacturing of the Bulk
Product that may be solely initiated by Abbott. Barrier assumes any and all responsibility to make any remediation, modification or change required by any Regulatory Agency (due to a Barrier filing) following the initial regulatory approval to the
manufacturing processes or test methods contained in the technical information or manufacturing instructions (“Required Manufacturing Changes”), or any intermediate step thereof, and will solely bear all expenses related thereto.

 (b) Except as provided in the previous section, it is hereby agreed between the parties that Abbott shall have
responsibility, and shall bear the expenses incurred accordingly, for all regulatory compliance matters related to or affecting the manufacture of Bulk Product at Abbott’s facility, including but not limited to cGMP issues and for maintaining
any and all authorizations and licenses necessary to manufacture and supply the Bulk Product to Barrier. 
 (c) For changes
during the term of this Supply Agreement to the Specifications or manufacturing process that are not Required Manufacturing Changes, (collectively “Discretionary Manufacturing Changes”), Abbott and Barrier must both agree to any
Discretionary Manufacturing Changes and will, to the extent commercially reasonable under the circumstances, cooperate in making such Discretionary Manufacturing Changes, and each agrees that it will not unreasonably withhold or delay its consent to
such Discretionary Manufacturing 

  

 5 

 
Changes proposed by the other party. All reasonable internal and external costs, including obsolete raw materials, regulatory filings, work-in-process,
packaging, and labeling materials associated with Discretionary Manufacturing Changes will be borne by Barrier only if such Discretionary Manufacturing Changes were requested by Barrier. Notwithstanding the foregoing, Abbott's standard change
control procedures will be utilized in reviewing such changes. In the event that Abbott is unable to implement any Discretionary Manufacturing Change requested by Barrier because such Discretionary Manufacturing Change would be inconsistent with
Abbott’s standard change control procedures, Abbott shall provide Barrier with a copy of the specific standard change control procedure implicated by such requested Discretionary Manufacturing Change. Both parties will cooperate to resolve any
procedural issues. 
  

	3.2	Within ninety (90) days following the submission of the first NDA to a Regulatory Agency, the parties shall agree to their respective responsibilities with regard to quality
assurance, release testing, sample and document retention, etc relating to Bulk Product which will be incorporated into a separate Delimitation of Responsibilities Agreement provided that, such Delimitation of Responsibilities Agreement will provide
that Abbott shall be responsible for release testing and retaining sample(s) and records for times consistent with all applicable laws and regulatory standards at no cost to Barrier. 

  

	3.3	Barrier shall have the right, on not less than thirty (30) days advance notice in writing and during regular business hours, to audit the Abbott facilities and equipment and
relevant records/reports being used in the manufacture of Bulk Product to ensure Abbott’s compliance with its obligations under Article 3.1 above not more than once per calendar year unless reasonable cause can be shown. Abbott shall use all
reasonable efforts to enable Barrier to carry out such an audit on less than said thirty (30) days notice if Barrier can demonstrate that such audit is required urgently. Any such audit shall be at Barrier’s expense and shall be carried
out in such manner as to minimize any disruption to Abbott’s operations. 

  

	3.4	 At Barrier’s request, Abbott shall also permit its facilities, equipment and relevant records and reports to be inspected under the terms of Article 3.3 above
by such Regulatory Agencies whose approval is required to enable Barrier to market Finished Product. Either party will inform the other within one business day of 

  

 6 

	 	 
any Regulatory Agency’s request to inspect in relation to Abbott’s production of Bulk Product. In no event will Barrier representatives be entitled
to (i) be present during the actual inspection of the Bulk Product, or (ii) make comments during the inspection to any representative of any Regulatory Agencies with respect to the inspection or the Bulk Product. Abbott will assist in
providing necessary data and documentation for preparation of responses to Regulatory Agency inquiries within reasonable timeframes. 

  

	3.5	Abbott shall use all reasonable efforts to remedy any deficiencies reported by such audit or inspection to meet the Regulatory Agency’s due date or time limit. All other
timelines will be mutually agreed upon by Abbott and Barrier. 

  

	3.6	During the term of this Supply Agreement, Abbott will advise Barrier without undue delay, but in any event within a period not to exceed seven (7) days (or such shorter time as
may be required in order for Barrier to comply with applicable law), of any occurrences or information arising out of Abbott’s manufacturing activities that have or could reasonably be expected to have adverse regulatory compliance and/or
reporting consequences concerning the Bulk Product, and Barrier will advise Abbott within seven (7) days (or such shorter time as may be required in order for Abbott to comply with applicable law) of any occurrences or information in connection
with Finished Product that, to its knowledge, have or could reasonably be expected to have adverse regulatory compliance and/or reporting consequences concerning the Bulk Product. 

  

	 	(a)	During the term of this Supply Agreement, Abbott will be responsible for handling and responding to any Regulatory Agency inspections with respect to Abbott’s manufacture of
the Bulk Product during the term of this Supply Agreement. Abbott will provide to Barrier any information reasonably requested by Barrier and all information requested by any Regulatory Agencies concerning any governmental inspection related to the
Bulk Product and will allow Regulatory Agencies to conduct reasonable inspections upon the request of such Regulatory Agencies. To the extent that Abbott requires the assistance of Barrier in order to fulfill its obligations pursuant to this
Section 3.6(a), Barrier agrees to fully cooperate and assist Abbott, at Abbott’s expense. 

  

	 	(b)	 In the event Abbott is inspected by any applicable Regulatory Agency, Abbott will notify Barrier without undue delay, but in any event within a period not to exceed
five (5) business days, of any written alleged violations or deficiencies relating to the Bulk Product and the corrective action to be taken. 

  

 7 

	 	 
Abbott will as expeditiously as practicable take any such corrective action required to comply with the provisions of this Supply Agreement. Prior to
submission of any written response submitted to any applicable Regulatory Agencies, Barrier will have an opportunity to review any portion of the response regarding written alleged violations or deficiencies relating to the Bulk Product.

  

	3.7	In the event that Barrier believes that a batch of Bulk Product fails to meet the Specifications, Barrier shall so notify Abbott in writing within sixty (60) business days of
Barrier’s receipt of said batch and provide Abbott with samples of the alleged non-conforming Bulk Product from the relevant batch for testing. Abbott’s liability shall be limited to replacement at its cost of any batch which the parties
agree fails to meet the Specifications, but shall include the Replacement Value of the Drug Substance and HPMC incorporated into any such Bulk Product that fails to meet the Specifications as well as any amounts payable by Barrier to Barrier’s
third party manufacturer of Finished Product to reimburse said third party manufacturer for any costs incurred by it as a result of manufacturing Finished Product incorporating such failed batch of Bulk Product that has been converted from the Bulk
Product within the sixty (60) days prior to notification. 

  

	3.8	If the parties disagree on the alleged failure of a batch to meet the Specifications, the parties will appoint an independent expert skilled in the art who will analyse samples of
the alleged deficient batch. Both parties will supply such expert with copies of such data and documentation as the expert may reasonably require in connection with such analysis. The expert’s opinion as to whether or not such batch has met the
Specifications shall be final and binding on the parties. The costs of such expert shall be borne by the party whose contention is rejected by the expert. 

 Article IV 
 Quantities and Forecasts 
  

	4.1	 Within ninety (90) days following Barrier’s first NDA filing with a Regulatory Agency for approval to sell Finished Product, Barrier shall forward to
Abbott a three (3) year non-binding forecast of Barrier’s requirements for Bulk Product. 

  

 8 

	 	 
Such three (3) year forecast shall thereafter be updated each year not later than 30th November for the three (3) years commencing on the 1st January immediately following.

  

	4.2	As soon as reasonably possible after Barrier submits its first NDA to a Regulatory Agency, Barrier shall place an order on Abbott for the quantity of Bulk Product required by
Barrier for its initial three (3) months’ launch stock of Finished Product and thereafter Barrier shall provide Abbott every calendar quarter with a rolling twenty-four (24) month forecast of its requirements for Bulk Product, of
which the forecast for the second three (3) month period shall be a firm commitment to purchase. Barrier will be required to purchase and take delivery of no less than 75% of the amount of Bulk Product included in the forecast for months 7
through 9 of each rolling forecast; Barrier will be required to purchase and take delivery of no less the 50% of the amount of Bulk Product included in the forecast for months 10 through 12 of each rolling forecast; the forecasts for months 13
through 24 of each rolling forecast will not be binding. Each forecast will be broken down for each month of such period into the quantity and shipping dates. Abbott will not, pursuant to any single purchase order, be obliged to supply any
quantities of Bulk Product that: (a) exceed the maximum supply amount established for the Bulk Product as set forth in Appendix 3 attached hereto, or (b) is less than the minimum order quantity for the Bulk Product ordered as set forth in
Appendix 3. 

  

	4.3	Barrier shall provide Abbott with detailed delivery requirements, including dates and destinations, with each order. 

  

	4.4	Barrier undertakes to purchase from Abbott its total requirements of Bulk Product for formulation into Finished Product and Abbott undertakes to supply Barrier’s total
requirements. In the event that Barrier’s requirements exceed its forecasts, Abbott will use all reasonable efforts to meet Barrier’s second quarter requirements up to a maximum of one hundred and twenty-five percent (125%) of the
third quarter forecast of the previous calendar quarter’s twenty-four (24) month forecast. 

  

	4.5	 Barrier shall specify the third parties from whom Drug Substance and HPMC shall be procured free of charge to Abbott and shall ensure that said third parties have
sufficient Drug Substance and HPMC available at all times to enable Abbott 

  

 9 

	 	 
to fulfil its obligations hereunder. Abbott will procure from said third parties sufficient quantities of Drug Substance and, if agreed between the parties,
HPMC to enable Abbott to supply Barrier’s total requirements of Bulk Product. Supplies of Drug Substance and HPMC shall at all times remain the property of Barrier. Abbott shall provide adequate and safe storage for all Drug Substance and HPMC
delivered to it and for all Bulk Product pending delivery to Barrier or a party designated by Barrier. 

  

	4.6	Abbott shall keep all Drug Substance, HPMC and Bulk Product insured, at Abbott’s expense, for their Replacement Value against any loss or damage. Abbott shall not be liable for
any loss or damage to the Drug Substance, HPMC or Bulk Product during transport. 

  

	4.7	Abbott shall use all reasonable efforts to achieve a minimum yield during formulation of the Drug Substance using its MeltrexTM Technology. Yield (“Yield”) is
defined as the relation between the Drug Substance content of the Bulk Product manufactured over a certain time span (calculated at nominal concentration), and the actual quantity of Drug Substance used to manufacture such quantity of Bulk Product.
At the end of each calendar year, the actual Yield achieved by Abbott will be compared to the minimum Yield agreed upon. Abbott will prepare for Barrier an explanation, by work order number, of all variances greater than three percent (3%). If
Abbott has used more Drug Substance than required to achieve the minimum Yield, Abbott will reimburse Barrier at the Replacement Value for the excess quantity of Drug Substance used. The initial minimum Yield will be defined after the manufacturing
of the first ten (10) commercial batches (not including the validation batches) after filing the NDA. The parties will thereafter review the minimum Yield on a yearly basis and the minimum Yield for the subsequent calendar year will be the
actual Yield for the previous calendar year. 

  

 10 

 Article V 
 Supply Price 
  

	5.1	Barrier and Abbott agree that the initial Supply Price for Bulk Product shall be as set out in Appendix 1 hereto provided, however, that such Supply Price shall never fall below
Abbott’s fully burdened cost of manufacture [***] (“Cost”) in which case the Supply Price shall be adjusted to such Cost. 

  

	5.2	Abbott shall have the right to adjust such Supply Price in accordance with any change in the Index of Producer Prices Industrial Products (“Erzeugerpreise gewerblicher
Produkte”) of the Statistisches Bundesamt Deutschland (using the year in which the first commercial batch is produced as the baseline) subject to any such adjustment being made only once in each calendar year and on three (3) months
written notice from Abbott to Barrier. All invoices shall be sent to by Abbott to Barrier at the address first set forth above and marked “Attention: Accounts Payable”. 

  

	5.3	Barrier shall pay the Supply Price (plus Value Added Tax, if applicable) to Abbott within thirty (30) days after receipt of the invoice for each shipment. A late payment
penalty at the rate of two percent (2%) per annum above the prime rate as noted in the Wall Street Journal will be applied to any overdue balance on a monthly basis. 

 Article VI 
 Intellectual Property Rights 
  

	6.1	For the term of this Supply Agreement, Barrier will grant to Abbott, or procure the grant to Abbott of, a royalty-free enabling license under any patents relating to Drug Substance
in as far as such a license is necessary for Abbott to develop and manufacture Bulk Product for Barrier and to supply such Bulk Product to Barrier or its designees or sublicensees. 

  

	6.2	 Abbott hereby grants to Barrier an exclusive, worldwide license and sublicense, as the case may be (the “License”) under any patents and know-how
owned or controlled by Abbott or any of its Affiliates relating to the formulation of Drug 

  

 11 

	 	 
Substance by MeltrexTM Technology but only in so far as such a License is necessary for Barrier to use or have used Bulk Product to make, have made, use
or sell Finished Product, itself or through its distributors or sublicensees. For the avoidance of doubt, such exclusive License shall not in any way restrict Abbott’s use of its MeltrexTM Technology to develop and manufacture products
which do not incorporate Drug Substance or to fulfill its obligations under this Supply Agreement. 

  

	6.3	In consideration of said License and in addition to the Supply Price, subject to Section 6.4 below, Barrier shall pay to Abbott a “Fee” of [***] of Net Sales
of Finished Product; provided that, if Barrier’s arrangement with a third party sublicensee or distributor requires such third party to pay Barrier a sales based royalty or sales based fee, then, in lieu of [***] of Net Sales,
Abbott’s Fee shall be [***] percentage points of such royalty or fee. An example of such calculation is contained in Appendix 4. In the event that Barrier’s arrangement with a third party sublicensee or distributor does not require
such third party to pay Barrier a sales based royalty or sales based fee, then Barrier shall pay to Abbott a sum equivalent to [***] of such third party’s Net Sales of Finished Product. For clarification, if a third party (not Abbott or an
Abbott Affiliate) is the Bulk Product supplier, then Abbott (and not such third party) shall receive the Fee. 

  

	6.4	Barrier’s obligation to pay the Fee to Abbott shall cease upon later of (i) the expiry of the last to expire of any Abbott patents which cover the manufacture of Bulk
Product and/or Finished Product, and (ii) the end of the initial ten (10) year term of this Supply Agreement provided that Abbott continues to be Barrier’s supplier of Bulk Product, such supply to be on reasonable commercial terms.

  

	6.5	The Fee shall be paid to Abbott quarterly in arrears, within forty-five (45) days after the end of each calendar quarter. 

  

	6.6	 Barrier shall keep or cause to be kept accurate records in sufficient detail to enable the payments due hereunder to be determined. Abbott may designate an
independent public accountant to review such records once a year during normal business hours to verify the accuracy of the payments made or payable hereunder, but only as to any period ending not more than three (3) years prior to the date of
such request. Said accountant shall disclose to Abbott only whether the records are correct or not and, if applicable, the specific details concerning any 

  

 12 

	 	 
discrepancies. Abbott will pay for the cost of any such review conducted at its request under this Section 6.6 unless such review reveals a discrepancy
of ten percent (10%) or more in the Net Sales or Fee, in which case Barrier will pay the costs of such review. 

  

	6.7	Abbott represents and warrants that it has such rights as are necessary to fulfill its obligations under this Agreement. 

  

	6.8	Barrier and its designees and sublicensees shall include wording, to be agreed with Abbott, on all packaging, labels, etc of Finished Product to the effect that such Finished
Product was formulated using MeltrexTM Technology. 

 Article VII 
 Confidentiality 
 Pursuant to the purposes of
this Supply Agreement, each party may from time to time disclose to the other party, orally, in writing or in an electronic medium, information of a confidential or proprietary nature (“Confidential Information”). Each party
undertakes to keep strictly secret such Confidential Information received from the other party and not to publish it or make commercial (including any public or press releases to third parties) or any other use of it without the express prior
consent in writing of the disclosing party, unless otherwise permitted under this Supply Agreement. The obligation of secrecy does not apply when and if the receiving party can prove that the Confidential Information 
  

	a)	was known to it or any of its Affiliates prior to the date it was transferred hereunder, as evidenced by written records; 

  

	b)	became or becomes known to it or any of its Affiliates through a third party having the right to disclose the same subsequent to the date it was received hereunder without it being
responsible therefor; 

  

	c)	was or becomes known to the public or generally available to the public otherwise than through the act or default of the receiving party or its agents; 

  

	d)	is independently developed by the receiving party or any of its Affiliates as evidenced by written records; or 

  

 13 

	e)	is required by law, regulatory, administrative or judicial order to be disclosed, in which event the receiving party shall notify the disclosing party as soon as possible prior to
such required disclosure and shall cooperate with the disclosing party’s efforts to limit such disclosure. 

 The foregoing obligations
shall cease after the expiration of a period of ten (10) years commencing on the Effective Date or five (5) years after the termination of this Supply Agreement whichever is the later. 
 Notwithstanding anything else in this Supply Agreement to the contrary, each party hereto (and each employee, representative, or other agent of any party) may disclose
to any and all persons, without limitation of any kind, the Federal income tax treatment and Federal income tax structure of any and all transaction(s) contemplated herein and all materials of any kind (including opinions or other tax analyses) that
are or have been provided to any party (or to any employee, representative, or other agent of any party) relating to such tax treatment or tax structure, provided, however, that this authorization of disclosure shall not apply to restrictions
reasonably necessary to comply with securities laws. This authorization of disclosure is retroactively effective immediately upon commencement of the first discussions regarding the transactions contemplated herein, and the parties aver and affirm
that this tax disclosure authorization has been given on a date which is no later than 30 days from the first day that any party hereto (or any employee, representative, or other agent of any party hereto) first made or provided a statement as to
the potential tax consequences that may result from the transactions contemplated hereby. 
 Article VIII 
 Term and Termination 
  

	8.1	 Barrier shall inform Abbott, within five (5) business days of such event, that (i) Barrier or its sublicensee or distributor has received confirmation of
acceptance for filing of the first NDA for Finished Product with a Regulatory Agency and (ii)

  

 14 

	 	 
Barrier or its sublicensee or distributor has made the first commercial sale of Finished Product. 

  

	8.2	This Supply Agreement shall come into effect on the Effective Date and remain in full force and effect for ten (10) years from the first day of the month following the month in
which the first commercial sale of Finished Product was made by Barrier or a sublicensee or distributor of Barrier. 

  

	8.3	Barrier may terminate this Supply Agreement upon twelve (12) months’ written notice to Abbott. Abbott may terminate this Supply Agreement (other than Sections 6.2 through
6.6 which shall survive) upon twelve (12) months’ written notice to Barrier provided that Abbott has put in place adequate alternative supply arrangements in accordance with Articles 2.4 and 2.5 above. 

  

	8.4	Either party may terminate this Supply Agreement for a material breach by the other party in the performance of its obligations hereunder by giving to the breaching party written
notice specifying such breach within forty-five (45) days after the non-breaching party becomes aware of the occurrence of such breach and, if the breaching party has not remedied or cured the default within sixty (60) days of such notice
being given (or, if a breach is not capable of being cured within such 60 day period, the breaching party has not promptly provided the other party with a detailed plan for curing such breach and has not promptly begun and continued all reasonable
efforts to execute such plan), then termination shall become effective, at the non-breaching party’s option at the end of said sixty (60) day period. 

  

	8.5	 In the event of any proceedings, voluntary or involuntary, in bankruptcy by or against Barrier or Abbott, or the appointment with or without the parties’
consent of a receiver for either party, or in the event of insolvency of either party, the other party shall be entitled to terminate the Supply Agreement upon giving written notice without any liability whatsoever. The parties agree that the
Licenses are, and shall be deemed to be, for purposes of Section 365(n) of the U.S. Bankruptcy Code, licenses of rights to “intellectual property” as defined under Section 101 of the U.S. Bankruptcy Code and that Barrier as the
licensee of such rights under this Supply Agreement shall retain and may fully exercise all of its rights and elections under the U.S. Bankruptcy Code. The parties further agree that, in the event of the commencement of a bankruptcy or similar
proceeding by or against Abbott, Barrier shall be entitled to a complete duplicate of (or complete access to, as appropriate) 

  

 15 

	 	 
any such intellectual property and all embodiments of such intellectual property, and to have the same promptly delivered to it (i) upon any such
commencement of a bankruptcy or similar proceeding upon its written request therefor, unless Abbott elects to continue to perform all of its obligations under this Supply Agreement or (ii) if not delivered under (i) above, upon rejection
of this Supply Agreement by or on behalf of Abbott upon written request therefor. 

  

	8.6	Upon termination of this Supply Agreement for any reason whatsoever Barrier and Abbott will cease to use any and all Confidential Information provided by the other party; except
that, in the case of (a) expiration pursuant to Section 8.2, (b) termination by Abbott pursuant to Section 8.3, or (c) termination by Barrier pursuant to Section 8.4 or 8.5, Barrier shall be entitled to continue to use
any Confidential Information necessary in order for Barrier to utilize the License. 

  

	8.7	Upon either (a) expiration of this Supply Agreement pursuant to Section 8.2, (b) termination of this Supply Agreement by Abbott pursuant to Section 8.3, or
(c) termination by Barrier pursuant to Section 8.4, Abbott shall deliver to Barrier a complete duplicate of (or complete access to, as appropriate) any intellectual property and all embodiments of such intellectual property, necessary for
Barrier or its sublicensee or designee to utilize the License to manufacture Bulk Product. 

  

	8.8	Termination of this Supply Agreement for any reason whatsoever will have no effect on any rights or obligations that have accrued prior to the effective date of such termination.

 Article IX 
 Miscellaneous 
  

	9.1	Nothing in this Supply Agreement will be deemed or construed as providing either party any right, title, interest, or license in or under any intellectual property right owned or
controlled by the other party other than explicitly specified in Article VI above. 

  

	9.2	Modifications and amendments to this Supply Agreement require the prior written consent of both parties. 

  

 16 

	9.3	No waiver of any requirement of this Supply Agreement, whether by conduct or otherwise, will be effective unless in writing. The waiver in any one or more instances will not be
deemed or construed to be a further or continuing waiver of any such requirement or of any other requirement of this Supply Agreement. 

  

	9.4	If any one or more of the provisions of this Supply Agreement will be held to be invalid, illegal, or unenforceable, the validity, legality, or enforceability of the remaining
provisions of this Supply Agreement will not in any way be affected or impaired thereby. 

  

	9.5	Any notice required or permitted to be given hereunder will be deemed sufficient if delivered by hand or sent by overnight courier to the parties at the addresses set forth below or
such other addresses as either party may designate. Notice will be deemed given when received. 

  

			
	 If to Barrier, to:
	  	 Chief Operating Officer
 Barrier Therapeutics,
Inc.
 Suite 3200
 600 College Road East
 Princeton, NJ 08540
 USA

		
	 If to Abbott, to:
	  	 Head of SOLIQS
 Abbott GmbH & Co. KG

Knollstrasse 50
 67061 Ludwigshafen
 Germany

  

	9.6	 Neither party will assign this Supply Agreement, or subcontract any of its obligations hereunder, to any other person or entity other than to one or more of its
Affiliates, without the prior written consent of the other party, which consent will not be unreasonably withheld; however, in the event of any assignment or subcontract, the party effecting such assignment or subcontract shall guarantee the
performance of the assignee or subcontractor in a form satisfactory to the other party. Notwithstanding the foregoing, either party may, without such written consent, assign this Supply Agreement, and its rights and obligations hereunder, in
connection with the transfer or sale of all or substantially all of its business, or in the event of its merger or consolidation or change in control or similar transaction 

  

 17 

	 	 
provided the permitted assignee shall have assumed all obligations of the assignor under this Supply Agreement. 

  

	9.7	This Supply Agreement will be binding upon and inure to the benefit of the permitted successors or permitted assigns of Abbott and Barrier. 

  

	9.8	The parties agree to attempt to resolve any dispute involving this Supply Agreement in good faith through upper management meetings between the parties and, if unresolved within
sixty (60) days of the first meeting, to arbitrate the dispute in accordance with the terms of Article 9.15. 

  

	9.9	This Supply Agreement shall be construed, interpreted and applied in accordance with the laws of Germany, without reference to its conflict of laws provisions, and the place of
jurisdiction shall be the Courts of Mannheim, Germany. 

  

	9.10	Neither party shall be liable for any failure or delay in performing its obligations hereunder when any such failure or delay shall be caused (directly or indirectly) by fires,
flood, earthquakes, accidents, explosions, sabotage, strikes or other labour disturbances, civil commotion, riots, invasions, wars, acts, restraints, requisitions, regulations, or directions of governmental authorities, shortages of labour, fuel,
power, or raw material, inability to obtain equipment or supplies, inability to obtain or delays in transportation, acts of God, or any cause beyond the reasonable control of that party. Performance under this Supply Agreement of the affected party
may be delayed during the occurrence of any of the circumstances described in this paragraph 9.10, provided that written notice of such circumstances is provided to the unaffected party. 

  

	9.11	 Neither party shall use the name of the other party in publicity or advertising in relation to any activities under this Supply Agreement without the prior written
approval of the other party which shall not be unreasonably withheld. Notwithstanding any other provision of this Supply Agreement, Barrier shall be permitted to describe this Supply Agreement in any document which Barrier files with the Securities
and Exchange Commission (“SEC”). Barrier shall provide Abbott with five (5) business days to review any SEC filing which describes this Supply Agreement and shall give due consideration to any reasonable comments provided by
Abbott. After any such filing Barrier may make subsequent filings and public disclosures in a manner consistent with the description contained in any such filed document without providing Abbott with an opportunity to review. Prior to 

  

 18 

	 	 
filing a copy of this Supply Agreement with the SEC, Barrier shall notify Abbott and, if requested in writing by Abbott within fifteen (15) business
days after such notification, request that the SEC grant confidential treatment to the provisions for which Abbott has requested such confidential treatment. 

  

	9.12	Each party warrants that it has the right and authority to enter into this Supply Agreement and that it is not under any other contractual obligation, express or implied,
inconsistent with the terms hereof. 

  

	9.13	Neither party shall make any representation or incur any obligation in the name or on behalf of the other party except as explicitly authorised hereunder. Nothing in this Supply
Agreement shall be deemed to establish a relationship of principal and agent between Barrier and Abbott nor any of their agents or employees for any purpose whatsoever. Nothing in this Supply Agreement shall be deemed to constitute the parties as a
partnership, association or other relationship. 

  

	9.14	This Supply Agreement constitutes the entire agreement of Abbott and Barrier with respect to the subject matter hereof and this Supply Agreement cancels and supersedes all
agreements of any kind related to the subject matter hereof entered into prior to the Effective Date of this Supply Agreement. 

  

	9.15	Abbott and Barrier shall each obtain and maintain in full force during the term of this Supply Agreement insurance policies from a reputable insurance company or pursuant to a
self-insurance programme providing Abbott with insurance coverage for the Bulk Product and Barrier with insurance coverage for the Drug Substance and Finished Product that is reasonably consistent with the levels of insurance coverage customarily
maintained in the pharmaceutical industry. 

  

	9.16	 All disputes, claims or controversies arising in connection with, pursuant to, or related to, this Supply Agreement shall be finally determined under the
Arbitration Rules of the International Chamber of Commerce (“ICC”) by three arbitrators, knowledgeable in the field of pharmaceuticals, conversant in the English language, and appointed by the ICC in accordance with said Rules,
except that any disputes regarding the validity, scope or enforceability of a patent shall be submitted to a court of competent jurisdiction. The arbitrator appointed to chair the arbitral tribunal shall be a lawyer fluent in English. The place of
arbitration shall be London, England. The language of the arbitration shall be English. Documents in other languages shall be permitted as exhibits but mutually acceptable translations 

  

 19 

	 	 
in English shall be provided by the offering party. The award may grant any relief appropriate under the applicable law, including without limitation
declaratory relief and/or specific performance. However, the parties agree that notwithstanding the applicable law, the arbitral tribunal shall not be empowered to award punitive damages against either party. The parties hereby agree that there
shall be no right of appeal to any court on the merits of the dispute. Judgement on the award may be entered in any court having jurisdiction over the award or any of the parties or their assets. 

  

	9.17	Each party hereby agrees to indemnify, defend and hold the other party and its Affiliates and each of their directors, officers, shareholders, agents, representatives and employees
(the “Indemnified Group”) harmless from and against any and all costs, expenses (including reasonable attorneys’ fees and amounts paid in settlement), damages and liabilities claimed by a third party (“Claim”)
resulting directly or indirectly from activities conducted by the indemnifying party, its Affiliates or any of their directors, officers, shareholders, agents, representatives, employees or sublicensees (the “Indemnifying Group”),
but only to the extent such Claim results from the negligence or wilful misconduct or breach of this Supply Agreement by the Indemnifying Group (and, in the case of Barrier, resulting from Barrier’s commercialisation of the Bulk Product and
Finished Product) except to the extent such Claim results from the negligence or wilful misconduct or breach of this Supply Agreement by the Indemnified Group. In the event that a party is seeking indemnification under this Section, it shall inform
the other party of a Claim as soon as reasonably practicable after it receives notice of the Claim, shall permit the indemnifying party to assume direction and control of the defence of the Claim (including the right to settle the Claim solely for
monetary consideration), and shall cooperate as requested in the defence and settlement of the Claim. The Indemnified Group shall not voluntarily make any payment or incur any expense in connection with any claim or suit without the consent of the
indemnifying party, provided that if the indemnifying party does not assume direction and control of the defence of the Claim, the Indemnified Group may assume direction and control of the defence of the Claim and, if successful, shall be reimbursed
by the indemnifying party for costs incurred in connection with such defence. 

  

 20 

	9.18	Except as may be asserted through a third party claim for which indemnification is required pursuant to Section 9.17 above, neither party will be liable to the other for
any loss of profits, loss of use or loss of goodwill or any indirect or consequential damages. 

 IN WITNESS WHEREOF, the parties have caused
this Supply Agreement to be executed by their authorized representatives as of the dates set forth below: 
  

									
	BARRIER THERAPEUTICS, INC.	 		 	ABBOTT GmbH & Co. KG
					
	By:	 	/s/ Al Altomari	 		 	By:	 	/s/ Dr. Jörg Breitenbach
	Name:	 	Al Altomari	 		 	Name:	 	Dr. Jörg Breitenbach
	Title:	 	Chief Operating Officer	 		 	Title:	 	Senior Director, Head of SOLIQS
					
		 		 		 	By:	 	/s/ Tatjana Häußer
		 		 		 	Name:	 	Tatjana Häußer
		 		 		 	Title:	 	 Counsel,
 PPG Legal Operations

  

 21 

 APPENDIX 1 
 Supply Price 
 Supply Price for Bulk Product (ex-works Ludwigshafen), 
 excluding the cost of Drug Substance and HPMC. 
 [***] 
 These prices may be changed from time-to-time on prior written notice in accordance with Article 5.2. 
 APPENDIX 2 
 Specifications for Bulk
Product 
 (to be agreed and attached prior to Barrier’s first submission of an NDA for Finished Product to a Regulatory Agency)

 Appendix 3 
 Maximum Capacity and Minimum Order Quantities 
 (to be agreed and attached prior to first launch of Finished Product) 

  

 22 

 Appendix 4 
 Example of Alternative Fee Calculation 
 Where Barrier’s arrangement with a third party sublicensee or
distributor requires such third party to pay Barrier a sales based royalty or fee: 
 Example 1. [***] 
 [***] 
 [***] 
 [***] 
 [***] 
 Example 2. [***] 
 [***] 
 [***] 
 [***] 
 [***] 
  

 23Credit and Security Agreement, dated June 29, 2007

 Exhibit 10.2 
 CREDIT AND SECURITY AGREEMENT 
 THIS CREDIT AND SECURITY AGREEMENT (as the same may be
amended, supplemented, restated or otherwise modified from time to time, the “Agreement”) is dated as of June 29, 2007 by and among (a) BARRIER THERAPEUTICS, INC., a Delaware corporation, and any additional Borrower
that may hereafter be added to this Agreement (each individually as a “Borrower”, and collectively as “Borrowers”), (b) MERRILL LYNCH CAPITAL, a division of Merrill Lynch Business Financial Services
Inc., individually as a Lender, and as Administrative Agent, and (c) the financial institutions or other entities from time to time parties hereto, each as a Lender. 
 RECITALS 
 Borrowers have requested that Lenders make available to Borrowers the
financing facilities as described herein. Lenders are willing to extend such credit to Borrowers under the terms and conditions herein set forth. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the premises and the agreements, provisions and covenants herein
contained, Borrowers, Lenders and Administrative Agent agree as follows: 
 ARTICLE 1 – DEFINITIONS 
 Section 1.1 Certain Defined Terms. 
 The following terms have the following meanings: 
 “Account Debtor” means “account debtor”, as defined in
Article 9 of the UCC, and any other obligor in respect of an Account. 
 “Accounts” means collectively any
“account” (as defined in Article 9 of the UCC), any accounts receivable (whether in the form of payments for services rendered or goods sold, rents, license fees or otherwise), any “payment intangibles” (as defined in Article 9
of the UCC), and IP Proceeds and all other rights to payment and/or reimbursement of every kind and description, whether or not earned by performance, and all proceeds of any of the foregoing. 
 “Administrative Agent” means Merrill Lynch, in its capacity as administrative agent for the Lenders hereunder, as such capacity is
established in, and subject to the provisions of, Article 11, and the successors of Merrill Lynch in such capacity. 
 “Affiliate” means with respect to any Person (a) any Person that directly or indirectly controls such Person, (b) any Person which is controlled by or is under common control with such controlling Person, and
(c) each of such Person’s (other than, with respect to any Lender, any Lender’s) officers or directors (or Persons functioning in substantially similar roles) and the spouses, parents, descendants and siblings of such officers,
directors or other Persons. As used in this definition, the term “control” of a Person means the possession, directly or indirectly, of the power to vote fifteen percent (15%) or more of any class of voting securities of such Person
or to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by contract or otherwise. 
 “Anti-Terrorism Laws” means any Laws relating to terrorism or money laundering, including Executive Order No. 13224 (effective September 24, 2001), the USA PATRIOT Act, the Laws comprising
or implementing the Bank Secrecy Act, and the Laws administered by OFAC. 
 “Approved Fund” means any (i) investment
company, fund, trust, securitization vehicle or conduit that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its business or (ii) any
Person (other than a natural person) which 

 
temporarily warehouses loans for any Lender or any entity described in the preceding clause (i) and that, with respect to each of the preceding clauses
(i) and (ii), is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) a Person (other than a natural person) or an Affiliate of a Person (other than a natural person) that administers or manages a Lender.

 “Asset Disposition” means any sale, lease, license, transfer, assignment or other consensual disposition by any Credit
Party of any asset. 
 “Assignment Agreement” means an assignment agreement in form and substance reasonably satisfactory to
Administrative Agent. 
 “Bankruptcy Code” means Title 11 of the United States Code entitled “Bankruptcy”, as the
same may be amended, modified or supplemented from time to time, and any successor statute thereto. 
 “Barrier Belgium”
means Barrier Therapeutics, N.V., a Belgian stock corporation and a wholly-owned Subsidiary of the Principal Borrower. 
 “Barrier
Canada” means Barrier Therapeutics Canada, Inc., a Canadian corporation and a wholly-owned Subsidiary of the Principal Borrower. 
 “Base Rate” means a rate per annum (rounded upwards, if necessary, to the nearest 1/100 of 1%) equal to (a) the rate of interest which is identified and normally published by Bloomberg Professional Service Page BBAM 1
as the offered rate for loans in United States dollars for the period of one (1) month under the caption British Bankers Association LIBOR Rates as of 11:00 a.m. (London time) as adjusted on a daily basis and effective on the second full
Business Day after each such day (unless such date is not a Business Day, in which event the next succeeding Business Day will be used); divided by (b) the sum of one minus the daily average during the preceding month of the
aggregate maximum reserve requirement (expressed as a decimal) then imposed under Regulation D of the Board of Governors of the Federal Reserve System (or any successor thereto) for “Eurocurrency Liabilities” (as defined therein). If
Bloomberg Professional Service (or another nationally-recognized rate reporting source acceptable to Administrative Agent) no longer reports the LIBOR or Administrative Agent determines in good faith that the rate so reported no longer accurately
reflects the rate available to Administrative Agent in the London Interbank Market or if such index no longer exists or if Page BBAM 1 no longer exists or accurately reflects the rate available to Administrative Agent in the London Interbank Market,
Administrative Agent may select a comparable replacement index or replacement page, as the case may be. 
 “Base Rate
Margin” means 3.0% per annum. 
 “Blocked Person” means any Person: (a) listed in the annex to, or is
otherwise subject to the provisions of, Executive Order No. 13224, (b) owned or controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject to the provisions of, Executive Order
No. 13224, (c) with which any Lender is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law, (d) that commits, threatens or conspires to commit or supports “terrorism” as defined in
Executive Order No. 13224, or (e) that is named a “specially designated national” or “blocked person” on the most current list published by OFAC or other similar list or is named as a “listed person” or
“listed entity” on other lists made under any Anti-Terrorism Law. 
 “Borrower” and “Borrowers”
mean the entity(ies) described in the first paragraph of this Agreement and each of their successors and permitted assigns. 
 “Borrower Representative” means Principal Borrower, in its capacity as Borrower Representative pursuant to the provisions of Section 2.9, or any successor Borrower Representative selected by Borrowers and approved by
Administrative Agent. 
  

 2 

 “Borrowing Base” means: 
 (a) the product of (i) eighty five percent (85%) multiplied by (ii) the aggregate net amount at such time of the Eligible Accounts;
plus 
 (b) the lesser of (i) fifty percent (50%) multiplied by the Orderly Liquidation Value of the Eligible
Inventory or (ii) fifty percent (50%) multiplied by the value of the Eligible Inventory, valued at the lower of first-in-first-out cost or market cost, and after factoring in all rebates, discounts and other incentives or rewards
associated with the purchase of the applicable Inventory); minus 
 (c) the amount of any reserves and/or adjustments provided for in
this Agreement. 
 “Borrowing Base Certificate” means a certificate, duly executed by a Responsible Officer of Borrower
Representative, appropriately completed and substantially in the form of Exhibit C hereto. 
 “Business Day”
means any day except a Saturday, Sunday or other day on which either the New York Stock Exchange is closed, or on which commercial banks in Chicago and New York City are authorized by law to close. 
 “CERCLA” means the Comprehensive Environmental Response, Compensation and Liability Act of 1980. 
 “Change in Control” means the occurrence of any of the following events: (a) any Person or two or more Persons acting in concert
shall have acquired beneficial ownership, directly or indirectly, of, or shall have acquired by contract or otherwise, or shall have entered into a contract or arrangement that, upon consummation, will result in its or their acquisition of or
control over, voting stock of Principal Borrower (or other securities convertible into such voting stock) representing 40% or more of the combined voting power of all voting stock of Principal Borrower or (b) Principal Borrower ceases to own,
directly or indirectly, 100% of the capital stock of any of its Subsidiaries (other than as expressly set forth in Schedule 5.4); or (c) “Change of Control”, “Change in Control”, or terms of similar import under any document
or instrument governing or relating to Debt of or equity in such Person. As used herein, “beneficial ownership” shall have the meaning provided in Rule 13d-3 of the Securities and Exchange Commission under the Securities Exchange Act of
1934. 
 “Closing Date” means the date of this Agreement. 
 “Code” means the Internal Revenue Code of 1986, as amended from time to time. 
 “Collateral” means all property, now existing or hereafter acquired, that is mortgaged or pledged to, or purported to be subjected to a
Lien in favor of, Administrative Agent, for the benefit of Administrative Agent and Lenders, pursuant to this Agreement and the Security Documents, including, without limitation, all of the property described in Schedule 9.1 hereto.

 “Commitment Annex” means Annex A to this Agreement. 
 “Commitment Expiry Date” means June 29, 2010. 
 “Compliance Certificate” means a certificate, duly executed by a Responsible Officer of Borrower Representative, appropriately completed and substantially in the form of Exhibit B
hereto. 
 “Contingent Obligation” means, with respect to any Person, any direct or indirect liability of such Person:
(a) with respect to any Debt of another Person (a “Third Party Obligation”) if the purpose or intent of such Person incurring such liability, or the effect thereof, is to provide assurance to the obligee of such Third Party
Obligation that such Third Party Obligation will be paid or discharged, or that any agreement relating thereto will be complied with, or that any holder of such Third Party Obligation will be protected, in whole or in part, against loss with respect
thereto; (b) with respect to any undrawn portion of any letter of credit issued for the account of such Person or as to which such Person is otherwise liable for the reimbursement of any drawing; (c) under any swap agreement 

  

 3 

 
or other derivative instrument, to the extent not yet due and payable; (d) to make take-or-pay or similar payments if required regardless of
nonperformance by any other party or parties to an agreement; or (e) for any obligations of another Person pursuant to any guaranty or pursuant to any agreement to purchase, repurchase or otherwise acquire any obligation or any property
constituting security therefor, to provide funds for the payment or discharge of such obligation or to preserve the solvency, financial condition or level of income of another Person. The amount of any Contingent Obligation shall be equal to the
amount of the obligation so guarantied or otherwise supported or, if not a fixed and determinable amount, the maximum amount so guarantied or otherwise supported. 
 “Credit Exposure” means any period of time during which the Revolving Loan Commitment is outstanding or any Reimbursement Obligation or other Obligation remains unpaid or any Letter of Credit or
Support Agreement remains outstanding; provided, however, that no Credit Exposure shall be deemed to exist solely due to the existence of contingent indemnification liability, absent the assertion of a claim, or the known existence of a claim
reasonably likely to be asserted, with respect thereto. 
 “Credit Party” means any guarantor under a guaranty of the
Obligations or any part thereof, any Borrower and any other Person (other than Administrative Agent, a Lender or a participant of a Lender), whether now existing or hereafter acquired or formed, that becomes obligated as a borrower, guarantor,
surety, indemnitor, pledgor, assignor or other obligor under any Financing Document; and “Credit Parties” means all such Persons, collectively. 
 “Debt” of a Person means at any date, without duplication, (a) all obligations of such Person for borrowed money, (b) all obligations of such Person evidenced by bonds, debentures, notes or
other similar instruments, (c) all obligations of such Person to pay the deferred purchase price of property or services, except trade accounts payable arising and paid on a timely basis and in the Ordinary Course of Business, (d) all
capital leases of such Person, (e) all non-contingent obligations of such Person to reimburse any bank or other Person in respect of amounts paid under a letter of credit, banker’s acceptance or similar instrument, (f) all equity
securities of such Person subject to repurchase or redemption otherwise than at the sole option of such Person, (g) all obligations secured by a Lien on any asset of such Person, whether or not such obligation is otherwise an obligation of such
Person, (h) “earnouts”, purchase price adjustments, profit sharing arrangements, deferred purchase money amounts and similar payment obligations or continuing obligations of any nature of such Person arising out of purchase and sale
contracts; (i) all Debt of others guarantied by such Person; (j) off-balance sheet liabilities and/or Pension Plan liabilities or Multiemployer Plan liabilities of such Person; (k) obligations arising under non-compete agreements; and
(l) obligations arising under bonus, deferred compensation, incentive compensation or similar arrangements, other than those arising in the Ordinary Course of Business. Without duplication of any of the foregoing, Debt of Borrowers shall
include any and all Loans and Letter of Credit Liabilities. 
 “Default” means any condition or event which with the giving
of notice or lapse of time or both would, unless cured or waived, become an Event of Default. 
 “Defaulted Lender” means,
so long as such failure shall remain in existence and uncured, any Lender which shall have failed to make any Loan or other credit accommodation, disbursement, settlement or reimbursement required pursuant to the terms of any Financing Document.

 “Deposit Account” means a “deposit account” (as defined in Article 9 of the UCC). 
 “Deposit Account Control Agreement” means an agreement, in form and substance satisfactory to Administrative Agent, among Administrative
Agent, any applicable Borrower and each bank or financial institution in which such Borrower maintains a Deposit Account pursuant to which Administrative Agent shall obtain “control” (as defined in Article 9 of the UCC) over such Deposit
Account. 
 “Dollars” or “$” means the lawful currency of the United States of America. 
 “Eligible Accounts” means, subject to the criteria below, an account receivable of a Borrower, which was generated in the Ordinary
Course of Business, which was generated originally in the name of such Borrower and not acquired via assignment or otherwise, and which Administrative Agent, in its good faith credit judgment and discretion, deems to be an Eligible Account. The net
amount of Eligible Accounts at any time shall be (a) the face 

  

 4 

 
amount of such Eligible Accounts as originally billed minus all cash collections and other proceeds of such Account received from or on behalf of the Account
Debtor thereunder as of such date and any and all returns, rebates, discounts (which may, at Administrative Agent’s option, be calculated on shortest terms), credits, allowances or excise taxes of any nature at any time issued, owing, claimed
by Account Debtors, granted, outstanding or payable in connection with such Accounts at such time, and (b) adjusted by applying percentages (known as “liquidity factors”) by payor and/or payor class based upon the applicable
Borrower’s actual recent collection history for each such payor and/or payor class in a manner consistent with Administrative Agent’s underwriting practices and procedures. Such liquidity factors may be adjusted by Administrative Agent
from time to time as warranted by Administrative Agent’s underwriting practices and procedures and using Administrative Agent’s good faith credit judgment. Without limiting the generality of the foregoing, no Account shall be an Eligible
Account if: 
 (a) the Account remains unpaid more than one hundred twenty (120) days past the invoice date (but in no event more than
one hundred fifty (150) days after the applicable goods or services have been rendered or delivered); 
 (b) the Account is subject to
any defense, set-off, recoupment, counterclaim, deduction, discount, credit, chargeback, freight claim, allowance, or adjustment of any kind (but only to the extent of such defense, set-off, recoupment, counterclaim, deduction, discount, credit,
chargeback, freight claim, allowance, or adjustment), or the applicable Borrower is not able to bring suit or otherwise enforce its remedies against the Account Debtor through judicial process; 
 (c) if the Account arises from the sale of goods, any part of any goods the sale of which has given rise to the Account has been returned, rejected,
lost, or damaged (but only to the extent that such goods have been so returned, rejected, lost or damaged); 
 (d) if the Account arises from
the sale of goods, the sale was not an absolute, bona fide sale, or the sale was made on consignment or on approval or on a sale-or-return or bill-and-hold or progress billing basis, or the sale was made subject to any other repurchase or return
agreement, or the goods have not been shipped to the Account Debtor or its designee or the sale was not made in compliance with applicable Laws; 
 (e) if the Account arises from the performance of services, the services have not actually been performed or the services were undertaken in violation of any law or the Account represents a progress billing for which services have not been
fully and completely rendered; 
 (f) the Account is subject to a Lien other than a Permitted Lien, or Administrative Agent does not have a
Lien on such Account; 
 (g) the Account is evidenced by Chattel Paper or an Instrument of any kind, or has been reduced to judgment, unless
Administrative Agent has “control” (as defined in Article 9 of the UCC) over and/or possession of (as applicable depending on whether such asset is tangible or electronic) such Chattel Paper or Instrument; 
 (h) the Account Debtor is an Affiliate or Subsidiary of a Credit Party, or if the Account Debtor holds any Debt of a Credit Party; 
 (i) more than twenty percent (20%) of the aggregate balance of all Accounts owing from the Account Debtor obligated on the Account are ineligible
under subclause (a) above (in which case, all Accounts from such Account Debtor shall be ineligible); 
 (j) without limiting the
provisions of subclause (i) above, fifty percent (50%) or more of the aggregate unpaid Accounts from the Account Debtor obligated on the Account are not deemed Eligible Accounts under this Agreement for any reason; 
 (k) the total unpaid Accounts of the Account Debtor obligated on the Account (other than with respect to Cardinal, McKesson, and AmerisourceBergen)
exceed twenty percent (20%) of the net amount of all Eligible 

  

 5 

 
Accounts owing from all Account Debtors (but only the amount of the Accounts of such Account Debtor exceeding such 20% limitation shall be considered
ineligible); 
 (l) any covenant, representation or warranty contained in the Financing Documents with respect to such Account has been
breached in any respect; 
 (m) the Account is unbilled or has not been invoiced to the Account Debtor in accordance with the procedures and
requirements of the applicable Account Debtor; 
 (n) the Account is an obligation of an Account Debtor that is the federal (or local)
government or a political subdivision thereof, unless Administrative Agent has agreed to the contrary in writing and Administrative Agent has received from the Account Debtor the acknowledgement of Administrative Agent’s notice of assignment of
such obligation pursuant to this Agreement; 
 (o) the Account is an obligation of an Account Debtor that has suspended business, made a
general assignment for the benefit of creditors, is unable to pay its debts as they become due or as to which a petition has been filed (voluntary or involuntary) under any law relating to bankruptcy, insolvency, reorganization or relief of debtors,
or the Account is an Account as to which any facts, events or occurrences exist which could reasonably be expected to impair the validity, enforceability or collectibility of such Account or reduce the amount payable or delay payment thereunder;

 (p) the Account Debtor has its principal place of business or executive office outside the United States 
 (q) the Account is payable in a currency other than United States dollars; 
 (r) the Account Debtor is an individual; 
 (s) the Borrower owning such Account has not signed and delivered
to Administrative Agent notices, in the form requested by Administrative Agent, directing the Account Debtors to make payment to the applicable Lockbox Account; 
 (t) the Account includes late charges or finance charges (but only such portion of the Account shall be ineligible); 
 (u) the Account arises out of the sale of any Inventory upon which any other Person holds, claims or asserts a Lien; or 
 (v) the Account or Account Debtor fails to meet such other specifications and requirements which may from time to time be established by Administrative Agent in its good faith credit judgment and discretion.

 “Eligible Assignee” means (i) a Lender, (ii) an Affiliate of a Lender, (iii) an Approved Fund, and
(iv) any other Person (other than a natural person) approved by (a) Administrative Agent, and (b) unless an Event of Default has occurred and is continuing, Borrower Representative (such approval of Borrower Representative not to be
unreasonably withheld or delayed, and shall be deemed provided unless expressly withheld by Borrower Representative within three (3) Business Days of request therefor); provided that notwithstanding the foregoing,
(x) “Eligible Assignee” shall not include Borrowers or any of Borrowers’ Affiliates or Subsidiaries and (y) no proposed assignee intending to assume all or any portion of the Revolving Loan Commitment shall be an
Eligible Assignee unless such proposed assignee either already holds a portion of such Revolving Loan Commitment, or has been approved as an Eligible Assignee by Administrative Agent. 
 “Eligible Inventory” means Inventory owned by Borrowers and acquired and dispensed by Borrowers in the Ordinary Course of Business that
Administrative Agent, in its good faith credit judgment and discretion, deems to be Eligible Inventory. Without limiting the generality of the foregoing, no Inventory shall be Eligible Inventory if: 
  

 6 

 (a) such Inventory is not owned by Borrowers free and clear of all Liens and rights of any other Person
(including the rights of a purchaser that has made progress payments and the rights of a surety that has issued a bond to assure Borrowers’ performance with respect to that Inventory); 
 (b) such Inventory is placed on consignment or is in transit; 
 (c) such Inventory is covered by a negotiable document of title, unless such document has been delivered to Administrative Agent with all necessary endorsements, free and clear of all Liens except those in favor of
Administrative Agent; 
 (d) such Inventory is excess, obsolete, unsalable, shopworn, seconds, damaged, unfit for sale, unfit for further
processing, is of substandard quality or is not of good and merchantable quality, free from any defects; 
 (e) such Inventory consists of
display items or packing or shipping materials, manufacturing supplies or Work-In-Process; 
 (f) such Inventory is not subject to a first
priority Lien in favor of Administrative Agent; 
 (g) such Inventory consists of goods that can be transported or sold only with licenses
that are not readily available or of any substances defined or designated as hazardous or toxic waste, hazardous or toxic material, hazardous or toxic substance, or similar term, by any environmental law or any Governmental Authority applicable to
Borrowers or their business, operations or assets; 
 (h) such Inventory is not covered by casualty insurance reasonably acceptable to
Administrative Agent; 
 (i) any covenant, representation or warranty contained in the Financing Documents with respect to such Inventory has
been breached; 
 (j) such Inventory is located on premises where the aggregate amount of all Inventory (valued at cost) of Borrowers located
thereon is less than Ten Thousand Dollars ($10,000); 
 (k) such Inventory is located on premises with respect to which Administrative Agent
has not received a landlord, warehouseman, bailee or mortgagee letter acceptable in form and substance to Administrative Agent; 
 (l) such
Inventory consists of (A) discontinued items, (B) slow-moving or excess items held in inventory, or (C) used items held for resale; 
 (m) such Inventory does not consist of finished goods; 
 (n) such Inventory does not meet all standards imposed by any Governmental
Authority, including with respect to its production, acquisition or importation (as the case may be); 
 (o) such Inventory has an expiration
date within the next twelve (12) months; 
 (p) such Inventory consists of products for which Borrowers have a greater than forty-eight
(48) month supply on hand; 
 (q) such Inventory is held for rental or lease by or on behalf of Borrowers; 
 (r) such Inventory is subject to any licensing, patent, royalty, trademark, trade name or copyright agreement with any third parties, which agreement
restricts the ability of Administrative Agent or any Lender to sell or otherwise dispose of such Inventory; or 
  

 7 

 (s) such Inventory fails to meet such other specifications and requirements which may from time to time
be established by Administrative Agent in its good faith credit judgment. Administrative Agent and Borrowers agree that Inventory shall be subject to periodic appraisal by Administrative Agent and that valuation of Inventory shall be subject to
adjustment pursuant to the results of such appraisal. Notwithstanding the foregoing, the valuation of Inventory shall be subject to any legal limitations on sale and transfer of such Inventory. 
 “Environmental Laws” means any and all Laws relating to the environment or the effect of the environment on human health or to
emissions, discharges or releases of pollutants, contaminants, medical wastes, Hazardous Materials or wastes into the environment, including ambient air, surface water, ground water or land, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of pollutants, contaminants, medical wastes, Hazardous Materials or wastes or the clean-up or other remediation thereof. 
 “ERISA” means the Employee Retirement Income Security Act of 1974, as the same may be amended, modified or supplemented from time to
time, and any successor statute thereto, and any and all rules or regulations promulgated from time to time thereunder. 
 “ERISA
Affiliate” shall mean any person required to be aggregated with any Borrower or any of its Subsidiaries under Section 414(b), 414(c), 414(m) or 414(o) of the Code. 
 “ERISA Employee Benefit Plan” means any employee benefit plan within the meaning of Section 3(3) (other than a Pension Plan or a
Multiemployer Plan) which is maintained or otherwise contributed to by any Borrower or any Subsidiary of any Borrower or any other ERISA Affiliate. 
 “Event of Default” has the meaning set forth in Section 10.1. 
 “Excluded Property” has the
meaning set forth in Schedule 9.1. 
 “Financing Documents” means this Agreement, any Notes, the Security
Documents, any fee letter among Merrill Lynch and any of the Borrowers relating to the transactions contemplated hereby, any subordination or intercreditor agreement pursuant to which any Debt and/or any Liens securing such Debt is subordinated to
all or any portion of the Obligations and all other documents, instruments and agreements related to the Obligations and heretofore executed, executed concurrently herewith or executed at any time and from time to time hereafter, as any or all of
the same may be amended, supplemented, restated or otherwise modified from time to time. 
 “GAAP” means generally accepted
accounting principles set forth from time to time in the opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting
Standards Board (or agencies with similar functions of comparable stature and authority within the United States accounting profession), which are applicable to the circumstances as of the date of determination. 
 “Governmental Authority” means any nation or government, any state or other political subdivision thereof, and any agency, department or
Person exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government and any corporation or other Person owned or controlled (through stock or capital ownership or otherwise) by any of the
foregoing, whether domestic or foreign. 
 “Hazardous Materials” means (a) any “hazardous substance” as
defined in CERCLA, (b) any “hazardous waste” as defined by the Resource Conservation and Recovery Act, (c) asbestos, (d) polychlorinated biphenyls, (e) petroleum, its derivatives, by-products and other hydrocarbons,
(f) mold, and (g) any other pollutant, medical waste, toxic, radioactive, caustic or otherwise hazardous substance regulated under Environmental Laws. 
 “Indemnitees” has the meaning set forth in Section 12.15. 
 “Intellectual
Property” means, with respect to any Person, all patents, patent applications and like protections, including improvements, divisions, continuations, continuations in part, renewals, reissues, extensions 

  

 8 

 
and continuations in part of the same, trademarks, trade names, trade styles, trade dress, service marks, logos and other business identifiers and, to the
extent permitted under applicable law, any applications therefore, whether registered or not, and the goodwill of the business of such Person connected with and symbolized thereby, copyright rights, copyright applications, copyright registrations
and like protections in each work of authorship and derivative works, whether published or unpublished, technology, know-how and processes, operating manuals, trade secrets, computer hardware and software, rights to unpatented inventions and all
applications and licenses therefor, used in or necessary for the conduct of business by such Person and all claims for damages by way of any past, present or future infringement of any of the foregoing. 
 “Investment” means any investment in any Person, whether by means of acquiring (whether for cash, property, services, securities or
otherwise) or holding securities, capital contributions, loans, time deposits, advances, guaranties or otherwise. The amount of any Investment shall be the original cost of such Investment plus the cost of all additions thereto, without any
adjustments for increases or decreases in value, or write-ups, write-downs or write-offs with respect thereto. 
 “IP
Proceeds” has the meaning set forth in Schedule 9.1. 
 “Laws” means any and all federal, state,
provincial, territorial, local and foreign statutes, laws, judicial decisions, regulations, guidances, guidelines, ordinances, rules, judgments, orders, decrees, codes, plans, injunctions, permits, concessions, grants, franchises, governmental
agreements and governmental restrictions, whether now or hereafter in effect, which are applicable to any Credit Party in any particular circumstance. “Laws” includes, without limitation, Environmental Laws. 
 “LC Issuer” means one or more banks, trust companies or other Persons in each case expressly identified by Administrative Agent from
time to time, in consultation with Borrowers, as an LC Issuer for purposes of issuing one or more Letters of Credit hereunder. Without limitation of Administrative Agent’s discretion to identify any Person as an LC Issuer, no Person shall be
designated as an LC Issuer unless such Person maintains reporting systems acceptable to Administrative Agent with respect to letter of credit exposure and agrees to provide regular reporting to Administrative Agent satisfactory to it with respect to
such exposure. 
 “Lender” means each of (a) Merrill Lynch, in its capacity as a lender hereunder, (b) each other
Person party hereto in its capacity as a lender hereunder, (c) each other Person that becomes a party hereto as Lender pursuant to Section 12.6, and (d) the respective successors of all of the foregoing, and “Lenders” means
all of the foregoing. 
 “Lender Letter of Credit” means a Letter of Credit issued by an LC Issuer that is also, at the time
of issuance of such Letter of Credit, a Lender. 
 “Letter of Credit” means a standby letter of credit issued for the
account of any Borrower by an LC Issuer which expires by its terms within one year after the date of issuance and in any event at least thirty (30) days prior to the Commitment Expiry Date. Notwithstanding the foregoing, a Letter of Credit may
provide for automatic extensions of its expiry date for one or more successive one (1) year periods provided that the LC Issuer that issued such Letter of Credit has the right to terminate such Letter of Credit on each such annual expiration
date and no renewal term may extend the term of the Letter of Credit to a date that is later than the thirtieth (30th) day prior to the Commitment Expiry Date. 
 “Letter of Credit Liabilities” means, at any time of calculation, the sum of (a) without duplication, the amount then available for drawing under all outstanding Lender Letters of Credit and all
Supported Letters of Credit, in each case without regard to whether any conditions to drawing thereunder can then be met, plus (b) without duplication, the aggregate unpaid amount of all reimbursement obligations in respect of previous
drawings made under all such Lender Letters of Credit and Supported Letters of Credit. 
 “Lien” means, with respect to any
asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind, or any other type of preferential arrangement that has the practical effect of creating a security interest, in respect of such asset. For the purposes of this
Agreement and the other Financing Documents, 

  

 9 

 
any Borrower or any Subsidiary shall be deemed to own subject to a Lien any asset which it has acquired or holds subject to the interest of a vendor or
lessor under any conditional sale agreement, capital lease or other title retention agreement relating to such asset. 
 “Litigation” means any action, suit or proceeding before any court, mediator, arbitrator or Governmental Authority. 
 “Loan(s)” means, the Revolving Loans. 
 “Lockbox” has the meaning set forth in Section 2.11.

 “Lockbox Account” means an account or accounts maintained at the Lockbox Bank into which collections of Accounts are
paid. 
 “Lockbox Bank” has the meaning set forth in Section 2.11. 
 “Material Adverse Effect” means with respect to any event, act, condition or occurrence of whatever nature (including any adverse
determination in any litigation, arbitration, or governmental investigation or proceeding), whether singly or in conjunction with any other event or events, act or acts, condition or conditions, occurrence or occurrences, whether or not related, a
material adverse change in, or a material adverse effect upon, any of (i) the condition (financial or otherwise), operations, business or properties of any of the Credit Parties, (ii) the rights and remedies of Administrative Agent or
Lenders under any Financing Document, or the ability of any Credit Party to perform any of its obligations under any Financing Document to which it is a party, (iii) the legality, validity or enforceability of any Financing Document,
(iv) the existence, perfection or priority of any security interest granted in any Financing Document, or (v) the value of any material Intellectual Property or material Collateral. 
 “Material Contracts” means (a) employment agreements covering the management of any Credit Party, (b) collective bargaining
agreements or other similar labor agreements covering any employees of any Credit Party, (c) agreements for managerial, consulting or similar services to which any Credit Party is a party or by which it is bound, (d) agreements regarding
any Credit Party, its assets or operations or any investment therein to which any of its equityholders is a party or by which it is bound, (e) real estate leases, Intellectual Property licenses, agreements providing for the sale or transfer of
rights to Intellectual Property providing for ongoing royalty or similar payment to the seller or transferor, or other lease or license agreements to which any Credit Party is a party, either as lessor or lessee, or as licensor or licensee (other
than licenses arising from the purchase of “off the shelf” products), or seller/transferor or buyer/transferee, (f) customer, distribution, marketing or supply agreements to which any Credit Party is a party, (g) partnership
agreements to which any Credit Party is a general partner or joint venture agreements to which any Credit Party is a party, (h) third party billing arrangements to which any Credit Party is a party, or (i) any other agreements or
instruments to which any Credit Party is a party, and the breach, nonperformance or cancellation of which, or the failure of which to renew, could reasonably be expected to have a Material Adverse Effect, provided that, in each case with respect to
the preceding clauses (a), (c), (d), (e) and (f) such agreement or contract requires payment of more than One Hundred Fifty Thousand Dollars ($150,000) in any year. 
 “Maximum Lawful Rate” has the meaning set forth in Section 2.7. 
 “Merrill Lynch” means Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services Inc., and its successors.

 “Multiemployer Plan” means a multiemployer plan within the meaning of Section 4001(a)(3) of ERISA. 
 “Non-Funding Lender” means a Lender that has delivered a notice to the Administrative Agent stating that such Lender shall cease making
Revolving Loans due to the non-satisfaction of one or more conditions set forth in Article 7, and specifying any such non-satisfied conditions; provided, however, that any Lender delivering any such notice shall be a Non-Funding Lender solely
over the period commencing on the Business Day following 

  

 10 

 
receipt by Administrative Agent of such notice, and terminating on such date that such Lender has either revoked the effectiveness of such notice or
acknowledged to Administrative Agent the satisfaction of the condition specified in such notice. 
 “Notes” shall have the
meaning set forth in Section 2.3. 
 “Notice of Borrowing” means a notice of a Responsible Officer of Borrower
Representative, appropriately completed and substantially in the form of Exhibit D hereto. 
 “Notice of LC Credit
Event” means a notice from a Responsible Officer of Borrower Representative to Administrative Agent with respect to any issuance, increase or extension of a Letter of Credit specifying: (a) the date of issuance or increase of a Letter
of Credit; (b) the identity of the LC Issuer with respect to such Letter of Credit, (c) the expiry date of such Letter of Credit; (d) the proposed terms of such Letter of Credit, including the face amount; and (e) the
transactions that are to be supported or financed with such Letter of Credit or increase thereof. 
 “Obligations” means all
obligations, liabilities and indebtedness (monetary (including post-petition interest, whether or not allowed) or otherwise) of each Credit Party under this Agreement or any other Financing Document, in each case howsoever created, arising or
evidenced, whether direct or indirect, absolute or contingent, now or hereafter existing, or due or to become due. In addition to, but without duplication of, the foregoing, the Obligations shall include, without limitation, all obligations,
liabilities and indebtedness arising from or in connection with all Support Agreements and all Lender Letters of Credit. 
 “OFAC” means the U.S. Department of Treasury Office of Foreign Assets Control. 
 “OFAC Lists”
means, collectively, the Specially Designated Nationals and Blocked Persons List maintained by OFAC pursuant to Executive Order No. 13224, 66 Fed. Reg. 49079 (Sept. 25, 2001) and/or any other list of terrorists or other restricted Persons
maintained pursuant to any of the rules and regulations of OFAC or pursuant to any other applicable Executive Orders. 
 “Ordinary
Course of Business” means, in respect of any transaction involving any Credit Party, the ordinary course of business of such Credit Party, as conducted by such Credit Party materially in accordance with past practices. 
 “Orderly Liquidation Value” means the net amount (after all costs of sale), expressed in terms of money, which Administrative Agent, in
its good faith discretion, estimates can be realized from a sale, as of a specific date, given a reasonable period to find a purchaser(s), with the seller being compelled to sell on an as-is/where-is basis. 
 “Organizational Documents” means, with respect to any Person other than a natural person, the documents by which such Person was
organized (such as a certificate of incorporation, certificate of limited partnership or articles of organization, and including, without limitation, any certificates of designation for preferred stock or other forms of preferred equity) and which
relate to the internal governance of such Person (such as by-laws, a partnership agreement or an operating, limited liability or members agreement). 
 “Payment Account” means the account specified on the signature pages hereof into which all payments by or on behalf of each Borrower to Administrative Agent under the Financing Documents shall be
made, or such other account as Administrative Agent shall from time to time specify by notice to Borrower Representative. 
 “Payment
Notification” means a written notification substantially in the form of Exhibit E hereto. 
 “Pension
Plan” means an employee pension benefit plan (other than a Multiemployer Plan) which is covered by Title IV of ERISA or subject to the minimum funding standards under Section 412 of the Code. 
 “Permits” means all governmental licenses, authorizations, provider numbers, supplier numbers, registrations, permits, drug or device
authorizations and approvals, certificates, franchises, qualifications, accreditations, consents and approvals required under all applicable Laws and required in order to carry on its 

  

 11 

 
business as now conducted. 
 “Permitted
Acquisitions” means the acquisition of all or substantially all of the assets of another Person, or of a business line or a unit or division of another Person, provided that after giving effect to such acquisition, no Event of Default has
occurred and is continuing or would exist after giving effect to such acquisition, there shall be no decrease in the Borrowers’ tangible net worth after giving effect to such acquisition (as confirmed to Administrative Agent pursuant to a
written certificate from a Responsible Officer of Borrowers) and the aggregate amount of such acquisitions during the term of this Agreement (together with the aggregate amount of all acquisitions permitted under clause (h) of the definition of
Permitted Investments during the term of this Agreement) shall not exceed Five Hundred Thousand Dollars ($500,000). 
 “Permitted
Affiliate” means with respect to any Person (a) any Person that directly or indirectly controls such Person, and (b) any Person which is controlled by or is under common control with such controlling Person. As used in this
definition, the term “control” of a Person means the possession, directly or indirectly, of the power to vote eighty percent (80%) or more of any class of voting securities of such Person or to direct or cause the direction of the
management or policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 
 “Permitted Asset
Dispositions” means the following Asset Dispositions provided that, at the time of such Asset Disposition, no Default or Event of Default exists or would result from such Asset Disposition: (i) dispositions of Inventory in the Ordinary
Course of Business and not pursuant to any bulk sale, (ii) dispositions of furniture, fixtures and equipment in the Ordinary Course of Business that the applicable Borrower or Subsidiary determines in good faith is no longer used or useful in
the business of such Borrower and its Subsidiaries, (iii) the granting of non-exclusive licenses or comparable rights, (iv) the granting of exclusive licenses or comparable rights consistent with the Borrower’s publicly articulated
business strategy, (v) dispositions approved by Administrative Agent and, if the disposition pertains to Intellectual Property or real property Collateral, by Required Lenders; (vi) the sale of the Products listed in Schedule
1.1 attached hereto for fair market value; (vii) the Asset Disposition described in Schedule 5.4 attached hereto; (viii) the sale of cash equivalents for fair market value; (ix) the granting of rights by the
Borrowers under the Intellectual Property Transfer and License Agreement dated May 6, 2002 with Johnson & Johnson Consumer Companies, as amended by the amendments set forth on Schedule 4.4 attached hereto; (x) the
granting of rights by the Borrowers under the Intellectual Property Transfer and License Agreement dated May 6, 2002 with Janssen Pharmaceutical Products LP, as amended by the amendments set forth on Schedule 4.4 attached hereto;
(xi) the Permitted Belgian Subsidiary Payments; and (xii) other Asset Dispositions not to exceed Five Hundred Thousand Dollars ($500,000) in the aggregate after the date hereof. 
 “Permitted Belgian Subsidiary Payments” means transfers of cash by the Principal Borrower to Barrier Belgium in an aggregate amount not
to exceed Six Million Dollars ($6,000,000) in the aggregate in any twelve-month period, provided that such transfers are made in the ordinary course of business for the funding of research and development for the benefit of the Principal Borrower,
and provided that any such transfer shall not be deemed a “Permitted Belgian Subsidiary Payment” if such transfer is made at a time when an Event of Default has occurred and is continuing. 
 “Permitted Contest” means, with respect to any tax obligation or other obligation allegedly or potentially owing from any Borrower to
any governmental tax authority or other third party, a contest maintained in good faith by appropriate proceedings promptly instituted and diligently conducted and with respect to which such reserve or other appropriate provision, if any, as shall
be required in accordance with GAAP shall have been made on the books and records and financial statements of the applicable Borrower(s); provided, however, that (a) compliance with the obligation that is the subject of such contest is
effectively stayed during such challenge; (b) Borrowers’ title to, and its right to use, the Collateral is not adversely affected thereby and Administrative Agent’s Lien and priority on the Collateral are not adversely affected,
altered or impaired thereby; (c) the Collateral or any part thereof or any interest therein shall not be in any danger of being sold, forfeited or lost by reason of such contest by Borrowers; (d) Borrowers have given Administrative Agent
notice of the intent to so contest the obligation and the commencement of such contest and upon request by Administrative Agent, from time to time, notice of the status of such contest by Borrowers and/or confirmation of the continuing satisfaction
of this definition; and (e) upon a final determination of such contest, Borrowers shall promptly comply with the requirements thereof. 
  

 12 

 “Permitted Contingent Obligations” means : (a) Contingent Obligations arising in
respect of the Debt under the Financing Documents and Letter of Credit Liabilities; (b) Contingent Obligations outstanding on the date of this Agreement and set forth on Schedule 5.1 (but not including any refinancings,
extensions, increases or amendments to the indebtedness underlying such Contingent Obligations other than extensions of the maturity thereof without any other change in terms); (c) Contingent Obligations incurred in the Ordinary Course of
Business with respect to surety and appeal bonds, performance bonds and other similar obligations not to exceed One Hundred Fifty Thousand Dollars ($150,000) in the aggregate at any time outstanding and with respect to bonds provided to utilities
with respect to utility services provided to Borrowers in the Ordinary Course of Business; and (d) other Contingent Obligations not permitted by the preceding clauses, not to exceed One Hundred Fifty Thousand Dollars ($150,000) in the aggregate
at any time outstanding. 
 “Permitted Distributions” means the following Restricted Distributions: (a) dividends by
any Subsidiary of any Borrower to such parent Borrower; (b) dividends solely in common stock; and (c) repurchases of stock of former employees, directors or consultants pursuant to stock repurchase agreements so long as an Event of Default
does not exist at the time of such repurchase and would not exist after giving effect to such repurchase, provided that such repurchase does not exceed One Hundred Fifty Thousand Dollars ($150,000) in the aggregate per fiscal year. 
 “Permitted Indebtedness” means: (a) Borrower’s Debt to Administrative Agent and each Lender under this Agreement and the other
Financing Documents; (b) Debt incurred as a result of endorsing negotiable instruments received in the Ordinary Course of Business; (c) purchase money Debt not to exceed Two Million Five Hundred Thousand Dollars ($2,500,000) at any time
(whether in the form of a loan or a lease) used solely to acquire equipment used in the Ordinary Course of Business and secured only by such equipment; (d) Debt existing on the date of this Agreement and described on Schedule 5.1
(but not including any refinancings, extensions, increases or amendments to such Debt other than extensions of the maturity thereof without any other change in terms); (e) Debt, if any, arising under swap agreements or other derivative
instruments; (f) trade accounts payable arising and paid on a timely basis and in the Ordinary Course of Business; (g) Debt in the form of insurance premiums financed through the applicable insurance company; and (h) Subordinated
Debt; (i) severance payments to former employees in the ordinary course of business; and (j) publicly issued convertible Debt with a maturity date not less than five years after the date of the this Agreement, the terms of which
convertible Debt do not include any payment obligations (of principal or otherwise) prior to the maturity date other than payment so accrued interest. 
 “Permitted Investments” means: (a) Investments shown on Schedule 5.5 and existing on the Closing Date; (b) (i) cash equivalents, and (ii) any similar short term
Investments permitted by Borrowers’ investment policy, as amended from time to time, provided that such investment policy (and any such amendment thereto) has been approved in writing by Administrative Agent; (c) Investments consisting of
the endorsement of negotiable instruments for deposit or collection or similar transactions in the Ordinary Course of Business; (d) Investments consisting of travel advances and loans to employees, officers or directors relating to the purchase
of equity securities of Borrowers or their Subsidiaries pursuant to employee stock purchase plans or agreements approved by Borrowers’ Board of Directors (or other governing body), but the aggregate of all such loans outstanding may not exceed
One Hundred Fifty Thousand Dollars ($150,000) at any time; (e) Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in settlement of delinquent obligations of, and
other disputes with, customers or suppliers arising in the Ordinary Course of Business; (f) Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates, in
the Ordinary Course of Business; provided that this subpart (f) shall not apply to Investments of Borrowers in any Subsidiary; (g) Investments consisting of Deposit Accounts or Securities Accounts subject to a Deposit Account Control
Agreement or Securities Account Control Agreement in favor of Administrative Agent or which are otherwise permitted under Section 5.9; (h) Permitted Acquisitions or the formation of new Subsidiaries provided that the Borrowers shall have
complied with Section 5.5(b); (j) the Permitted Belgian Subsidiary Payments; and (k) other Investments in an amount not exceeding One Hundred Fifty Thousand Dollars ($150,000) in the aggregate. 
 “Permitted Liens” means: (a) deposits or pledges of cash to secure obligations under workmen’s compensation, social security
or similar laws, or under unemployment insurance (but excluding Liens arising under ERISA) pertaining to a Borrower’s employees, if any; (b) deposits or pledges of cash to secure bids, tenders, contracts (other than contracts for the
payment of money or the deferred purchase price of property or services), 

  

 13 

 
leases, statutory obligations, surety and appeal bonds and other obligations of like nature arising in the Ordinary Course of Business;
(c) carrier’s, warehousemen’s, mechanic’s, workmen’s, materialmen’s or other like Liens on Collateral, other than Intellectual Property and any Collateral which is part of the Borrowing Base, arising in the Ordinary
Course of Business with respect to obligations which are not due, or which are being contested pursuant to a Permitted Contest; (d) Liens on Collateral, other than Intellectual Property and Accounts, for taxes or other governmental charges not
at the time delinquent or thereafter payable without penalty or the subject of a Permitted Contest; (e) attachments, appeal bonds, judgments and other similar Liens on Collateral other than Intellectual Property, Accounts or Inventory, for sums
not exceeding One Hundred Fifty Thousand Dollars ($150,000) in the aggregate arising in connection with court proceedings; provided, however, that the execution or other enforcement of such Liens is effectively stayed and the claims secured
thereby are the subject of a Permitted Contest; (f) Liens and encumbrances in favor of Administrative Agent under the Financing Documents; (g) Liens on assets, other than Intellectual Property and Accounts, to the extent existing on the
date hereof and set forth on Schedule 5.2; and (h) any Lien on any equipment securing Debt permitted under subpart (c) of the definition of Permitted Indebtedness provided, however, that such Lien attaches concurrently
with or within twenty (20) days after the acquisition thereof; (i) Liens in favor of other financial institutions for customary fees arising in connection with Deposit Accounts or Securities Accounts held by such financial institutions.

 “Permitted Modifications” means (a) such amendments or other modifications to a Borrower’s Organizational
Documents as are required under this Agreement or by applicable Law and fully disclosed to Administrative Agent within thirty (30) days after such amendments or modifications have become effective, (b) such amendments or modifications to a
Borrower’s Organizational Documents (other than those involving a change in the name of a Borrower or involving a reorganization of the Borrower under the laws of a different jurisdiction) that would not adversely affect the rights and
interests of the Administrative Agent or Lenders and fully disclosed to Administrative Agent within thirty (30) days after such amendments or modifications have become effective, and (c) such modifications to the name of a Borrower or
involving a reorganization of the Borrower under the laws of a different jurisdiction so long as the provisions of Section 9.2(a) are fully complied with prior to the effectiveness of such amendments or modifications. 
 “Person” means any natural person, corporation, limited liability company, professional association, limited partnership, general
partnership, joint stock company, joint venture, association, company, trust, bank, trust company, land trust, business trust or other organization, whether or not a legal entity, and any Governmental Authority. 
 “Principal Borrower” means Barrier Therapeutics, Inc., a Delaware corporation. 
 “Pro Rata Share” means (a) with respect to a Lender’s obligation to make Revolving Loans, such Lender’s right to receive
payments of principal and interest with respect thereto, such Lender’s right to receive the unused line fee described in Section 2.2(b), and such Lender’s obligation to share in Letter of Credit Liabilities and to receive the related
Letter of Credit fee described in Section 2.5(b), the Revolving Loan Commitment Percentage of such Lender, and (b) for all other purposes with respect to any Lender, the percentage obtained by dividing (i) the sum of the
Revolving Loan Commitment Amount of such Lender (or, in the event the Revolving Loan Commitment shall have been terminated, such Lender’s then existing Revolving Loan Outstandings), by (ii) the sum of the Revolving Loan Commitment
(or, in the event the Revolving Loan Commitment shall have been terminated, the then existing Revolving Loan Outstandings) of all Lenders 
 “Reimbursement Obligations” means, at any date, the obligations of each Borrower then outstanding to reimburse (a) Administrative Agent for payments made by Administrative Agent under a Support Agreement, and/or
(b) any LC Issuer, for payments made by such LC Issuer under a Lender Letter of Credit. 
 “Required Lenders” means at
any time Lenders holding (a) sixty-six and two thirds percent (66 2/3%) or more of the Revolving Loan Commitment, or (b) if the Revolving Loan Commitment has been terminated, sixty-six and two thirds percent (66 2/3%) or more of the sum of
(x) the then aggregate outstanding principal balance of the Loans plus (y) the then aggregate amount of Letter of Credit Liabilities. 
  

 14 

 “Responsible Officer” means any of the Chief Executive Officer, Chief Financial Officer,
or Vice President of Finance of the applicable Borrower. 
 “Restricted Distribution” means as to any Person (a) any
dividend or other distribution (whether in cash, securities or other property) on any equity interest in such Person (except those payable solely in its equity interests of the same class), (b) any payment on account of (i) the purchase,
redemption, retirement, defeasance, surrender, cancellation, termination or acquisition of any equity interests in such Person or any claim respecting the purchase or sale of any equity interest in such Person or (ii) any option, warrant or
other right to acquire any equity interests in such Person, (c) any management fees, salaries, bonuses or comparable compensation to any Person holding greater than fifteen percent (15%) of the equity interest in a Borrower or a Subsidiary
of a Borrower (other than (A) payments of salaries to individuals, (B) directors fees, (C) the issuance of stock options or restricted stock to employees, consultants and board members, and (D) advances and reimbursements to
employees or directors, all in the Ordinary Course of Business and consistent with past practices), an Affiliate of a Borrower or an Affiliate of any Subsidiary of a Borrower, (d) any lease or rental payments to an Affiliate or Subsidiary of a
Borrower, or (e) repayments of or debt service on loans or other indebtedness held by any Person holding an equity interest in a Borrower or a Subsidiary of a Borrower, an Affiliate of a Borrower or an Affiliate of any Subsidiary of a Borrower
unless permitted under and made pursuant to a Subordination Agreement applicable to such loans or other indebtedness. 
 “Revolving
Lender” means each Lender having a Revolving Loan Commitment Amount in excess of zero (or, in the event the Revolving Loan Commitment shall have been terminated at any time, each Lender at such time having Revolving Loan Outstandings in
excess of zero). 
 “Revolving Loan Availability” means, at any time, the Revolving Loan Limit less the Revolving Loan
Outstandings. 
 “Revolving Loan Borrowing” means a borrowing of a Revolving Loan. 
 “Revolving Loan Commitment” means the sum of each Lender’s Revolving Loan Commitment Amount, which is equal to Twelve Million and
No/100 Dollars ($12,000,000.00). 
 “Revolving Loan Commitment Amount” means, (i) as to any Lender that is a Lender on
the Closing Date, the dollar amount set forth opposite such Lender’s name on the Commitment Annex under the column “Revolving Loan Commitment Amount”, as such amount may be adjusted from time to time by any amounts assigned (with
respect to such Lender’s portion of Revolving Loans outstanding and its commitment to make Revolving Loans) pursuant to the terms of any and all effective Assignment Agreements to which such Lender is a party and (ii) as to any Lender that
becomes a Lender after the Closing Date, the amount of the “Revolving Loan Commitment Amount(s)” of other Lender(s) assigned to such new Lender pursuant to the terms of the effective Assignment Agreement(s) pursuant to which such new
Lender shall become a Lender, as such amount may be adjusted from time to time by any amounts assigned (with respect to such Lender’s portion of Revolving Loans outstanding and its commitment to make Revolving Loans) pursuant to the terms of
any and all effective Assignment Agreements to which such Lender is a party. 
 “Revolving Loan Commitment Percentage”
means, as to any Lender, (a) on the Closing Date, the percentage set forth opposite such Lender’s name on the Commitment Annex under the column “Revolving Loan Commitment Percentage” (if such Lender’s name is not so set
forth thereon, then, on the Closing Date, such percentage for such Lender shall be deemed to be zero), and (b) on any date following the Closing Date, the percentage equal to the Revolving Loan Commitment Amount of such Lender on such date
divided by the Revolving Loan Commitment on such date. 
 “Revolving Loan Limit” means, at any time, the lesser of
(a) the Revolving Loan Commitment and (b) the Borrowing Base. 
 “Revolving Loan Note” means any Note evidencing
any portion of any Revolving Loan. 
  

 15 

 “Revolving Loan Outstandings” means at any time of calculation the sum of the then
existing aggregate outstanding principal amount of Revolving Loans and the then existing Letter of Credit Liabilities. 
 “Revolving
Loans” has the meaning set forth in Section 2.1(a)(i). 
 “SEC” means the United States Securities and
Exchange Commission. 
 “Securities Account” means a “securities account” (as defined in Article 9 of the UCC), an
investment account, or other account in which Investment Property or Securities are held or invested for credit to or for the benefit of any Borrower. 
 “Securities Account Control Agreement” means an agreement, in form and substance satisfactory to Administrative Agent, among Administrative Agent, any applicable Borrower and each securities
intermediary in which such Borrower maintains a Securities Account pursuant to which Administrative Agent shall obtain “control” (as defined in Article 9 of the UCC) over such Securities Account. 
 “Security Document” means this Agreement and any other agreement, document or instrument executed concurrently herewith or at any time
hereafter pursuant to which one or more Credit Parties or any other Person either (a) guaranties payment or performance of all or any portion of the Obligations, and/or (b) provides, as security for all or any portion of the Obligations, a
Lien on any of its assets in favor of Administrative Agent for its own benefit and the benefit of the Lenders, as any or all of the same may be amended, supplemented, restated or otherwise modified from time to time. 
 “Solvent” means, with respect to any Person, that such Person (a) owns and will own assets the fair saleable value of which are
(i) greater than the total amount of its liabilities (including Contingent Obligations) required to be classified upon a balance sheet as liabilities in accordance with GAAP, and (ii) greater than the amount that will be required to pay
the probable liabilities of its then existing debts as they become absolute and matured considering all financing alternatives and potential asset sales reasonably available to it; (b) has capital that is not unreasonably small in relation to
its business as presently conducted or after giving effect to any contemplated transaction; and (c) does not intend to incur and does not believe that it will incur debts beyond its ability to pay such debts as they become due. 
 “Subordinated Debt” means any Debt of Borrowers subject to a Subordination Agreement and incurred with the prior written consent of
Administrative Agent pursuant to the applicable Subordinated Debt Documents related thereto and provided in advance to Administrative Agent, all of which documents must be in form and substance acceptable to Administrative Agent in its sole
discretion. As of the Closing Date, there is no Subordinated Debt. 
 “Subordinated Debt Documents” means, with respect to
any Debt subject to a Subordination Agreement, any and all documents evidencing and/or securing such Debt. As of the Closing Date, there are no Subordinated Debt Documents. 
 “Subordination Agreement” means any agreement between Administrative Agent and another creditor of Borrowers, as the same may be
amended, supplemented, restated or otherwise modified from time to time in accordance with the terms thereof, pursuant to which the Debt owing from any Borrower(s) and/or the Liens securing such Debt granted by any Borrower(s) to such creditor are
subordinated in any way to the Obligations and the Liens created under the Security Documents, the terms and provisions of which such Subordination Agreements have been agreed to by and are acceptable to Administrative Agent in the exercise of its
sole discretion. 
 “Subsidiary” means, with respect to any Person, (a) any corporation of which an aggregate of more
than fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, capital stock of any other class or classes of such
corporation shall have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, owned legally or beneficially by such Person or one or more Subsidiaries of such Person, or with respect to
which any such Person has the right to vote or designate the vote of more than fifty percent (50%) of 

  

 16 

 
such capital stock whether by proxy, agreement, operation of law or otherwise, and (b) any partnership or limited liability company in which such Person
and/or one or more Subsidiaries of such Person shall have an interest (whether in the form of voting or participation in profits or capital contribution) of more than fifty percent (50%) or of which any such Person is a general partner or may
exercise the powers of a general partner. Unless the context otherwise requires, each reference to a Subsidiary shall be a reference to a Subsidiary of a Borrower. 
 “Support Agreement” has the meaning set forth in Section 2.5(a). 
 “Supported
Letter of Credit” means a Letter of Credit issued by an LC Issuer in reliance on one or more Support Agreements. 
 “Taxes” has the meaning set forth in Section 2.8. 
 “Termination Date” means the earlier to
occur of (a) the Commitment Expiry Date, or (b) any date on which Administrative Agent or Required Lenders elect to accelerate the maturity of the Loans or terminate the Revolving Loan Commitment pursuant to Section 10.2. 

“UCC” means the Uniform Commercial Code of the State of New York or of any other state the laws of which are required to be applied
in connection with the perfection of security interests in any Collateral. 
 “United States” means the United States of
America. 
 “Work-In-Process” means Inventory that is not a product that is finished and approved by a Borrower in
accordance with applicable Laws and such Borrower’s normal business practices for release and delivery to customers. 
 Section 1.2 Accounting Terms and Determinations. Accounting terms not defined in this Agreement shall be construed following GAAP, and calculations and determinations must be made following GAAP, in each case, applied on a basis
consistent with the most recent audited financial statements of Principal Borrower delivered to Administrative Agent prior to the Closing Date; provided, however, that if at any time any change in GAAP would affect the computation of any financial
ratio or financial requirement set forth in any Financing Document, and either Borrowers, the Administrative Agent or the Required Lenders shall so request, the Administrative Agent and Borrowers shall negotiate in good faith to amend such ratio or
requirement to preserve the original intent thereof in light of such change in GAAP (subject to the approval of the Required Lenders). 
 Section 1.3 Other Definitional Provisions. References in this Agreement to “Articles”, “Sections”, “Annexes”, “Exhibits” or “Schedules” shall be to Articles, Sections, Annexes,
Exhibits or Schedules of or to this Agreement unless otherwise specifically provided. Any term defined herein may be used in the singular or plural. “Include”, “includes” and “including” shall be deemed to be followed
by “without limitation”. Except as otherwise specified or limited herein, references to any Person include the successors and assigns of such Person. References “from” or “through” any date mean, unless otherwise
specified, “from and including” or “through and including”, respectively. References to any statute or act shall include all related current regulations and all amendments and any successor statutes, acts and regulations.
References to any statute or act, without additional reference, shall be deemed to refer to federal statutes and acts of the United States. References to any agreement, instrument or document shall include all schedules, exhibits, annexes and other
attachments thereto. As used in this Agreement, the meaning of the term “material” or the phrase “in all material respects” is intended to refer to an act, omission, violation or condition which reflects or could reasonably be
expected to result in a Material Adverse Effect. References to capitalized terms that are not defined herein, but are defined in the UCC, shall have the meanings given them in the UCC. All Riders attached hereto are hereby incorporated herein by
this reference and made a part hereof. Headings and captions used in the Financing Documents (including the Exhibits, Schedules and Annexes hereto and thereto) are included for convenience of reference only and shall not be given any substantive
effect. 
 ARTICLE 2 – LOANS AND LETTERS OF CREDIT 
  

 17 

 Section 2.1 Loans. 
 (a) Revolving Loans. 
 (i) Revolving
Loans and Borrowings. On the terms and subject to the conditions set forth herein, each Lender severally agrees to make Loans to Borrowers from time to time as set forth herein (each a “Revolving Loan”, and collectively,
“Revolving Loans”) equal to such Lender’s Revolving Loan Commitment Percentage of Revolving Loans requested by Borrowers hereunder, provided, however, that after giving effect thereto, the Revolving Loan Outstandings shall not
exceed the Revolving Loan Limit. Borrowers may prepay or repay Revolving Loans without reduction in the Revolving Loan Commitment from time to time and may reborrow Revolving Loans pursuant to this Section 2.1(a). Borrowers shall deliver to
Administrative Agent a Notice of Borrowing with respect to each proposed Revolving Loan Borrowing, such Notice of Borrowing to be delivered no later than noon (Chicago time) two (2) Business Days prior to such proposed borrowing. Each Borrower
and each Revolving Lender hereby authorizes Administrative Agent to make Revolving Loans on behalf of Revolving Lenders, at any time in its sole discretion, (A) as provided in Section 2.5(c), with respect to obligations arising under
Support Agreements and/or Lender Letters of Credit, and (B) to pay principal owing in respect of the Loans and interest, fees, expenses and other charges of any Credit Party from time to time arising under this Agreement or any other Financing
Document. The Borrowing Base shall be determined by Administrative Agent based on the most recent Borrowing Base Certificate delivered to Administrative Agent in accordance with this Agreement and such other information as may be available to
Administrative Agent. Without limiting any other rights and remedies of Administrative Agent hereunder or under the other Financing Documents, the Revolving Loans shall be subject to Administrative Agent’s continuing right to withhold from the
Borrowing Base reserves, and to increase and decrease such reserves from time to time, if and to the extent that in Administrative Agent’s good faith credit judgment and discretion, such reserves are necessary. 
 (ii) Mandatory Revolving Loan Repayments and Prepayments. 
 (A) The Revolving Loan Commitment shall terminate on the Termination Date. On such Termination Date, there shall become due, and Borrowers shall pay, the entire outstanding principal amount of each Revolving Loan,
together with accrued and unpaid interest thereon. 
 (B) If at any time the Revolving Loan Outstandings exceed the Revolving Loan Limit,
then, on the next succeeding Business Day, Borrowers shall repay the Revolving Loans or cash collateralize Letter of Credit Liabilities in the manner specified in Section 2.5(e) or cancel outstanding Letters of Credit, or any combination of the
foregoing, in an aggregate amount equal to such excess. 
 (C) Principal payable on account of Revolving Loans shall be payable by Borrowers
to Administrative Agent (A) immediately upon the receipt by any Borrower or Administrative Agent of any payments on or proceeds from any of the Accounts, to the extent of such payments or proceeds, and (B) in full on the Termination Date.

 (iii) Optional Prepayments. Borrowers may from time to time prepay the Revolving Loans in whole or in part; provided,
however, that any such partial prepayment shall be in an amount equal to One Hundred Thousand Dollars ($100,000) or a higher integral multiple of Twenty Five Thousand Dollars ($25,000). 
 Section 2.2 Interest, Interest Calculations and Certain Fees. 
 (a) Interest. From and following the Closing Date, the Loans and the other Obligations shall bear interest at the sum of the Base Rate plus the applicable Base Rate Margin, subject to the provisions of
Section 10.4 below regarding default rates of interest. Interest on the Loans shall be paid in arrears on the first (1st) day of each month and on the Termination Date. Interest on all other Obligations shall be payable on demand and on
the Termination Date. All interest accruing on and after the Termination Date shall be immediately due and payable as it accrues. For purposes of calculating interest, all funds transferred from the Payment Account for application to any Revolving
Loans shall be subject to a three (3) Business Day clearance period. 
  

 18 

 (b) Unused Line Fee. From and following the Closing Date, Borrowers shall pay Administrative
Agent, for the benefit of all Lenders committed to make Revolving Loans, in accordance with their respective Pro Rata Shares, a fee in an amount equal to (i) (A) the Revolving Loan Commitment minus (B) the average daily balance
of the sum of the Revolving Loan Outstandings during the preceding month, multiplied by (ii) one half of one percent (0.50%) per annum. Such fee is to be paid monthly in arrears on the first day of each month. 
 (c) Collateral Fee. From and following the Closing Date, Borrowers shall pay Administrative Agent, for its own account and not for the benefit of
any other Lenders, a fee in an amount equal to (i) the average daily balance of the sum of the Revolving Loan Outstandings during the preceding month, multiplied by (ii) one percent (1.0%) per annum. Such fee is to be paid
monthly in arrears on the first day of each month. 
 (d) Commitment Fee.
Borrowers shall pay Administrative Agent, for the benefit of all Lenders committed to make Revolving Loans on the Closing Date, in accordance with their respective Pro Rata Shares, a fee in an amount equal to (i) the Revolving Loan Commitment,
multiplied by (ii) one percent (1.0%), which commitment fee shall be due and payable on the first (1st) anniversary of the Closing Date.

 (e) Deferred Revolving Loan Commitment Fee. If Lenders’ funding obligations in respect of the Revolving Loan Commitment
under this Agreement terminate for any reason (whether by voluntary termination by Borrowers, by reason of the occurrence of an Event of Default or otherwise) prior to the Commitment Expiry Date, Borrowers shall pay to Administrative Agent, for the
benefit of all Lenders committed to make Revolving Loans on the Closing Date, a fee as compensation for the costs of such Lenders being prepared to make funds available to Borrowers under this Agreement, equal to an amount determined by
multiplying the Revolving Loan Commitment by the following applicable percentage amount: three percent (3.0%) for the first year following the Closing Date, and two percent (2.0%) thereafter. All fees payable pursuant to this
paragraph shall be deemed fully earned and non-refundable as of the Closing Date. 
 (f) Audit Fees. Borrowers shall pay to Administrative Agent, for its own account and not for the benefit of any other Lenders, all reasonable fees and expenses in connection with audits and inspections of Borrowers’ books and
records, audits, valuations or appraisals of the Collateral, audits of Borrowers’ compliance with applicable Laws and such other matters as Administrative Agent shall deem appropriate, which shall be due and payable on the later of (i) the
first Business Day of the month following the date of issuance by Administrative Agent of a written request for payment thereof to Borrowers, or (ii) the tenth (10th) day following the issuance of such notice; provided, that so long as no Event of Default or Default has occurred, Borrowers shall be liable for such fees and expenses for no more than four (4) such audits
in any given calendar year. 
 (g) Wire Fees. Borrowers shall pay to Administrative Agent, for its own account and not for the
account of any other Lenders, on written demand, any and all fees, costs or expenses which Administrative Agent pays to a bank or other similar institution (including, without limitation, any fees paid by Administrative Agent to any other Lender)
arising out of or in connection with (i) the forwarding to Borrowers or any other Person on behalf of Borrowers, by Administrative Agent, of proceeds of the Loans made by any Lender to Borrowers pursuant to this Agreement, and (ii) the
depositing for collection, by Administrative Agent, of any check or item of payment received or delivered to Administrative Agent on account of Obligations. 
 (h) Late Charges. If payments of principal (other than a final installment of principal upon the Termination Date), interest due on the Obligations, or any other amounts due hereunder or under the other
Financing Documents are not timely made and remain overdue for a period of five (5) days, Borrowers, without notice or demand by Administrative Agent, promptly shall pay to Administrative Agent, for the benefit of the Lenders according to their
Pro Rata Shares, as additional compensation in administering the Obligations, an amount equal to five percent (5.0%) of each delinquent payment. 
 (i) Computation of Interest and Related Fees. All interest and fees under each Financing Document shall be calculated on the basis of a 360-day year for the actual number of days elapsed. The date of funding of
a Loan shall be included in the calculation of interest. The date of payment of a Loan shall be excluded from the calculation of interest. If a Loan is repaid on the same day that it is made, one (1) day’s interest shall be charged.

  

 19 

 Section 2.3 Notes. The portion of the Loans made by each Lender shall be evidenced, if so
requested by such Lender, by one or more promissory notes executed by Borrowers on a joint and several basis (each, a “Note”) in an original principal amount equal to such Lender’s Revolving Loan Commitment. 
 Section 2.4 [RESERVED] 
 Section 2.5 Letters of Credit and Letter of Credit Fees. 
 (a) Letter of Credit. On the terms and subject to the
conditions set forth herein, the Revolving Loan Commitment may be used by Borrowers, in addition to the making of Revolving Loans hereunder, for the issuance, prior to that date which is thirty (30) days prior to the Termination Date, by
(i) Administrative Agent, of letters of credit, guaranties or other agreements or arrangements (each, a “Support Agreement”) to induce an LC Issuer to issue or increase the amount of, or extend the expiry date of, one or more
Letters of Credit and (ii) a Lender, identified by Administrative Agent, as an LC Issuer, of one or more Lender Letters of Credit, so long as, in each case: 
 (i) Administrative Agent shall have received a Notice of LC Credit Event at least five (5) Business Days before the relevant date of issuance, increase or extension; and 
 (ii) after giving effect to such issuance, increase or extension, (A) the aggregate Letter of Credit Liabilities under all Letters of Credit do not
exceed One Million Dollars ($1,000,000), and (B) the Revolving Loan Outstandings do not exceed the Revolving Loan Limit. 
 Nothing in
this Agreement shall be construed to obligate any Lender to issue, increase the amount of or extend the expiry date of any letter of credit, which act or acts, if any, shall be subject to agreements to be entered into from time to time between
Borrowers and such Lender. Each Lender that is an LC Issuer hereby agrees to give Administrative Agent prompt written notice of each issuance of a Lender Letter of Credit by such Lender and each payment made by such Lender in respect of Lender
Letters of Credit issued by such Lender. 
 (b) Letter of Credit Fee. Borrowers shall pay to Administrative Agent, for the benefit of
the Revolving Lenders in accordance with their respective Pro Rata Shares, a letter of credit fee with respect to the Letter of Credit Liabilities for each Letter of Credit, computed for each day from the date of issuance of such Letter of Credit to
the date that is the last day a drawing is available under such Letter of Credit, at a rate per annum equal to the Base Rate Margin then applicable to Revolving Loans. Such fee shall be payable in arrears on the last day of each calendar month prior
to the Termination Date and on such date. In addition, Borrowers agree to pay promptly to the LC Issuer any customary fronting or other fees that it may charge in connection with any Letter of Credit. 
 (c) Reimbursement Obligations of Borrowers. If either (i) Administrative Agent shall make a payment to an LC Issuer pursuant to a Support
Agreement, or (ii) any Lender shall honor any draw request under, and make payment in respect of, a Lender Letter of Credit, (A) the applicable Borrower shall reimburse Administrative Agent or such Lender, as applicable, for the amount of
such payment by the end of the day on which Administrative Agent or such Lender shall make such payment and (B) Borrowers shall be deemed to have immediately requested that Revolving Lenders make a Revolving Loan, in a principal amount equal to
the amount of such payment (but solely to the extent such Borrower shall have failed to directly reimburse Administrative Agent or, with respect to Lender Letters of Credit, the applicable LC Issuer, for the amount of such payment). Administrative
Agent shall promptly notify Revolving Lenders of any such deemed request and each Revolving Lender (other than any such Revolving Lender that was a Non-Funding Lender at the time the applicable Supported Letter of Credit or Lender Letter of Credit
was issued) hereby agrees to make available to Administrative Agent not later than noon (Chicago time) on the Business Day following such notification from Administrative Agent such Revolving Lender’s Pro Rata Share of such Revolving Loan. Each
Revolving Lender (other than any applicable Non-Funding Lender specified above) hereby absolutely and unconditionally agrees to fund such Revolving Lender’s Pro Rata Share of the Loan described in the immediately preceding sentence, unaffected
by any circumstance whatsoever, including, without limitation, (x) the occurrence and continuance of a Default or Event of Default, (y) the fact that, whether before or after giving effect to the making of any such Revolving Loan, the
Revolving Loan Outstandings exceed or will exceed the Revolving Loan Limit, and/or (z) the non-satisfaction of 

  

 20 

 
any conditions set forth in Section 7.2. Administrative Agent hereby agrees to apply the gross proceeds of each Revolving Loan deemed made pursuant to
this Section 2.5(c) in satisfaction of Borrowers’ reimbursement obligations arising pursuant to this Section 2.5(c). Borrowers shall pay interest, on demand, on all amounts so paid by Administrative Agent pursuant to any Support
Agreement or to any applicable Lender in honoring a draw request under any Lender Letter of Credit for each day from the date of such payment until Borrowers reimburse Administrative Agent or the applicable Lender therefore (whether pursuant to
clause (A) or (B) of the first sentence of this subsection (c)) at a rate per annum equal to the sum of two percent (2%) plus the interest rate applicable to Revolving Loans for such day. 
 (d) Reimbursement and Other Payments by Borrowers. The obligations of each Borrower to reimburse Administrative Agent and/or the applicable LC
Issuer pursuant to Section 2.5(c) shall be absolute, unconditional and irrevocable, and shall be performed strictly in accordance with the terms of this Agreement, under all circumstances whatsoever, including the following: 
 (i) any lack of validity or enforceability of, or any amendment or waiver of or any consent to departure from, any Letter of Credit or any related
document; 
 (ii) the existence of any claim, set-off, defense or other right which any Borrower may have at any time against the beneficiary
of any Letter of Credit, the LC Issuer (including any claim for improper payment), Administrative Agent, any Lender or any other Person, whether in connection with any Financing Document or any unrelated transaction, provided, however, that
nothing herein shall prevent the assertion of any such claim by separate suit or compulsory counterclaim; 
 (iii) any statement or any other
document presented under any Letter of Credit proving to be forged, fraudulent, invalid or insufficient in any respect or any statement therein being untrue or inaccurate in any respect whatsoever; 
 (iv) any affiliation between the LC Issuer and Administrative Agent; or 
 (v) to the extent permitted under applicable law, any other circumstance or happening whatsoever, whether or not similar to any of the foregoing. 
 (e) Deposit Obligations of Borrowers. In the event any Letters of Credit are outstanding at the time that Borrowers prepay or are required to
repay the Obligations or the Revolving Loan Commitment is terminated, Borrowers shall (i) deposit with Administrative Agent for the benefit of all Revolving Lenders cash in an amount equal to one hundred and five percent (105%) of the
aggregate outstanding Letter of Credit Liabilities to be available to Administrative Agent, for its benefit and the benefit of issuers of Letters of Credit, to reimburse payments of drafts drawn under such Letters of Credit and pay any fees and
expenses related thereto, and (ii) prepay the fee payable under Section 2.5(b) with respect to such Letters of Credit for the full remaining terms of such Letters of Credit assuming that the full amount of such Letters of Credit as of the
date of such repayment or termination remain outstanding until the end of such remaining terms. Upon termination of any such Letter of Credit and provided no Event of Default has occurred and is continuing, the unearned portion of such prepaid fee
attributable to such Letter of Credit shall be refunded to Borrowers, together with the deposit described in the preceding clause (i) to the extent not previously applied by Administrative Agent in the manner described herein. 
 (f) Participations in Support Agreements and Lender Letters of Credit. 
 (i) Concurrently with the issuance of each Supported Letter of Credit, Administrative Agent shall be deemed to have sold and transferred to each Revolving
Lender (other than any Non-Funding Lenders at the time of such issuance), and each such Revolving Lender shall be deemed irrevocably and immediately to have purchased and received from Administrative Agent, without recourse or warranty, an undivided
interest and participation in, to the extent of such Lender’s Pro Rata Share of the Revolving Loan Commitment, Administrative Agent’s Support Agreement liabilities and obligations in respect of such Supported Letter of Credit and
Borrowers’ Reimbursement Obligations with respect thereto. Concurrently with the issuance of each Lender Letter of Credit, the LC Issuer in respect thereof shall be deemed to have sold and transferred to each Revolving Lender (other than

  

 21 

 
any Non-Funding Lenders at the time of such issuance), and each such Revolving Lender shall be deemed irrevocably and immediately to have purchased and
received from such LC Issuer, without recourse or warranty, an undivided interest and participation in, to the extent of such Lender’s Pro Rata Share of the Revolving Loan Commitment, such Lender Letter of Credit and Borrowers’
Reimbursement Obligations with respect thereto. Any purchase obligation arising pursuant to the immediately two preceding sentences shall be absolute and unconditional and shall not be affected by any circumstances whatsoever. 
 (ii) If either (x) Administrative Agent makes any payment or disbursement under any Support Agreement and/or (y) an LC Issuer makes any payment
or disbursement under any Lender Letter of Credit, and (A) Borrowers have not reimbursed Administrative Agent or the applicable LC Issuer, as applicable, in full for such payment or disbursement in accordance with Section 2.5(c), or
(B) any reimbursement under any Support Agreement or Lender Letter of Credit received by Administrative Agent or any LC Issuer, as applicable, from Borrowers is or must be returned or rescinded upon or during any bankruptcy or reorganization of
any Credit Party or otherwise, each Revolving Lender (other than any Revolving Lender that was a Non-Funding Lender at the time of the issuance of such Supported Letter of Credit or Lender Letter of Credit) shall be irrevocably and unconditionally
obligated to pay to Administrative Agent or the applicable LC Issuer, as applicable, its Pro Rata Share of such payment or disbursement (but no such payment shall diminish the Obligations of Borrowers under Section 2.5(c)). To the extent any
such Revolving Lender shall not have made such amount available to Administrative Agent or the applicable LC Issuer, as applicable, by noon (Chicago time) on the Business Day on which such Lender receives notice from Administrative Agent or the
applicable LC Issuer, as applicable, of such payment or disbursement, or return or rescission, as applicable, such Lender agrees to pay interest on such amount to Administrative Agent or the applicable LC Issuer, as applicable, forthwith on demand
accruing daily at the Federal Funds Rate, for the first three (3) days following such Lender’s receipt of such notice, and thereafter at the Base Rate plus the Base Rate Margin in respect of Revolving Loans. Any Revolving Lender’s
failure to make available to Administrative Agent or the applicable LC Issuer, as applicable, its Pro Rata Share of any such payment or disbursement, or return or rescission, as applicable, shall not relieve any other Lender of its obligation
hereunder to make available such other Revolving Lender’s Pro Rata Share of such payment, but no Revolving Lender shall be responsible for the failure of any other Lender to make available such other Lender’s Pro Rata Share of any such
payment or disbursement, or return or rescission. 
 Section 2.6 General Provisions Regarding Payment; Loan Account. 

(a) All payments to be made by each Borrower under any Financing Document, including payments of principal and interest made hereunder and pursuant to
any other Financing Document, and all fees, expenses, indemnities and reimbursements, shall be made without set-off, recoupment or counterclaim, in lawful money of the United States and in immediately available funds. If any payment hereunder
becomes due and payable on a day other than a Business Day, such payment shall be extended to the next succeeding Business Day and, with respect to payments of principal, interest thereon shall be payable at the then applicable rate during such
extension (it being understood and agreed that, solely for purposes of calculating financial covenants and computations contained herein and determining compliance therewith, if payment is made, in full, on any such extended due date, such payment
shall be deemed to have been paid on the original due date without giving effect to any extension thereto). Any payments received in the Payment Account before noon (Chicago time) on any date shall be deemed received by Administrative Agent on such
date, and any payments received in the Payment Account after noon (Chicago time) on any date shall be deemed received by Administrative Agent on the next succeeding Business Day. Unless otherwise specified herein, the settlement of all payments and
fundings hereunder between or among the parties hereto shall be made in lawful money of the United States and in immediately available funds. 
 (b) Administrative Agent shall endeavor to provide Borrowers with a monthly statement regarding the Loans hereunder (but neither Administrative Agent nor any Lender shall have any liability if Administrative Agent shall fail to provide any
such statement). Unless any Borrower notifies Administrative Agent of any objection to any such statement (specifically describing the basis for such objection) within ninety (90) days after the date of receipt thereof, it shall be deemed
final, binding and conclusive upon Borrowers in all respects as to all matters reflected therein, absent manifest error. 
  

 22 

 Section 2.7 Maximum Interest. In no event shall the interest charged with respect to the
Loans or any other Obligations of any Borrower under any Financing Document exceed the maximum amount permitted under the laws of the State of New York or of any other applicable jurisdiction. Notwithstanding anything to the contrary herein or
elsewhere, if at any time the rate of interest payable hereunder or under any Note or other Financing Document (the “Stated Rate”) would exceed the highest rate of interest permitted under any applicable law to be charged (the
“Maximum Lawful Rate”), then for so long as the Maximum Lawful Rate would be so exceeded, the rate of interest payable shall be equal to the Maximum Lawful Rate; provided, however, that if at any time thereafter the Stated
Rate is less than the Maximum Lawful Rate, each Borrower shall, to the extent permitted by law, continue to pay interest at the Maximum Lawful Rate until such time as the total interest received is equal to the total interest which would have been
received had the Stated Rate been (but for the operation of this provision) the interest rate payable. Thereafter, the interest rate payable shall be the Stated Rate unless and until the Stated Rate again would exceed the Maximum Lawful Rate, in
which event this provision shall again apply. In no event shall the total interest received by any Lender exceed the amount which it could lawfully have received had the interest been calculated for the full term hereof at the Maximum Lawful Rate.
If, notwithstanding the prior sentence, any Lender has received interest hereunder in excess of the Maximum Lawful Rate, such excess amount shall be applied to the reduction of the principal balance of the Loans or to other amounts (other than
interest) payable hereunder, and if no such principal or other amounts are then outstanding, such excess or part thereof remaining shall be paid to Borrowers. Any such reduction in the principal balance shall be applied to the Obligations owing to
Lenders in accordance with the Pro Rata Share of each Lender. In computing interest payable with reference to the Maximum Lawful Rate applicable to any Lender, such interest shall be calculated at a daily rate equal to the Maximum Lawful Rate
divided by the number of days in the year in which such calculation is made. 
 Section 2.8 Taxes; Capital Adequacy.

 (a) All payments of principal and interest on the Loans and all other amounts payable hereunder shall be made free and clear of and
without deduction for any present or future income, excise, stamp, documentary, payroll, employment, property or franchise taxes and other taxes, fees, duties, levies, assessments, withholdings or other charges of any nature whatsoever (including
interest and penalties thereon) imposed by any taxing authority, excluding taxes imposed on or measured by Administrative Agent’s or any Lender’s net income by the jurisdictions under which Administrative Agent or such Lender is organized
or conducts business (other than solely as the result of entering into any of the Financing Documents or taking any action thereunder) (all non-excluded items being called “Taxes”). If any withholding or deduction from any payment
to be made by any Borrower hereunder is required in respect of any Taxes pursuant to any applicable Law, then Borrowers will: (i) pay directly to the relevant authority the full amount required to be so withheld or deducted; (ii) promptly
forward to Administrative Agent an official receipt or other documentation satisfactory to Administrative Agent evidencing such payment to such authority; and (iii) pay to Administrative Agent for the account of Administrative Agent and Lenders
such additional amount or amounts as is necessary to ensure that the net amount actually received by Administrative Agent and each Lender will equal the full amount Administrative Agent and such Lender would have received had no such withholding or
deduction been required. If any Taxes are directly asserted against Administrative Agent or any Lender with respect to any payment received by Administrative Agent or such Lender hereunder, Administrative Agent or such Lender may pay such Taxes and
upon written demand by Administrative Agent (which shall be accompanied by a statement setting forth the basis for such a demand and the calculation of the amount due) Borrowers will promptly pay such additional amounts (including any penalty,
interest or expense) as is necessary in order that the net amount received by such Person after the payment of such Taxes (including any Taxes on such additional amount) shall equal the amount such Person would have received had such Taxes not been
asserted so long as such amounts have accrued on or after the day which is two hundred seventy (270) days prior to the date on which Administrative Agent or such Lender first made written demand therefor. 
 (b) If any Borrower fails to pay any Taxes when due to the appropriate taxing authority or fails to remit to Administrative Agent, for the account of
Administrative Agent and the respective Lenders, the required receipts or other required documentary evidence, Borrowers shall indemnify Administrative Agent and Lenders for any incremental Taxes, interest or penalties that may become payable by
Administrative Agent or any Lender as a result of any such failure. 
  

 23 

 (c) Each Lender that (i) is organized under the laws of a jurisdiction other than the United States,
and (ii)(A) is a party hereto on the Closing Date or (B) purports to become an assignee of an interest as a Lender under this Agreement after the Closing Date (unless such Lender was already a Lender hereunder immediately prior to such
assignment) (each such Lender a “Foreign Lender”) shall execute and deliver to each of Borrowers and Administrative Agent one or more (as Borrowers or Administrative Agent may reasonably request) United States Internal Revenue
Service Forms W-8ECI, W-8BEN, W-8IMY (as applicable) and other applicable forms, certificates or documents prescribed by the United States Internal Revenue Service or reasonably requested by Administrative Agent certifying as to such Lender’s
entitlement to a complete exemption from withholding or deduction of Taxes. Borrowers shall not be required to pay additional amounts to any Lender pursuant to this Section 2.8 with respect to United States withholding and income Taxes to the
extent that the obligation to pay such additional amounts would not have arisen but for the failure of such Lender to comply with this paragraph other than as a result of a change in law. 
 (d) If any Lender shall determine in its commercially reasonable judgment that the adoption or taking effect of, or any change in, any applicable Law
regarding capital adequacy, in each instance, after the Closing Date, or any change after the Closing Date in the interpretation, administration or application thereof by any Governmental Authority, central bank or comparable agency charged with the
interpretation, administration or application thereof, or the compliance by any Lender or any Person controlling such Lender with any request, guideline or directive regarding capital adequacy (whether or not having the force of law) of any such
Governmental Authority, central bank or comparable agency adopted or otherwise taking effect after the Closing Date, has or would have the effect of reducing the rate of return on such Lender’s or such controlling Person’s capital as a
consequence of such Lender’s obligations hereunder or under any Support Agreement or Lender Letter of Credit to a level below that which such Lender or such controlling Person could have achieved but for such adoption, taking effect, change,
interpretation, administration, application or compliance (taking into consideration such Lender’s or such controlling Person’s policies with respect to capital adequacy) then from time to time, upon written demand by such Lender (which
demand shall be accompanied by a statement setting forth the basis for such demand and a calculation of the amount thereof in reasonable detail, a copy of which shall be furnished to Administrative Agent), Borrowers shall promptly pay to such Lender
such additional amount as will compensate such Lender or such controlling Person for such reduction, so long as such amounts have accrued on or after the day which is two hundred seventy (270) days prior to the date on which such Lender first
made demand therefor. 
 Section 2.9 Appointment of Borrower Representative. Each Borrower hereby designates Borrower
Representative as its representative and agent on its behalf for the purposes of giving instructions with respect to and receiving the disbursement of the proceeds of the Loans, requesting Letters of Credit giving and receiving all other notices and
consents hereunder or under any of the other Financing Documents and taking all other actions (including in respect of compliance with covenants) on behalf of any Borrower or Borrowers under the Financing Documents. Borrower Representative hereby
accepts such appointment. Notwithstanding anything to the contrary contained in this Agreement, no Borrower other than Borrower Representative shall be entitled to take any of the foregoing actions. The proceeds of each Loan made hereunder shall be
advanced to or at the direction of Borrower Representative and if not used by Borrower Representative in its business (for the purposes provided in this Agreement) shall be deemed to be immediately advanced by Borrower Representative to the
appropriate other Borrower hereunder as an intercompany loan (collectively, “Intercompany Loans”). All Letters of Credit and Support Agreements issued hereunder shall be issued at Borrower Representative’s request therefor and
shall be allocated to the appropriate Borrower’s Intercompany Loan account by Borrower Representative. All collections of each Borrower in respect of Accounts and other proceeds of Collateral of each Borrower received by Administrative Agent
and applied to the Obligations shall be deemed to be repayments of the Intercompany Loans owing by such Borrower to Borrower Representative. Borrowers shall maintain accurate books and records with respect to all Intercompany Loans and all
repayments thereof. Administrative Agent and each Lender may regard any notice or other communication pursuant to any Financing Document from Borrower Representative as a notice or communication from all Borrowers, and may give any notice or
communication required or permitted to be given to any Borrower or all Borrowers hereunder to Borrower Representative on behalf of such Borrower or all Borrowers. Each Borrower agrees that each notice, election, representation and warranty,
covenant, agreement and undertaking made on its behalf by Borrower Representative shall be deemed for all purposes to have been made by such Borrower and shall be binding upon and enforceable against such Borrower to the same extent as if the same
had been made directly by such Borrower. 
  

 24 

 Section 2.10 Joint and Several Liability. Borrowers are defined collectively to include all
Persons named as one of the Borrowers herein; provided, however, that any references herein to “any Borrower”, “each Borrower” or similar references, shall be construed as a reference to each individual Person named as one of the
Borrowers herein. Each Person so named shall be jointly and severally liable for all of the obligations of Borrowers under this Agreement. Each Borrower, individually, expressly understands, agrees and acknowledges, that the credit facilities would
not be made available on the terms herein in the absence of the collective credit of all of the Persons named as the Borrowers herein, the joint and several liability of all such Persons, and the cross-collateralization of the collateral of all such
Persons. Accordingly, each Borrower, individually acknowledges that the benefit to each of the Persons named as one of the Borrowers as a whole constitutes reasonably equivalent value, regardless of the amount of the credit facilities actually
borrowed by, advanced to, or the amount of collateral provided by, any individual Borrower. In addition, each entity named as one of the Borrowers herein hereby acknowledges and agrees that all of the representations, warranties, covenants,
obligations, conditions, agreements and other terms contained in this Agreement shall be applicable to and shall be binding upon and measured and enforceable individually against each Person named as one of the Borrowers herein as well as all such
Persons when taken together. By way of illustration, but without limiting the generality of the foregoing, the terms of Section 10.1 of this Agreement are to be applied to each individual Person named as one of the Borrowers herein (as well as
to all such Persons taken as a whole), such that the occurrence of any of the events described in Section 10.1 of this Agreement as to any Person named as one of the Borrowers herein shall constitute an Event of Default even if such event has
not occurred as to any other Persons named as the Borrowers or as to all such Persons taken as a whole. 
 Section 2.11 Collections
and Lockbox Account. 
 (a) Borrowers shall maintain a lockbox (the “Lockbox”) with a United States depository
institution designated from time to time by Administrative Agent and reasonably approved by Borrower (the “Lockbox Bank”), subject to the provisions of this Agreement, and shall execute with the Lockbox Bank a Deposit Account
Control Agreement and such other agreements related to such Lockbox as Administrative Agent may require. Borrowers shall ensure that all collections of Accounts are paid directly from Account Debtors into the Lockbox for deposit into the Lockbox
Account and/or directly into the Lockbox Account; provided, however, unless Administrative Agent shall otherwise direct by written notice to Borrowers, Borrowers shall be permitted to cause Account Debtors who are individuals to pay Accounts
directly to Borrowers, which Borrowers shall then administer and apply in the manner required below. 
 (b) All funds deposited into a
Lockbox Account shall be transferred into the Payment Account by the close of each Business Day. 
 (c) Notwithstanding anything in any
lockbox agreement or Deposit Account Control Agreement to the contrary, Borrowers agree that they shall be liable for any fees and charges in effect from time to time and charged by the Lockbox Bank in connection with the Lockbox and the Lockbox
Account, and that Administrative Agent shall have no liability therefor. Borrowers hereby indemnify and agree to hold Administrative Agent harmless from any and all liabilities, claims, losses and demands whatsoever, including reasonable
attorneys’ fees and expenses, arising from or relating to actions of Administrative Agent or the Lockbox Bank pursuant to this Section or any lockbox agreement or Deposit Account Control Agreement or similar agreement, except to the extent of
such losses arising solely from Administrative Agent’s gross negligence or willful misconduct. 
 (d) Administrative Agent shall apply,
on a daily basis, all funds transferred into the Payment Account pursuant to this Section to reduce the outstanding Revolving Loans in such order of application as Administrative Agent shall elect. If as the result of collections of Accounts
pursuant to the terms and conditions of this Section a credit balance exists with respect to the Payment Account, such credit balance shall not accrue interest in favor of Borrowers, but Administrative Agent shall transfer such funds into an account
designated by Borrower Representative for so long as no Event of Default exists. 
 (e) To the extent that any collections of Accounts or
proceeds of other Collateral are not sent directly to the Lockbox but are received by any Borrower, such collections shall be held in trust for the benefit of Administrative Agent pursuant to an express trust created hereby and immediately remitted,
in the form received, to the applicable Lockbox and Lockbox Account. No such funds received by any Borrower shall be commingled with 

  

 25 

 
other funds of the Borrowers. 
 (f) Borrowers
acknowledge and agree that compliance with the terms of this Section is essential, and that Administrative Agent and Lenders will suffer immediate and irreparable injury and have no adequate remedy at law, if any Borrower, through acts or omissions,
causes or permits Account Debtors to send payments other than to the Lockbox, or if any Borrower fails to immediately deposit collections of Accounts or proceeds of other Collateral in the Lockbox Account as herein required. Accordingly, in addition
to all other rights and remedies of Administrative Agent and Lenders hereunder, Administrative Agent shall have the right to seek specific performance of the Borrowers’ obligations under this Section, and any other equitable relief as
Administrative Agent may deem necessary or appropriate, and Borrowers waive any requirement for the posting of a bond in connection with such equitable relief. 
 (g) Borrowers shall not, and Borrowers shall not suffer or permit any Credit Party to, (i) withdraw any amounts from any Lockbox Account, (ii) change the procedures or sweep instructions under the agreements
governing any Lockbox Accounts, or (iii) send to or deposit in any Lockbox Account any funds other than payments made with respect to and proceeds of Accounts or other Collateral. Borrowers shall, and shall cause each Credit Party to, cooperate
with Administrative Agent in the identification and reconciliation on a daily basis of all amounts received in or required to be deposited into the Lockbox Accounts. If more than five percent (5%) of the collections of Accounts received by
Borrowers during any given fifteen (15) day period is not identified or reconciled to the reasonable satisfaction of Administrative Agent within ten (10) Business Days of receipt, Administrative Agent shall not be obligated to make further
advances under this Agreement until such amount is identified or is reconciled to the reasonable satisfaction of Administrative Agent, as the case may be. In addition, if any such amount cannot be identified or reconciled to the satisfaction of
Administrative Agent, Administrative Agent may utilize its own staff or, if it deems necessary, engage an outside auditor, in either case at Borrowers’ expense (which in the case of Administrative Agent’s own staff shall be in accordance
with Administrative Agent’s then prevailing customary charges (plus expenses)), to make such examination and report as may be necessary to identify and reconcile such amount. 
 (h) If any Borrower breaches its obligation to direct payments of the proceeds of the Collateral to the Lockbox Account, Administrative Agent, as the
irrevocably made, constituted and appointed true and lawful attorney for Borrowers, may, by the signature or other act of any of Administrative Agent’s officers (without requiring any of them to do so), direct any Account Debtor to pay proceeds
of the Collateral to Borrowers by directing payment to the Lockbox Account. 
 ARTICLE 3 – REPRESENTATIONS AND WARRANTIES

 To induce Administrative Agent and Lenders to enter into this Agreement and to make the Loans and other credit accommodations
contemplated hereby, each Borrower hereby represents and warrants to Administrative Agent and each Lender that: 
 Section 3.1
Existence and Power. Each Credit Party is an entity as specified on Schedule 3.1, is duly organized, validly existing and in good standing under the laws of the jurisdiction specified on Schedule 3.1 and no other
jurisdiction, has the same legal name as it appears in such Credit Party’s Organizational Documents and an organizational identification number (if any), in each case as specified on Schedule 3.1, (as such name may be amended in
accordance with the provisions hereof) and has all powers and all Permits necessary or desirable in the operation of its business as presently conducted or as proposed to be conducted, except where the failure to have such Permits could not
reasonably be expected to have a Material Adverse Effect. Each Credit Party is qualified to do business as a foreign entity in each jurisdiction in which it is required to be so qualified, which jurisdictions as of the Closing Date are specified on
Schedule 3.1, except where the failure to be so qualified could not reasonably be expected to have a Material Adverse Effect. Except as set forth on Schedule 3.1, no Credit Party, over the five (5) year period
preceding the Closing Date, (a) has had any name other than its current name, or (b) was incorporated or organized under the laws of any jurisdiction other than its current jurisdiction of incorporation or organization. 
 Section 3.2 Organization and Governmental Authorization; No Contravention; Binding Effect. The execution, delivery and performance by each
Credit Party of the Financing Documents to which it is a party are 

  

 26 

 
within its powers, have been duly authorized by all necessary action pursuant to its Organizational Documents, require no further action by or in respect of,
or filing with, any Governmental Authority and do not violate, conflict with or cause a breach or a default under (a) any Law applicable to any Credit Party or any of the Organizational Documents of any Credit Party, or (b) any agreement
or instrument binding upon it, except for such violations, conflicts, breaches or defaults as could not, with respect to this clause (b), reasonably be expected to have a Material Adverse Effect. This Agreement and each of the other Financing
Documents to which any Credit Party is a party constitutes a valid and binding agreement or instrument of such Credit Party, enforceable against such Credit Party in accordance with its respective terms, except as the enforceability thereof may be
limited by bankruptcy, insolvency or other similar laws relating to the enforcement of creditors’ rights generally and by general equitable principles. 
 Section 3.3 Capitalization. The authorized equity securities of each of the Credit Parties as of the Closing Date, including all preemptive or other outstanding rights, options, warrants, conversion rights
or similar agreements or understandings, are as set forth on Schedule 3.3. 
 Section 3.4 Financial Information;
Solvency. All information delivered to Administrative Agent and pertaining to the financial condition of any Credit Party fairly presents in all material respects the financial position of such Credit Party as of such date in conformity with
GAAP (and as to unaudited financial statements, subject to normal year-end adjustments and the absence of footnote disclosures). Since December 31, 2006, there has been no material adverse change in the business, operations, properties, or
condition (financial or otherwise) of any Credit Party. Each Borrower and each additional Credit Party is Solvent. 
 Section 3.5
Anti-Terrorism Laws. None of the Credit Parties, their Affiliates or any of their respective agents acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement is (i) in violation of any
Anti-Terrorism Law, (ii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law, or
(iii) is a Blocked Person. No Credit Party nor, to the knowledge of any Credit Party, any of its Affiliates or agents acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement, (x) conducts any
business or engages in making or receiving any contribution of funds, goods or services to or for the benefit of any Blocked Person, or (y) deals in, or otherwise engages in any transaction relating to, any property or interest in property
blocked pursuant to Executive Order No. 13224, any similar executive order or other Anti-Terrorism Law. 
 Section 3.6 Full
Disclosure. None of the written information (financial or otherwise) furnished by or on behalf of any Credit Party to Administrative Agent or any Lender in connection with the consummation of the transactions contemplated by the Financing
Documents and/or in connection with the Financing Documents after the Closing Date, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained herein or therein not misleading in
light of the circumstances under which such statements were made. All financial projections delivered to Administrative Agent and Lenders by Borrowers (or their agents) have been prepared on the basis of the assumptions stated therein. Subject to
any reasonable and customary assumptions, qualifications and limitation stated therein, such projections represented such Borrower’s good faith estimate as of the date thereof of such Borrower’s future financial performance and such
assumptions were believed by such Borrower to be reasonable as of the date thereof in light of business conditions then prevailing; provided, however, that Borrowers can give no assurance that any such projections will be attained. 
 Section 3.7 Interest Rate. The rate of interest paid under the Notes and the method and manner of the calculation thereof do not violate any
usury or other law or applicable Laws, any of the Organizational Documents or any of the Financing Documents. 
 Section 3.8 Taxes.
All Federal, state and local tax returns, reports and statements (including all such with respect to employee income tax withholding, social security and unemployment taxes) required to be filed by or on behalf of each Credit Party have been
filed with the appropriate Governmental Authorities in all jurisdictions in which such returns, reports and statements are required to be filed for all periods for which returns were due and, except to the extent subject to a Permitted Contest, all
taxes (including real property taxes, employee income tax withholding, social security and unemployment taxes) and other charges shown to be due and payable in respect 

  

 27 

 
thereof have been timely paid prior to the date on which any fine, penalty, interest, late charge or loss may be added thereto for nonpayment thereof (and,
with respect to any employee income tax withholding, social security and unemployment taxes not yet due, adequate provision for the payment thereof has been made). Except to the extent subject to a Permitted Contest, all state and local sales and
use Taxes required to be paid by each Credit Party have been paid. 
 Section 3.9 Compliance with Covenants. Each Credit Party is
in full compliance with all of the terms and provisions of this Agreement and the other Financing Documents, specifically including without limitation each of the affirmative and negative covenants contained in Articles 4 and 5 below, and no Default
or Event of Default has occurred and is continuing. 
 Section 3.10 Litigation. There is no litigation or governmental proceeding
pending or threatened in writing against any Credit Party in which an adverse decision could reasonably be expected to have a Material Adverse Effect or which in any manner draws into question the validity and enforceability of the Financing
Documents. 
 ARTICLE 4 – AFFIRMATIVE COVENANTS 
 Each Borrower agrees that, so long as any Credit Exposure exists: 
 Section 4.1 Financial Statements
and Other Reports. Each Borrower will deliver to Administrative Agent: (1) as soon as available, but no later than forty (40) days after the last day of each quarter, a company prepared consolidated balance sheet, cash flow and income
statement covering Borrower’s consolidated operations during the period, prepared under GAAP, consistently applied (subject to normal year-end adjustments and the absence of footnote disclosures), certified by a Responsible Officer and in a
form acceptable to Administrative Agent; (2) as soon as available, but no later than ninety (90) days after the last day of Borrower’s fiscal year, audited consolidated financial statements prepared under GAAP, consistently applied,
together with an unqualified opinion on the financial statements from an independent certified public accounting firm acceptable to Administrative Agent in its reasonable discretion; (3) within five (5) days of delivery or filing thereof,
copies of all statements, reports and notices made available to Borrower’s security holders or to any holders of Subordinated Debt and copies of all reports and other filings made by Borrower with any stock exchange on which any securities of
any Borrower are traded and/or the SEC; (4) a prompt report of any legal actions pending or threatened in writing against any Borrower or any of its Subsidiaries that could result in damages or costs to any Borrower or any of its Subsidiaries
of One Hundred Fifty Thousand Dollars ($150,000) or more; (5) prompt written notice of an event that materially and adversely affects the value of any Intellectual Property; and (6) budgets, sales projections, operating plans and other
financial information and information, reports or statements regarding the Borrowers, their business and the Collateral as Administrative Agent may from time to time reasonably request. Each Borrower will, in conjunction with the delivery of each
set of financial statements required under clause (l) above, deliver to Administrative Agent, a duly completed Compliance Certificate signed by a Responsible Officer which shall, inter alia, set forth calculations showing compliance with
the financial covenants (if any) set forth in this Agreement. Promptly upon their becoming available, Borrowers shall deliver to Administrative Agent copies of all swap agreements or other derivative instruments to which any Borrower is a party.
Each Borrower will, within ten (10) days after the last day of each month, deliver to Administrative Agent a duly completed Borrowing Base Certificate signed by a Responsible Officer, with aged listings of accounts receivable and accounts
payable (by invoice date). 
 Section 4.2 Payment and Performance of Liabilities and Obligations. Each Borrower will (and will
cause each of its Subsidiaries to): (a) pay and discharge at or prior to maturity, all of their respective obligations and liabilities, including all tax liabilities of all kind, except for such obligations and/or liabilities (i) that may
be the subject of a Permitted Contest, and (ii) the nonpayment or nondischarge of which could not reasonably be expected to have a Material Adverse Effect; (b) maintain in accordance with GAAP, appropriate reserves for the accrual of all
of their respective obligations and liabilities, including all tax liabilities of all kind; and (c) not breach or permit any Subsidiary to breach, or permit to exist any default under, the terms of any Material Contract or any other lease,
commitment, contract, instrument or obligation to which it is a party, or by which its properties or assets are bound, except for such breaches or defaults which could not reasonably be expected to have a Material Adverse Effect. 
  

 28 

 Section 4.3 Maintenance of Existence; Property; Insurance. 
 (a) Each Borrower will preserve, renew and keep in full force and effect and in good standing (i) their respective existence and (ii) their
respective rights, privileges and franchises necessary or desirable in the normal conduct of business. 
 (b) Each Borrower will, and will
cause each of its Subsidiaries to, at all times be the lawful owner of, have good and marketable title to and be in lawful possession of, or have valid leasehold interests in, all properties and other assets (real or personal, tangible, intangible
or mixed) purported or reported to be owned or leased (as the case may be) by such Person. Each Borrower will keep all property useful and necessary in its business in good working order and condition, ordinary wear and tear excepted. If all or any
part of the Collateral useful or necessary in its business, or upon which any Borrowing Base is calculated, becomes damaged or destroyed, each Borrower will promptly and completely repair and/or restore the affected Collateral in a good and
workmanlike manner, regardless of whether Administrative Agent agrees to disburse insurance proceeds or other sums to pay costs of the work of repair or reconstruction. 
 (c) Each Borrower will, and will cause each of its Subsidiaries to, maintain (i) all insurance described on Schedule 4.3, upon the terms and with the coverages and rights in favor of Administrative
Agent and Lenders as described in Schedule 4.3, and (ii) such other insurance coverage in such amounts and with respect to such risks as Administrative Agent may reasonably from time to time upon not less than fifteen
(15) days’ notice request, consistent with industry standards; provided, however, that, in no event shall such insurance be in amounts or with coverage less than, or with carriers with qualifications inferior to, any of the
insurance or carriers in existence as of the Closing Date (or required to be in existence after the Closing Date under a Financing Document), as evidenced by the insurance certificates attached hereto as Schedule 4.3. All such
insurance shall be provided by insurers having an A.M. Best policyholders rating reasonably acceptable to Administrative Agent. Borrowers will deliver to Administrative Agent and the Lenders (i) at least five (5) days prior to expiration
of any policy of insurance, evidence of renewal of such insurance upon the terms and conditions herein required, (ii) upon the request of any Lender through Administrative Agent from time to time full information as to the insurance carried,
(iii) within five (5) days of receipt of notice from any insurer, a copy of any notice of cancellation, nonrenewal or material change in coverage from that existing on the date of this Agreement, and (iv) forthwith, notice of any
cancellation or nonrenewal of coverage by any Borrower. In the event any Borrower (i) fails to maintain the insurance coverage required by this Agreement, or (ii) fails to provide Administrative Agent with evidence of the insurance
coverage required by this Agreement and such failure to provide evidence continues for five (5) Business Days, Administrative Agent may (but shall have no obligation to) purchase insurance at Borrowers’ expense to protect Administrative
Agent’s and each Lender’s interests in the Collateral and to protect Administrative Agent and Lenders from liability claims relating to the Borrowers’ operations, and the costs and expenses of Administrative Agent in obtaining and
paying the premiums on any such insurance shall constitute part of the Obligations for which the Borrowers are jointly and severally liable hereunder and which are secured by the Collateral. Without limiting the generality of the foregoing, in the
event that any Credit Party shall at any time receive any insurance proceeds under any property or casualty insurance maintained by any Credit Party in connection with any casualty event involving the Collateral, Borrowers shall and shall cause each
Credit Party to (regardless of any rights Borrowers may have under clause (1) of the immediately following sentence) immediately turn over and deliver to Administrative Agent any and all such proceeds in the form received together with any
necessary endorsement thereto by any and all applicable Credit Parties. 
 Section 4.4 Compliance with Laws and Contracts. Each
Borrower will, and will cause each of its Subsidiaries to, comply with the requirements of all applicable Laws and all Material Contracts, except to the extent that failure to so comply could not reasonably be expected to (a) have a Material
Adverse Effect, or (b) result in any Lien upon either (i) a material portion of the assets of any such Person in favor of any Governmental Authority, (ii) any Intellectual Property, or (iii) any Collateral upon which the
Borrowing Base is calculated. Schedule 4.4 sets forth a complete list of Material Contracts as of the Closing Date, and the closing on and consummation of the transactions contemplated by the Financing Documents will not give rise to a
right of termination under any such Material Contract listed on Schedule 4.4 in favor of any party (other than a Credit Party) to such Material Contract. 
 Section 4.5 Inspection of Property, Books and Records. Each Borrower will permit at the sole cost 

  

 29 

 
of Borrowers (subject, however, to any limitations set forth in Section 2.2(i)), representatives of Administrative Agent and of any Lender to visit and
inspect any of their respective properties, to examine and make abstracts or copies from any of their respective books and records, to conduct a collateral audit and analysis of their respective operations and the Collateral, and to discuss their
respective affairs, finances and accounts with their respective officers, employees and independent public accountants as often as may reasonably be desired. In the absence of an Event of Default, Administrative Agent or any Lender exercising any
rights pursuant to this Section shall give the applicable Borrower or any applicable Subsidiary commercially reasonable prior notice of such exercise. No notice shall be required during the existence and continuance of any Event of Default or any
time during which Administrative Agent reasonably believes an Event of Default exists. 
 Section 4.6 Use of Proceeds. Borrowers
shall use the proceeds of Revolving Loans solely for solely for working capital needs of Borrowers and their Subsidiaries. No portion of the proceeds of the Loans will be used for family, personal, agricultural or household use. 
 Section 4.7 Estoppel Certificates. After written request by Administrative Agent, Borrowers, within fifteen (15) days and at their
expense, will furnish Administrative Agent with a statement, duly acknowledged and certified, setting forth (a) the amount of the original principal amount of the Notes, and the unpaid principal amount of the Notes, (b) the rate of
interest of the Notes, (c) the date payments of interest and/or principal were last paid, (d) any offsets or defenses to the payment of the Obligations, and if any are alleged, the nature thereof, (e) that the Notes and this Agreement
have not been modified or if modified, giving particulars of such modification, and (f) that there has occurred and is then continuing no Default or Event of Default or if such Default or Event of Default exists, the nature thereof, the period
of time it has existed, and the action being taken to remedy such Default or Event of Default. After written request by Administrative Agent, Borrowers, within fifteen (15) days and at their expense, will furnish Administrative Agent with a
certificate, signed by a Responsible Officer of Borrowers, updating all of the representations and warranties contained in this Agreement and the other Financing Documents and certifying that all of the representations and warranties contained in
this Agreement and the other Financing Documents, as updated pursuant to such certificate, are true, accurate and complete as of the date of such certificate. 
 Section 4.8 Notices of Certain Events. 
 (a) Borrowers will give prompt written notice to
Administrative Agent (a) of any litigation or governmental proceedings pending or threatened (in writing) against Borrowers or other Credit Party which would reasonably be expected to have a Material Adverse Effect with respect to Borrowers or
any other Credit Party or which in any manner calls into question the validity or enforceability of any Financing Document, (b) upon any Borrower becoming aware of the existence of any Default or Event of Default, (c) if any Credit Party
is in breach or default under or with respect to any Material Contract, or if any Credit Party is in breach or default under or with respect to any other contract, agreement, lease or other instrument to which it is a party or by which its property
is bound or affected, which breach or default could reasonably be expected to have a Material Adverse Effect, (d) of any strikes or other labor disputes pending or, to any Borrower’s knowledge, threatened against any Credit Party,
(e) if there is any infringement or written claim of infringement by any other Person with respect to any Intellectual Property rights of any Credit Party that could reasonably be expected to have a Material Adverse Effect, or if there is any
claim by any other Person that that any Credit Party in the conduct of its business is infringing on the Intellectual Property Rights of others, and (f) of all returns, recoveries, disputes and claims that involve more than Two Hundred Fifty
Thousand Dollars ($250,000). Borrowers represent and warrant that Schedule 4.8 sets forth a complete list of all matters existing as of the Closing Date for which notice could be required under this Section and all litigation or
governmental proceedings pending or threatened (in writing) against Borrowers or other Credit Party as of the Closing Date. 
 (b) Without
limiting the generality of the foregoing, Borrowers will give prompt written notice to Administrative Agent (a) of the issuance of any notice, notification, demand, request for information, citation, summons, complaint or order, filing of any
complaint, assessment of any penalty or initiation or initiation or threat to initiate any investigation or review , in each such case whether by any Governmental Authority or other Person, with respect to any (i) alleged violation by any
Credit Party of any Environmental Law, (ii) alleged failure by any Credit Party to have any Permits relating to or granted under any Environmental Law required in connection with the conduct of its business or to comply with the terms and
conditions thereof, except where the failure to have such 

  

 30 

 
Permits relating to or granted under any Environmental Law could not reasonably be expected to have a Material Adverse Effect, (iii) any generation,
treatment, storage, recycling, transportation or disposal of any Hazardous Materials, or (iv) release of Hazardous Materials; (b) if any property now owned or leased by any Credit Party or, to the knowledge of any Borrower, any property
previously owned or leased by any Credit Party, to which any Credit Party has, directly or indirectly, transported or arranged for the transportation of any Hazardous Materials, becomes listed or, to any Borrower’s knowledge, becomes proposed
for listing, on the National Priorities List promulgated pursuant to CERCLA, or CERCLIS (as defined in CERCLA) or any similar state list or becomes the subject of Federal, state or local enforcement actions or, to the knowledge of any Borrower,
other investigations which may lead to claims against any Credit Party for clean-up costs, remedial work, damage to natural resources or personal injury claims, including, without limitation, claims under CERCLA. Borrowers represent and warrant that
Schedule 4.8 sets forth a complete list of all matters existing as of the Closing Date for which notice could be required under this Section. For purposes of this Section 4.8(b), each Credit Party shall be deemed to include any
business or business entity (including a corporation) that is, in whole or in part, a predecessor of such Credit Party. 
 Section 4.9 Intellectual Property. Each Credit Party shall own, or be licensed to use or otherwise have the right to use, all Intellectual Property that is material to the condition (financial or other), business or operations
of such Credit Party. All Intellectual Property existing as of the Closing Date and registered with any United States or foreign Governmental Authority (including without limitation any and all applications for the registration of any Intellectual
Property with any such United States or foreign Governmental Authority) and all licenses under which any Borrower is the licensee of any such registered Intellectual Property (or any such application for the registration of Intellectual Property)
owned by another Person are set forth on Schedule 4.9. Such Schedule 4.9 indicates in each case whether such registered Intellectual Property (or application therefor) is owned or licensed by such Credit Party, and in the
case of any such licensed registered Intellectual Property (or application therefor), lists the name and address of the licensor and the name and date of the agreement pursuant to which such item of Intellectual Property is licensed and whether or
not such license is an exclusive license and indicates whether there are any purported restrictions in such license on the ability to such Credit Party to grant a security interest in and/or to transfer any of its rights as a licensee under such
license. Except as indicated on Schedule 4.9, and except for Permitted Asset Dispositions, the applicable Credit Party is and all times shall be the sole and exclusive owner of the entire and unencumbered right, title and interest in
and to each such registered Intellectual Property (or application therefor) purported to be owned by such Borrower, free and clear of any Liens and/or licenses in favor of third parties or agreements or covenants not to sue such third parties for
infringement. All Intellectual Property of each Credit Party is and shall be fully protected and/or duly and properly registered, filed or issued in the appropriate office and jurisdictions for such registrations, filings or issuances, except where
the failure to do so would not reasonably be expected to have a Material Adverse Effect. Borrowers shall not become a party to, nor become bound by, any material license or other agreement with respect to which any Borrower is the licensee that
prohibits or otherwise restricts such Borrower from granting a security interest in such Borrower’s interest in such license or agreement or other property. Each Credit Party shall at all times conduct its business without infringement or claim
of infringement of any Intellectual Property rights of others. Each Credit Party shall, to the extent it determines, in the exercise of its reasonable business judgment, that it is prudent to do the following: (a) protect, defend and maintain
the validity and enforceability of its Intellectual Property; (b) promptly advise Administrative Agent in writing of material infringements of its Intellectual Property; and (c) not allow any Intellectual Property material to
Borrower’s business to be abandoned, forfeited or dedicated to the public without Administrative Agent’s written consent. 
 Section 4.10 Further Assurances. 
 (a) Each Borrower will, at its own cost and expense, cause to be promptly and duly
taken, executed, acknowledged and delivered all such further acts, documents and assurances as may from time to time be necessary or as Administrative Agent or the Required Lenders may from time to time reasonably request in order to carry out the
intent and purposes of the Financing Documents and the transactions contemplated thereby. 
 (b) Upon receipt of an affidavit of an officer
of Administrative Agent or a Lender as to the loss, theft, destruction or mutilation of any Note or any other Financing Document which is not of public record, and, in the case of any such mutilation, upon surrender and cancellation of such Note or
other applicable Financing Document, Borrowers will issue, in lieu thereof, a replacement Note or other applicable Financing Document, dated the date of 

  

 31 

 
such lost, stolen, destroyed or mutilated Note or other Financing Document in the same principal amount thereof and otherwise of like tenor. 
 (c) Upon the request of Administrative Agent, Borrowers shall obtain a landlord’s agreement or mortgagee agreement, as applicable, from the lessor
of each leased property or mortgagee of owned property with respect to any business location where any portion of the Collateral included in or proposed to be included in the Borrowing Base, or the records relating to such Collateral and/or software
and equipment relating to such records or Collateral, is stored or located, which agreement or letter shall be reasonably satisfactory in form and substance to Administrative Agent. Borrowers shall timely and fully pay and perform its obligations
under all leases and other agreements with respect to each leased location where any Collateral, or any records related thereto, is or may be located. 
 (d) Before the Closing Date, and thereafter (as and when determined by Administrative Agent in its discretion), Administrative Agent shall have the right to perform, all at Borrowers’ expense, the searches
described in clauses (a), (b), (c) and (d) below against Borrowers and any other Credit Party, the results of which are to be consistent with Borrowers’ representations and warranties under this Agreement and the satisfactory results
of which shall be a condition precedent to all advances of Loan proceeds, all issuances of Lender Letters of Credit and all undertakings in respect of Support Agreements: (a) UCC searches with the Secretary of State of each jurisdiction in
which the applicable Person is organized, and, if applicable, local UCC fixture filings searches in each jurisdiction where any real estate Collateral or fixtures Collateral is located; (b) judgment, pending litigation, federal tax lien,
personal property tax lien, and corporate and partnership tax lien searches, in the state and/or local filing offices (as applicable) of each jurisdiction where the applicable Person maintains its executive offices, a place of business, or assets
and the jurisdiction in which the applicable Person is organized; (c) real property title and lien searches in each jurisdiction in which any real property Collateral is located; and (d) searches of applicable corporate, limited liability
company, partnership and related records to confirm the continued existence, organization and good standing of the applicable Person and the exact legal name under which such Person is organized. 
 (e) Upon the request of Administrative Agent, Borrowers shall make available to Administrative Agent, without expense to Administrative Agent, Borrowers
and their officers, employees and agents and Borrowers’ books and records, to the extent that Administrative Agent may deem them reasonably necessary to prosecute or defend any third-party suit or proceeding instituted by or against
Administrative Agent or any Lender with respect to the Financing Documents, any Collateral or relating to any Borrower. 
 Section 4.11 Power of Attorney. Each of the officers of Administrative Agent is hereby irrevocably made, constituted and appointed the true and lawful attorney for Borrowers (without requiring any of them to act as such) with
full power of substitution to do the following: (a) endorse the name of Borrowers upon any and all checks, drafts, money orders, and other instruments for the payment of money that are payable to Borrowers and constitute collections on
Borrowers’ Accounts; (b) so long as Administrative Agent has provided not less than three (3) Business Days’ prior written notice to Borrowers to perform the same and Borrowers have failed to take such action, execute in the name
of Borrowers any schedules, assignments, instruments, documents, and statements that Borrowers are obligated to give Administrative Agent under this Agreement; (c) after the occurrence and during the continuance of an Event of Default, take any
action Borrowers are required to take under this Agreement; (d) so long as Administrative Agent has provided not less than three (3) Business Days’ prior written notice to Borrowers to perform the same and Borrowers have failed to
take such action, do such other and further acts and deeds in the name of Borrowers that Administrative Agent may deem necessary or desirable to enforce any Account or other Collateral or perfect Administrative Agent’s security interest or Lien
in any Collateral; and (e) after the occurrence and during the continuance of an Event of Default, do such other and further acts and deeds in the name of Borrowers that Administrative Agent may deem necessary or desirable to enforce its rights
with regard to any Account or other Collateral. This power of attorney shall be irrevocable and coupled with an interest. 
 Section 4.12 Post Closing Requirements. Borrowers shall complete each of the post closing obligations and/or provide to Administrative Agent each of the documents, instruments, agreements and information listed on Schedule
4.12 attached hereto on or before the date set forth for each such item thereon, each of which shall be completed or provided in form and substance satisfactory to Administrative Agent. 
  

 32 

 Section 4.13 Hazardous Materials; Remediation. 
 (a) If any release or disposal of Hazardous Materials shall occur or shall have occurred on any real property or any other assets of any Borrower or any
Subsidiary or any other Credit Party, such Borrower will cause, or direct the applicable Subsidiary or Credit Party to cause, the prompt containment and removal of such Hazardous Materials and the remediation of such real property or other assets as
is necessary to comply with all Environmental Laws and to preserve the value of such real property or other assets. Without limiting the generality of the foregoing, each Borrower shall, and shall cause each other Subsidiary and Credit Party to,
materially comply with each Environmental Law requiring the performance at any real property by any Borrower or any other Subsidiary or Credit Party of activities in response to the release or threatened release of a Hazardous Material. 

(b) Borrowers will provide Agent within thirty (30) days after written demand therefor with a bond, letter of credit or similar financial
assurance evidencing to the reasonable satisfaction of Agent that sufficient funds are available to pay the cost of removing, treating and disposing of any Hazardous Materials or Hazardous Materials Contamination and discharging any assessment which
may be established on any property as a result thereof, such demand to be made, if at all, upon Agent’s reasonable business determination that the failure to remove, treat or dispose of any Hazardous Materials or Hazardous Materials
Contamination, or the failure to discharge any such assessment could reasonably be expected to have a Material Adverse Effect. 
 Section 4.14 Updates of Representations. Borrowers shall deliver to Administrative Agent within ten (10) days of the written request of Administrative Agent an Officer’s Certificate updating all of the representations
and warranties contained in this Agreement and the other Financing Documents and certifying that all of the representations and warranties contained in this Agreement and the other Financing Documents, as updated pursuant to such Officer’s
Certificate, are true, accurate and complete as of the date of such Officer’s Certificate. 
 ARTICLE 5 – NEGATIVE COVENANTS 

 Each Borrower agrees that, so long as any Credit Exposure exists: 
 Section 5.1 Debt; Contingent Obligations. No Borrower will, or will permit any Subsidiary to, directly or indirectly, create, incur, assume,
guarantee or otherwise become or remain directly or indirectly liable with respect to, any Debt, except for Permitted Indebtedness. No Borrower will, or will permit any Subsidiary to, directly or indirectly, create, assume, incur or suffer to exist
any Contingent Obligations, except for Permitted Contingent Obligations. 
 Section 5.2 Liens. No Borrower will, or will permit
any Subsidiary to, directly or indirectly, create, assume or suffer to exist any Lien on any asset now owned or hereafter acquired by it, including, without limitation, a pledge of any stock or other ownership interests of any Subsidiary, except for
Permitted Liens. 
 Section 5.3 Restricted Distributions. No Borrower will, or will permit any Subsidiary to, directly or
indirectly, declare, order, pay, make or set apart any sum for any Restricted Distribution, except for Permitted Distributions. 
 Section 5.4 Consolidations, Mergers and Sales of Assets; Change in Control. No Borrower will, or will permit any Subsidiary to, directly or indirectly (a) consolidate or merge or amalgamate with or into any other Person, or
(b) consummate any Asset Dispositions other than Permitted Asset Dispositions. No Borrower will suffer or permit to occur any Change in Control with respect to itself, any Subsidiary or any guarantor of the Obligations. 
 Section 5.5 Purchase of Assets, Investments; New Subsidiaries. 
 (a) No Borrower will, or will permit any Subsidiary to, directly or indirectly, without the prior written consent of Administrative Agent, (a) acquire or enter into any agreement to acquire any assets other than
in the Ordinary Course of Business or Permitted Acquisitions; (b) engage or enter into any agreement to engage in any joint venture or partnership with any other Person, other than Permitted Asset Dispositions; or (c) form, acquire or own
or enter into any agreement to form, acquire or own any Investment in any Person, including any new 

  

 33 

 
Subsidiary, other than pursuant to Permitted Investments or Permitted Acquisitions. 
 (b) Except as set forth in Schedule 5.5 attached hereto, with regard to each Subsidiary existing as of the Closing Date and upon the
formation or acquisition of a new Subsidiary as part of a Permitted Investment, Borrowers shall (i) pledge, have pledged or cause or have caused to be pledged to Administrative Agent pursuant to a pledge agreement in form and substance
satisfactory to Administrative Agent, all (or in the case of each foreign Subsidiary, sixty-five percent) of the outstanding equity interests of such Subsidiary owned directly or indirectly by any Borrower, along with undated stock or equivalent
powers for such equity interests, executed in blank; (ii) unless Administrative Agent shall agree otherwise in writing, cause the Subsidiary to take such other actions (including entering into or joining any Security Documents) as are necessary
or advisable in the reasonable opinion of the Administrative Agent in order to grant the Administrative Agent, acting on behalf of the Lenders, a first priority Lien to secure the Obligations of all Credit Parties on all real and personal property
and leasehold estates of such Subsidiary in existence as of such date and in all after acquired property; (iii) unless Administrative Agent shall agree otherwise in writing, cause such Subsidiary to either (at the election of Administrative
Agent) become a Borrower hereunder with joint and several liability for all obligations of Borrowers hereunder and under the other Financing Documents pursuant to a joinder agreement or other similar agreement in form and substance satisfactory to
Administrative Agent or to become a guarantor of the Obligations pursuant to a guaranty and suretyship agreement in form and substance satisfactory to Administrative Agent; and (iv) cause the Subsidiary to deliver certified copies of such
Subsidiary’s certificate or articles of incorporation, together with good standing certificates, by-laws (or other operating agreement or governing documents), resolutions of the Board of Directors or other governing body, approving and
authorizing the execution and delivery of the Security Documents, incumbency certificates and to execute and/or deliver such other documents and legal opinions or to take such other actions as may be requested by the Administrative Agent, in each
case, in form and substance satisfactory to the Administrative Agent. 
 Section 5.6 Transactions with Affiliates. Except as
otherwise disclosed on Schedule 5.6, and except for transactions that are disclosed to Administrative Agent in advance of being entered into and which contain terms that are no less favorable to the applicable Borrower or any
Subsidiary, as the case may be, than those which might be obtained from a third party not an Affiliate of any Credit Party, no Borrower will, or will permit any Subsidiary to, directly or indirectly, enter into or permit to exist any transaction
(including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of any Borrower. 
 Section 5.7 Modification of Organizational Documents. No Borrower will, or will permit any Subsidiary to, directly or indirectly, amend or otherwise modify any Organizational Documents of such Person, except for Permitted
Modifications. 
 Section 5.8 Conduct of Business. No Borrower will, or will permit any Subsidiary to, directly or indirectly,
engage in any line of business other than those businesses engaged in on the Closing Date and described on Schedule 5.8 and businesses reasonably related thereto. 
 Section 5.9 Deposit Accounts and Securities Accounts. No Borrower will, or will permit any Subsidiary to, directly or indirectly, establish
any new Deposit Account or Securities Account without prior written notice to Administrative Agent and unless Administrative Agent, such Borrower or such Subsidiary and the bank, financial institution or securities intermediary at which the account
is to be opened enter into a Deposit Account Control Agreement or Securities Account Control Agreement prior to or concurrently with the establishment of such Deposit Account or Securities Account. Borrowers represent and warrant that Schedule
5.9 lists all of the Deposit Accounts and Securities Accounts of each Borrower as of the Closing Date. The provisions of this Section requiring Deposit Account Control Agreements shall not apply to Deposit Accounts exclusively used for
payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of Borrowers’ employees and identified to Administrative Agent by Borrowers as such. 
 Section 5.10 Payments and Modifications of Subordinated Debt. No Borrower will, or will permit any Subsidiary to, directly or indirectly,
(a) declare, pay, make or set aside any amount for payment in respect of Subordinated Debt unless permitted pursuant to the applicable Subordination Agreement or (b) amend or otherwise modify the terms of any Subordinated Debt if the
effect of such amendment or modification is to (i) increase the 

  

 34 

 
interest rate or fees on, or change the manner or timing of payment of, such Subordinated Debt; (ii) change the dates upon which payments of principal
or interest are due on, or the principal amount of, such Subordinated Debt; (iii) change any event of default or add or make more restrictive any covenant with respect to such Subordinated Debt; (iv) change the prepayment provisions of
such Subordinated Debt or any of the defined terms related thereto; (v) change the subordination provisions thereof (or the subordination terms of any guarantee thereof); (vi) change or amend any other term if such change or amendment
would materially increase the obligations of the obligor or confer additional material rights on the holder of such Subordinated Debt in a manner adverse to any Borrower, any Subsidiaries, Administrative Agent or Lenders; or (viii) otherwise
conflict with the terms of or be prohibited under the terms of any Subordination Agreement applicable thereto. Each Borrower shall, prior to entering into any such amendment or modification, deliver to Administrative Agent reasonably in advance of
the execution thereof, any final or execution form copy thereof and, if approval of Required Lenders is required by the terms of this Agreement prior to the taking of any such action, such Borrower agrees not to take, nor permit any of its
Subsidiaries to take, any such action with respect to any such items without obtaining such approval from Required Lenders. 
 Section 5.11 Compliance with Anti-Terrorism Laws. Administrative Agent hereby notifies Borrowers that pursuant to the requirements of Anti-Terrorism Laws, and Administrative Agent’s policies and practices, Administrative
Agent is required to obtain, verify and record certain information and documentation that identifies Borrowers and its principals, which information includes the name and address of each Borrower and its principals and such other information that
will allow Administrative Agent to identify such party in accordance with Anti-Terrorism Laws. No Borrower will, or will permit any Subsidiary to, directly or indirectly, knowingly enter into any Material Contracts with any Blocked Person or any
Person listed on the OFAC Lists. Each Borrower shall immediately notify Administrative Agent if such Borrower has knowledge that any Borrower or any additional Credit Party becomes a Blocked Person or becomes listed on the OFAC Lists or (a) is
convicted on, (b) pleads nolo contendere to, (c) is indicted on, or (d) is arraigned and held over on charges involving money laundering or predicate crimes to money laundering. No Borrower will, or will permit any Subsidiary
to, directly or indirectly, (i) conduct any business or engage in any transaction or dealing with any Blocked Person, including, without limitation, the making or receiving of any contribution of funds, goods or services to or for the benefit
of any Blocked Person, (ii) deal in, or otherwise engage in any transaction relating to, any property or interests in property blocked pursuant to Executive Order No. 13224, any similar executive order or other Anti-Terrorism Law, or
(iii) engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in Executive Order No. 13224 or other Anti-Terrorism Law.

 Section 5.12 Regulated Entities and Activities; Pensions. No Borrower will, or will permit any of its Subsidiaries (or, in the
case of clauses (c), (d), (e) or (f), any ERISA Affiliate) to, (a) become an “investment company” or a company “controlled” by an “investment company” or a “subsidiary” of an “investment
company,” all within the meaning of the Investment Company Act of 1940; (b) undertake as one of its important activities extending credit to purchase or carry margin stock (as defined in Regulation U of the Board of Governors of the
Federal Reserve System) or use any of the proceeds of any Loan directly or indirectly for the purchase of purchasing or carrying, or for the purpose of reducing or retiring any indebtedness which was originally used to purchase or carry, any margin
stock; (c) maintain or contribute to or become obligated to maintain or contribute to any Pension Plan or any Multiemployer Plan or incur any liability under Title IV of ERISA; (d) fail to meet the applicable minimum funding requirements
of ERISA with respect to any ERISA Employee Benefit Plan (to the extent any such minimum funding requirements exist with respect to any such ERISA Employee Benefit Plan), or permit a “reportable event”, as defined in Section 4043(c)
of ERISA (other than an event for which the notice requirement is waived), or a non-exempt prohibited transaction, as described in Section 406 of ERISA, to occur with respect to any Pension Plan, or make any amendment to any ERISA Employee
Benefit Plan which will result or could reasonably be expected to result in the imposition of a Lien on any property or assets of any Borrower or any such Subsidiary (or ERISA Affiliate) or the requirement that any Borrower or any such Subsidiary
(or ERISA Affiliate) post a bond or provide other security under ERISA or the Code; (e) withdraw or permit any such Subsidiary (or ERISA Affiliate) to withdraw from participation in, permit partial or complete termination of, or permit the
occurrence of any other event with respect to, any present Pension Plan that could reasonably be expected to result in any liability of any Borrower to the Pension Benefit Guaranty Corporation or its successors or any other governmental agency,
(f) fail to pay (or cause its Subsidiaries to pay) all amounts and make all contributions necessary to fund all present Pension Plans in accordance with their terms, or fail to fund or make any and all contributions to any “401(k)”,

  

 35 

 
“profit sharing” or similar defined contribution plan except to the extent that failure to so fund or make contributions to any such
“401(k)”, “profit sharing” or similar defined contribution plan would not reasonably be expected to have a Material Adverse Effect, or (f) fail to comply with the Federal Fair Labor Standards Act. 
 Section 5.13 Margin Regulations. No Borrower will, or will permit any Subsidiary to, use any of the proceeds from the Loans, directly or
indirectly, for the purpose of purchasing or carrying any “margin stock” (as defined in Regulation U of the Federal Reserve Board), for the purpose of reducing or retiring any indebtedness which was originally incurred to purchase or carry
any “margin stock” or for any other purpose which might cause any of the Loans to be considered a “purpose credit” within the meaning of Regulation T, U or X of the Federal Reserve Board. 
 Section 5.14 Foreign Bank Accounts. Borrowers will not maintain in excess of One Million Five Hundred Thousand Dollars ($1,500,000), in the
aggregate, of cash, Investment Property, Securities or other assets in Deposit Accounts or Securities Accounts maintained outside of the United States. In addition, no Borrower will deposit or transfer any cash, Investment Property, Securities or
other assets in or to any Deposit Account or Securities Account maintained outside of the United States at any time that an Event of Default has occurred and is continuing. 
 ARTICLE 6 – [RESERVED] 
 ARTICLE 7 – CONDITIONS 
 Section 7.1 Conditions to Closing. The obligation of each Lender to make the initial Loans, of Administrative Agent to issue any Support
Agreements on the Closing Date and of any LC Issuer to issue any Lender Letter of Credit on the Closing Date shall be subject to the receipt by Administrative Agent of each agreement, document and instrument set forth on the closing checklist
prepared by Administrative Agent or its counsel, each in form and substance satisfactory to Administrative Agent and Lenders and their respective counsel, and such other closing deliverables reasonably requested by Administrative Agent and Lenders,
and to the satisfaction of the following conditions precedent, each to the satisfaction of Administrative Agent and Lenders and their respective counsel in their sole discretion: (a) the payment of all fees, expenses and other amounts due and
payable under each Financing Document; (b) the absence, since December 31, 2006, of any material adverse change in any aspect of the business, operations, properties, or condition (financial or otherwise) of any Credit Party or any seller
of any assets or business to be purchased by any Borrower contemporaneous with the Closing Date, or any event or condition which could reasonably be expected to result in such a material adverse change; and (c) the receipt by Administrative
Agent of such other documents, instruments and/or agreements as Administrative Agent may reasonably request. 
 Section 7.2
Conditions to Each Loan, Support Agreement and Lender Letter of Credit. In addition to the conditions set forth in Section 7.1, the obligation of the Lenders to make a Loan (other than Revolving Loans made pursuant to Section 2.5(c))
or an advance in respect of any Loan, of Administrative Agent to issue any Support Agreement or of any LC Issuer to issue any Lender Letter of Credit, including on the Closing Date, is subject to the satisfaction of the following additional
conditions, compliance with which shall be determined by Administrative Agent: (a) the fact that, immediately before and after such advance or issuance, no Default or Event of Default shall have occurred and be continuing; (b) the fact
that the representations and warranties of each Credit Party contained in the Financing Documents shall be true, correct and complete on and as of the date of such advance or issuance, except to the extent that any such representation or warranty
relates to an earlier date in which case such representation or warranty shall be true and correct as of such earlier date; and (c) the fact that no Material Adverse Effect shall have occurred and be continuing with respect to Borrowers or any
Credit Party since the date of this Agreement. Each giving of a Notice of LC Credit Event hereunder, each giving of a Notice of Borrowing hereunder and each acceptance by any Borrower of the proceeds of any Loan made hereunder shall be deemed to be
(y) a representation and warranty by each Borrower on the date of such notice or acceptance as to the facts specified in this Section, and (z) a restatement by each Borrower that each and every one of the representations made by it in any
of the Financing Documents is true and correct in all material respects (except to the extent that such 

  

 36 

 
representations and warranties expressly relate solely to an earlier date). 
 ARTICLE 8 – [RESERVED] 
 ARTICLE 9 – SECURITY AGREEMENT 
 Section 9.1 Generally. As security for the payment and performance of the Obligations, and without limiting any other grant of a Lien and
security interest in any Security Document, Borrowers hereby assign and grant to Administrative Agent, for the benefit of Lenders and Administrative Agent, a continuing first priority Lien on and security interest in, upon, and to the personal
property set forth on Schedule 9.1 attached hereto and made a part hereof. The Administrative Agent and the Lenders hereby acknowledge and agree that they will not file a security agreement or other filing with the United States Patent
and Trademark Office or the United States Copyright Office with regard to the Collateral. 
 Section 9.2 Representations and
Warranties and Covenants Relating to Collateral. 
 (a) Borrowers shall not, and shall not permit any Credit Party to, take any of the
following actions or make any of the following changes unless Borrowers have given at least thirty (30) days prior written notice to Administrative Agent of Borrowers’ intention to take any such action (which such written notice shall
include an updated version of any Schedule impacted by such change) and have executed any and all documents, instruments and agreements and taken any other actions which Administrative Agent may request after receiving such written notice in order
to protect and preserve the Liens, rights and remedies of Administrative Agent with respect to the Collateral: (i) change the legal name or organizational identification number of any Borrower as it appears in official filings in the
jurisdiction of its organization, (ii) change the jurisdiction of incorporation or formation of any Borrower or Credit Party or allow any Borrower or Credit Party to designate any jurisdiction as an additional jurisdiction of incorporation for
such Borrower or Credit Party, or change the type of entity that it is, or (iii) change its chief executive office, principal place of business, or the location of its records concerning the Collateral or move any Collateral to or place any
Collateral on any location that is not then listed on the Schedules and/or establish any business location at any location that is not then listed on the Schedules. 
 (b) Borrowers shall not adjust, settle or compromise the amount or payment of any Account, or release wholly or partly any Account Debtor, or allow any credit or discount thereon (other than adjustments, settlements,
compromises, credits and discounts in the Ordinary Course of Business, made while no Default or Event of Default exists and in amounts which are not material with respect to the Account and which, after giving effect thereto, do not cause the
Borrowing Base to be less than the Revolving Loan Outstandings) without the prior written consent of Administrative Agent, which consent shall not be unreasonably withheld. Without limiting the generality of this Agreement or any other provisions of
any of the Financing Documents relating to the rights of Administrative Agent after the occurrence and during the continuance of an Event of Default, Administrative Agent shall have the right at any time after the occurrence and during the
continuance of an Event of Default to: (i) exercise the rights of Borrowers with respect to the obligation of any Account Debtor to make payment or otherwise render performance to Borrowers and with respect to any property that secures the
obligations of any Account Debtor or any other Person obligated on the Collateral, and (ii) adjust, settle or compromise the amount or payment of such Accounts. 
 (c) (i) Borrowers shall deliver to Administrative Agent all Tangible Chattel Paper and all Instruments and Documents owned by any Borrower and constituting part of the Collateral duly endorsed and accompanied by duly
executed instruments of transfer or assignment, all in form and substance satisfactory to Administrative Agent. Borrowers shall provide Administrative Agent with “control” (as defined in Article 9 of the UCC) of all Electronic Chattel
Paper owned by any Borrower and constituting part of the Collateral by having Administrative Agent identified as the assignee on the records pertaining to the single authoritative copy thereof and otherwise complying with the applicable elements of
control set forth in the UCC. Borrowers also shall deliver to Administrative Agent all security agreements securing any such Chattel Paper and securing any such Instruments. Borrowers will mark conspicuously all such Chattel Paper and all such
Instruments and Documents with a legend, in form and substance satisfactory to Administrative Agent, indicating that such Chattel Paper and such Instruments and Documents are subject to the security interests and Liens in favor of Administrative
Agent created pursuant to 

  

 37 

 
this Agreement and the Security Documents. Borrowers shall comply with all the provisions of Section 5.9 with respect to the Deposit Accounts and
Securities Accounts of Borrowers. 
 (ii) Borrowers shall deliver to Administrative Agent all letters of credit on which any Borrower is the
beneficiary and which give rise to Letter-of-Credit Rights owned by such Borrower which constitute part of the Collateral in each case duly endorsed and accompanied by duly executed instruments of transfer or assignment, all in form and substance
satisfactory to Administrative Agent. Borrowers shall take any and all actions as may be necessary or desirable, or that Administrative Agent may request, from time to time, to cause Administrative Agent to obtain exclusive “control” (as
defined in Article 9 of the UCC) of any such Letter-of-Credit Rights in a manner acceptable to Administrative Agent. 
 (iii) Borrowers shall
promptly advise Administrative Agent upon any Borrower becoming aware that it has any interests in any Commercial Tort Claim that constitutes part of the Collateral, which such notice shall include descriptions of the events and circumstances giving
rise to such Commercial Tort Claim and the dates such events and circumstances occurred, the potential defendants with respect such Commercial Tort Claim and any court proceedings that have been instituted with respect to such Commercial Tort Claim,
and Borrowers shall, with respect to any such Commercial Tort Claim, execute and deliver to Administrative Agent such documents as Administrative Agent shall request to perfect, preserve or protect the Liens, rights and remedies of Administrative
Agent with respect to any such Commercial Tort Claim. 
 (iv) Except for Accounts and Inventory in an aggregate amount not to exceed One
Hundred Thousand Dollars ($100,000), no Accounts or Inventory or other Collateral shall at any time be in the possession or control of any warehouse, consignee, bailee or any of Borrowers’ agents or processors without prior written notice to
Administrative Agent and the receipt by Administrative Agent, if Administrative Agent has so requested, of warehouse receipts, consignment agreements or bailee lien waivers (as applicable) satisfactory to Administrative Agent prior to the
commencement of such possession or control. Borrowers have notified Administrative Agent that Inventory is currently located at the locations set forth on Schedule 9.2. Borrowers shall, upon the request of Administrative Agent, notify
any such warehouse, consignee, bailee, agent or processor of the security interests and Liens in favor of Administrative Agent created pursuant to this Agreement and the Security Documents, instruct such Person to hold all such Collateral for
Administrative Agent’s account subject to Administrative Agent’s instructions and shall obtain an acknowledgement from such Person that such Person holds the Collateral for Administrative Agent’s benefit. 
 (v) Upon request of Administrative Agent, Borrowers shall promptly deliver to Administrative Agent any and all certificates of title, applications for
title or similar evidence of ownership of all such tangible Personal Property and shall cause Administrative Agent to be named as lienholder on any such certificate of title or other evidence of ownership. Borrowers shall not permit any such
tangible Personal Property to become Fixtures to real estate unless such real estate is subject to a Lien in favor of Administrative Agent. 
 (vi) Each Borrower hereby authorizes Administrative Agent to file without the signature of such Borrower one or more UCC financing statements relating to liens on personal property relating to all or any part of the Collateral, which
financing statements may list Administrative Agent as the “secured party” and such Borrower as the “debtor” and which describe and indicate the collateral covered thereby as all or any part of the Collateral under the Financing
Documents (including an indication of the collateral covered by any such financing statement as “all assets” of such Borrower now owned or hereafter acquired, excluding only the Excluded Property) in such jurisdictions as Administrative
Agent from time to time determines are appropriate, and to file without the signature of such Borrower any continuations of or corrective amendments to any such financing statements, in any such case in order for Administrative Agent to perfect,
preserve or protect the Liens, rights and remedies of Administrative Agent with respect to the Collateral. 
 (vii) Borrowers shall furnish
to Administrative Agent from time to time any statements and schedules further identifying or describing the Collateral and any other information, reports or evidence concerning the Collateral as Administrative Agent may reasonably request from time
to time. 
 Section 9.3 UCC Remedies. 
  

 38 

 (a) Upon the occurrence of and during the continuance of an Event of Default under this Agreement or the
other Financing Documents, Administrative Agent, in addition to all other rights, options, and remedies granted to Administrative Agent under this Agreement or at law or in equity, may exercise, either directly or through one or more assignees or
designees, all rights and remedies granted to it under all Financing Documents and under the UCC in effect in the applicable jurisdiction(s) and under any other applicable law; including, without limitation: 
 (i) The right to take possession of, send notices regarding, and collect directly the Collateral, with or without judicial process; 
 (ii) The right to (by its own means or with judicial assistance) enter any of Borrowers’ premises and take possession of the Collateral, or render
it unusable, or to render it usable or saleable, or dispose of the Collateral on such premises in compliance with subsection (iii) below and to take possession of Borrowers’ original books and records, to obtain access to Borrowers’
data processing equipment, computer hardware and software relating to the Collateral and to use all of the foregoing and the information contained therein in any manner Administrative Agent deems appropriate, without any liability for rent, storage,
utilities, or other sums, and Borrowers shall not resist or interfere with such action (if Borrowers’ books and records are prepared or maintained by an accounting service, contractor or other third party agent, Borrowers hereby irrevocably
authorize such service, contractor or other agent, upon notice by Administrative Agent to such Person that an Event of Default has occurred and is continuing, to deliver to Administrative Agent or its designees such books and records, and to follow
Administrative Agent’s instructions with respect to further services to be rendered); 
 (iii) The right to require Borrowers at
Borrowers’ expense to assemble all or any part of the Collateral and make it available to Administrative Agent at any place designated by Administrative Agent; 
 (iv) The right to notify postal authorities to change the address for delivery of Borrowers’ mail to an address designated by Administrative Agent and to receive, open and dispose of all mail addressed to any
Borrower. 
 (v) The right to enforce Borrowers’ rights against Account Debtors and other obligors, including, without limitation,
(i) the right to collect Accounts directly in Administrative Agent’s own name (as agent for Lenders) and to charge the collection costs and expenses, including attorneys’ fees, to Borrowers, and (ii) the right, in the name of
Administrative Agent or any designee of Administrative Agent or Borrowers, to verify the validity, amount or any other matter relating to any Accounts by mail, telephone, telegraph or otherwise, including, without limitation, verification of
Borrowers’ compliance with applicable Laws. Borrowers shall cooperate fully with Administrative Agent in an effort to facilitate and promptly conclude such verification process. Such verification may include contacts between Administrative
Agent and applicable federal, state and local regulatory authorities having jurisdiction over the Borrowers’ affairs, all of which contacts Borrowers hereby irrevocably authorize. 
 (b) Each Borrower agrees that a notice received by it at least ten (10) days before the time of any intended public sale, or the time after which
any private sale or other disposition of the Collateral is to be made, shall be deemed to be reasonable notice of such sale or other disposition. If permitted by applicable law, any perishable Collateral which threatens to speedily decline in value
or which is sold on a recognized market may be sold immediately by Administrative Agent without prior notice to Borrowers. At any sale or disposition of Collateral, Administrative Agent may (to the extent permitted by applicable law) purchase all or
any part of the Collateral, free from any right of redemption by Borrowers, which right is hereby waived and released. Each Borrower covenants and agrees not to interfere with or impose any obstacle to Administrative Agent’s exercise of its
rights and remedies with respect to the Collateral. Administrative Agent shall have no obligation to clean-up or otherwise prepare the Collateral for sale. Administrative Agent may comply with any applicable state or federal law requirements in
connection with a disposition of the Collateral and compliance will not be considered to adversely affect the commercial reasonableness of any sale of the Collateral. Administrative Agent may sell the Collateral without giving any warranties as to
the Collateral. Administrative Agent may specifically disclaim any warranties of title or the like. This procedure will not be considered to adversely affect the commercial reasonableness of any sale of the Collateral. If Administrative Agent sells
any of the Collateral upon credit, Borrowers will be credited only with payments actually made by the purchaser, received by Administrative Agent and applied to the 

  

 39 

 
indebtedness of the purchaser. In the event the purchaser fails to pay for the Collateral, Administrative Agent may resell the Collateral and Borrowers shall
be credited with the proceeds of the sale. Borrowers shall remain liable for any deficiency if the proceeds of any sale or disposition of the Collateral are insufficient to pay all Obligations. 
 (c) Without restricting the generality of the foregoing and for the purposes aforesaid, each Borrower hereby appoints and constitutes Administrative
Agent its lawful attorney-in-fact with full power of substitution in the Collateral, upon the occurrence and during the continuance of an Event of Default, to use unadvanced funds remaining under this Agreement or which may be reserved, escrowed or
set aside for any purposes hereunder at any time, or to advance funds in excess of the face amount of the Notes, to pay, settle or compromise all existing bills and claims, which may be Liens or security interests, or to avoid such bills and claims
becoming Liens against the Collateral; to execute all applications and certificates in the name of such Borrower and to prosecute and defend all actions or proceedings in connection with the Collateral; and to do any and every act which such
Borrower might do in its own behalf; it being understood and agreed that this power of attorney shall be a power coupled with an interest and cannot be revoked. 
 (d) To the extent permissible under applicable agreements, Administrative Agent and each Lender is hereby granted an irrevocable, non-exclusive, royalty-free license or other right to use, without charge,
Borrowers’ labels, mask works, rights of use of any name, any other Intellectual Property and advertising matter, and any similar property as it pertains to the Collateral, in completing production of, advertising for sale, and selling any
Collateral and, in connection with Administrative Agent’s exercise of its rights under this Article, Borrowers’ rights under all licenses and all franchise agreements inure to Administrative Agent’s and each Lender’s
benefit. 
 ARTICLE 10 – EVENTS OF DEFAULT 
 Section 10.1 Events of Default. 
 For purposes of the Financing Documents, the occurrence of any
of the following conditions and/or events, whether voluntary or involuntary, by operation of law or otherwise, shall constitute an “Event of Default”: 
 (a) any Borrower shall fail to pay when due any principal, interest, premium or fee under any Financing Document or any other amount payable under any Financing Document, in each case within three (3) Business
Days after any such principal, interest or fee becomes due, or there shall occur any default in the performance of or compliance with Section 2.11 or 4.14; 
 (b) any Credit Party defaults in the performance of or compliance with any term contained in this Agreement or in any other Financing Document (other than occurrences described in other provisions of this
Section 10.1 for which a different grace or cure period is specified or for which no grace or cure period is specified and thereby constitute immediate Events of Default) and such default is not remedied by the Credit Party or waived by
Administrative Agent within (i) with respect to any default under Article 5, Section 4.1, Section 4.3(a), or Section 4.3(c), five (5) days of the occurrence of such default or the event giving rise to such default;
(ii) with respect to all other matters, twenty (20) days after the Borrower Representative receives notice thereof from Administrative Agent; 
 (c) any representation, warranty, certification or statement made by any Credit Party or any other Person in any Financing Document or in any certificate, financial statement or other document delivered pursuant to
any Financing Document is incorrect in any respect (or in any material respect if such representation, warranty, certification or statement is not by its terms already qualified as to materiality) when made (or deemed made); 
 (d) (i) failure of any Credit Party to pay when due or within any applicable grace period any principal, interest or other amount on Debt (other than the
Loans), or the occurrence of any breach, default, condition or event with respect to any Debt (other than the Loans), if the effect of such failure or occurrence is to cause or to permit the holder or holders of any such Debt to cause, Debt or other
liabilities having an individual principal amount in excess of One Hundred Fifty Thousand Dollars ($150,000) or having an aggregate principal amount in excess of One Hundred Fifty Thousand Dollars ($150,000) to become or be declared due prior to its
stated maturity; or (ii) the occurrence of any breach or default under any terms or provisions of any Subordinated Debt Document or under any 

  

 40 

 
agreement subordinating the Subordinated Debt to all or any portion of the Obligations or the occurrence of any event requiring the prepayment of any
Subordinated Debt; 
 (e) any Credit Party or any Subsidiary of a Borrower shall commence a voluntary case or other proceeding seeking
liquidation, reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other
similar official of it or any substantial part of its property, or shall consent to any such relief or to the appointment of or taking possession by any such official in an involuntary case or other proceeding commenced against it, or shall make a
general assignment for the benefit of creditors, or shall fail generally to pay its debts as they become due, or shall take any corporate action to authorize any of the foregoing; 
 (f) an involuntary case or other proceeding shall be commenced against any Credit Party or any Subsidiary of a Borrower seeking liquidation,
reorganization or other relief with respect to it or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, custodian or other similar official of it
or any substantial part of its property, and such involuntary case or other proceeding shall remain undismissed and unstayed for a period of sixty (60) days; or an order for relief shall be entered against any Credit Party or any Subsidiary of
a Borrower under applicable federal bankruptcy, insolvency or other similar law in respect of (i) bankruptcy, liquidation, winding-up, dissolution or suspension of general operations, (ii) composition, rescheduling, reorganization,
arrangement or readjustment of, or other relief from, or stay of proceedings to enforce, some or all of the debts or obligations, or (iii) possession, foreclosure, seizure or retention, sale or other disposition of, or other proceedings to
enforce security over, all or any substantial part of the assets of such Credit Party or Subsidiary; 
 (g) (i) institution of any steps by
any Person to terminate any Pension Plan of any Borrower, or any of its Subsidiaries or ERISA Affiliates (if any such Pension Plan exists) if as a result of such termination any Credit Party or any ERISA Affiliate could be required to make a
contribution to such Pension Plan, or could incur a liability or obligation to such Pension Plan, in excess of One Hundred Thousand Dollars ($100,000), (ii) a contribution failure occurs with respect to any Pension Plan of any Borrower, or any
of its Subsidiaries or ERISA Affiliates (if any such Pension Plan exists) sufficient to give rise to a Lien on any property or assets of any Borrower or any of its Subsidiaries or ERISA Affiliates under Section 302(f) of ERISA, or
(iii) there shall occur any complete withdrawal or partial withdrawal from a Multiemployer Plan by any Borrower, or any of its Subsidiaries or ERISA Affiliate (if any such Multiemployer Plan to which any Borrower, or any of its Subsidiaries or
ERISA Affiliate contributes exists) and the withdrawal liability (without unaccrued interest) of Borrowers, and their Subsidiaries and ERISA Affiliates to Multiemployer Plans to which any of them contributes or has contributed (including any
outstanding withdrawal liability that such Borrower, or any applicable Subsidiary or ERISA Affiliate has incurred on the date of such withdrawal) exceeds One Hundred Thousand Dollars ($100,000) ; 
 (h) one or more judgments or orders for the payment of money (not paid or fully covered by insurance maintained in accordance with the requirements of
this Agreement and as to which the relevant insurance company has acknowledged coverage) aggregating in excess of $150,000 shall be rendered against any or all Credit Parties and either (i) enforcement proceedings shall have been commenced by
any creditor upon any such judgments or orders, or (ii) there shall be any period of twenty (20) consecutive days during which a stay of enforcement of any such judgments or orders, by reason of a pending appeal, bond or otherwise, shall
not be in effect; 
 (i) any Lien created by any of the Security Documents shall at any time fail to constitute a valid and perfected Lien on
all of the Collateral purported to be encumbered thereby, subject to no prior or equal Lien except Permitted Liens, or any Credit Party shall so assert; 
 (j) the institution by any Governmental Authority of criminal proceedings against any Credit Party; 
 (k) a
default or event of default occurs under any guaranty of any portion of the Obligations; 
 (l) any Borrower makes any payment on account of
any Debt that has been subordinated to any of the Obligations, other than payments specifically permitted by the terms of such subordination; 
  

 41 

 (m) if the Principal Borrower is or becomes an entity whose equity is registered with the SEC, and/or is
publicly traded on and/or registered with a public securities exchange, the Principal Borrower’s equity fails to remain registered with the SEC in good standing, and/or such equity fails to remain publicly traded on and registered with a public
securities exchange; 
 (n) the occurrence of any fact, event or circumstance that has or that could reasonably be expected to result in a
Material Adverse Effect, if such default shall have continued unremedied for a period of ten (10) days after written notice from Administrative Agent; or 
 (o) Administrative Agent determines, based on information available to it and in its reasonable judgment, that there is a reasonable likelihood that Borrowers shall fail to comply with one or more financial covenants
in Article 6, if any, during the next succeeding financial reporting period. 
 All cure periods provided for in this Section shall run
concurrently with any cure period provided for in any applicable Financing Documents under which the default occurred. 
 Section 10.2 Acceleration and Suspension or Termination of Revolving Loan Commitment. Upon the occurrence and during the continuance of an Event of Default, (a) by notice to Borrower Representative suspend or terminate the
Revolving Loan Commitment and the obligations of Administrative Agent and Lenders with respect thereto, in whole or in part (and, if in part, each Lender’s Revolving Loan Commitment shall be reduced in accordance with its Pro Rata Share),
and/or (b) by notice to Borrower Representative declare the Obligations to be, and the Obligations shall thereupon become, immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby
waived by each Borrower and Borrowers will pay the same; provided, however, that in the case of any of the Events of Default specified in Section 10.1(e) or 10.1(f) above, without any notice to any Borrower or any other act by
Administrative Agent or the Lenders, the Revolving Loan Commitment and the obligations of Administrative Agent and the Lenders with respect thereto shall thereupon immediately and automatically terminate and all of the Obligations shall become
immediately and automatically due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby waived by each Borrower and Borrowers will pay the same. 
 Section 10.3 Cash Collateral. If (a) any Event of Default specified in Section 10.1(e) or 10.1(f) shall occur, (b) the
Obligations shall have otherwise been accelerated pursuant to Section 10.2, or (c) the Revolving Loan Commitment and the obligations of Administrative Agent and the Lenders with respect thereto shall have been terminated pursuant to
Section 10.2, then without any request or the taking of any other action by Administrative Agent or the Lenders, Borrowers shall immediately comply with the provisions of Section 2.5(e) with respect to the deposit of cash collateral to
secure the existing Letter of Credit Liability and future payment of related fees. 
 Section 10.4 Default Rate of Interest. At
the election of Administrative Agent or Required Lenders, after the occurrence of an Event of Default and for so long as it continues, (a) the Loans and other Obligations shall bear interest at rates that are five percent (5.0%) per annum
in excess of the rates otherwise payable under this Agreement, and (b) the fee described in Section 2.5(b) shall increase by a rate that is five percent (5.0%) in excess of the rate otherwise payable under such Section; provided that,
notwithstanding anything to the contrary contained in the foregoing or otherwise in this Agreement, the increased rates of default interest and fees under Section 2.5(b) provided for in this section shall be applicable automatically and
immediately upon the occurrence and during the continuance of any Event of Default occurring under Section 10.1(e) or 10.1(f) above without the necessity of any further affirmative action by any party. 
 Section 10.5 Setoff Rights. During the continuance of any Event of Default, each Lender is hereby authorized by each Borrower at any time or
from time to time, with reasonably prompt subsequent notice to such Borrower (any prior or contemporaneous notice being hereby expressly waived) to set off and to appropriate and to apply any and all (a) balances held by such Lender or any of
such Lender’s Affiliates at any of its offices for the account of such Borrower or any of its Subsidiaries (regardless of whether such balances are then due to such Borrower or its Subsidiaries), and (b) other property at any time held or
owing by such Lender to or for the credit or for the account of such Borrower or any of its Subsidiaries, against and on account of any of the Obligations; except that no Lender shall exercise any such right without the prior written consent of
Administrative Agent. Any Lender 

  

 42 

 
exercising a right to set off shall purchase for cash (and the other Lenders shall sell) interests in each of such other Lender’s Pro Rata Share of the
Obligations as would be necessary to cause all Lenders to share the amount so set off with each other Lender in accordance with their respective Pro Rata Share of the Obligations. Each Borrower agrees, to the fullest extent permitted by law, that
any Lender and any of such Lender’s Affiliates may exercise its right to set off with respect to the Obligations as provided in this Section. 
 Section 10.6 Application of Proceeds. Notwithstanding anything to the contrary contained in this Agreement, upon the occurrence and during the continuance of an Event of Default, (a) each Borrower irrevocably waives the
right to direct the application of any and all payments at any time or times thereafter received by Administrative Agent from or on behalf of such Borrower or any other Credit Party of all or any part of the Obligations, and, as between Borrowers on
the one hand and Administrative Agent and Lenders on the other, Administrative Agent shall have the continuing and exclusive right to apply and to reapply any and all payments received against the Obligations in such manner as Administrative Agent
may deem advisable notwithstanding any previous application by Administrative Agent, and (b) the proceeds of any sale of, or other realization upon, all or any part of the Collateral shall be applied: first, to all fees, costs,
indemnities, liabilities, obligations and expenses incurred by or owing to Administrative Agent with respect to this Agreement, the other Financing Documents or the Collateral; second, to all fees, costs, indemnities, liabilities, obligations
and expenses incurred by or owing to any Lender with respect to this Agreement, the other Financing Documents or the Collateral; third, to accrued and unpaid interest on the Obligations (including any interest which, but for the provisions of
the Bankruptcy Code, would have accrued on such amounts); fourth, to the principal amount of the Obligations outstanding and to provide cash collateral to secure any and all Letter of Credit Liability and future payment of related fees, as
provided for in Section 2.5(e); and fifth to any other indebtedness or obligations of Borrowers owing to Administrative Agent or any Lender under the Financing Documents. Any balance remaining shall be delivered to Borrowers or to
whoever may be lawfully entitled to receive such balance or as a court of competent jurisdiction may direct. In carrying out the foregoing, (x) amounts received shall be applied in the numerical order provided until exhausted prior to the
application to the next succeeding category, and (y) each of the Persons entitled to receive a payment in any particular category shall receive an amount equal to its pro rata share of amounts available to be applied pursuant thereto for such
category. 
 Section 10.7 Waivers and Remedies. 
 (a) Except as otherwise provided for in this Agreement and to the fullest extent permitted by applicable law, each Borrower waives: (i) presentment, demand and protest, and notice of presentment, dishonor, intent
to accelerate, acceleration, protest, default, nonpayment, maturity, release, compromise, settlement, extension or renewal of any or all Financing Documents, the Notes or any other notes, commercial paper, Accounts, contracts, Documents,
Instruments, Chattel Paper and guaranties at any time held by Lenders on which any Borrower may in any way be liable, and hereby ratifies and confirms whatever Lenders may do in this regard; (ii) all rights to notice and a hearing prior to
Administrative Agent’s or any Lender’s taking possession or control of, or to Administrative Agent’s or any Lender’s replevy, attachment or levy upon, any Collateral or any bond or security which might be required by any court
prior to allowing Administrative Agent or any Lender to exercise any of its remedies; and (iii) the benefit of all valuation, appraisal, marshalling and exemption Laws. The rights and remedies herein and therein provided shall be cumulative and
not exclusive of any rights or remedies provided by law. Any reference in any Financing Document to the “continuing” nature of any Event of Default shall not be construed as establishing or otherwise indicating that any Borrower or any
other Credit Party has the independent right to cure any such Event of Default, but is rather presented merely for convenience should such Event of Default be waived in accordance with the terms of the applicable Financing Documents. 
 (b) Each Borrower for itself and all its successors and assigns, (i) agrees that its liability shall not be in any manner affected by any
acquiescence in non-compliance, indulgence, extension of time, renewal, waiver, or modification made, granted or consented to by Administrative Agent or any Lender; (ii) consents to any indulgences and all extensions of time, renewals, waivers,
or modifications that may be granted by Administrative Agent or any Lender with respect to the payment or other provisions of the Financing Documents, and to any substitution, exchange or release of the Collateral, or any part thereof, with or
without substitution, and agrees to the addition or release of any Borrower, endorsers, guarantors, or sureties, or whether primarily or secondarily liable, without notice to any other Borrower and without affecting its liability hereunder;
(iii) agrees that its liability shall be unconditional 

  

 43 

 
and without regard to the liability of any other Borrower, Administrative Agent or any Lender for any tax on the indebtedness; and (iv) to the fullest
extent permitted by law, expressly waives the benefit of any statute or rule of law or equity now provided, or which may hereafter be provided, which would produce a result contrary to or in conflict with the foregoing. 
 (c) Any delay or forbearance by Administrative Agent or any Lender in exercising any right or remedy under any of the Financing Documents, or otherwise
afforded by applicable law, including any failure to accelerate the maturity date of the Loans, shall not be a waiver of or preclude the exercise of any right or remedy nor shall it serve as a novation of the Notes or as a reinstatement of the Loans
or a waiver of such right of acceleration or the right to insist upon strict compliance of the terms of the Financing Documents. Administrative Agent’s or any Lender’s acceptance of payment of any sum secured by any of the Financing
Documents after the due date of such payment shall not be a waiver of Administrative Agent’s and such Lender’s right to either require prompt payment when due of all other sums so secured or to declare a default for failure to make prompt
payment. 
 (d) Without limiting the generality of anything contained in this Agreement or the other Financing Documents, each Borrower
agrees that if an Event of Default is continuing (i) Administrative Agent and Lenders shall not be subject to any “one action” or “election of remedies” law or rule, and (ii) all Liens and other rights, remedies or
privileges provided to Administrative Agent or Lenders shall remain in full force and effect until Administrative Agent or Lenders have exhausted all remedies against the Collateral and any other properties owned by Borrowers and the Financing
Documents and other security instruments or agreements securing the Loans have been foreclosed, sold and/or otherwise realized upon in satisfaction of Borrowers’ obligations under the Financing Documents. 
 (e) Administrative Agent shall have the right from time to time to partially foreclose upon any Collateral in any manner and for any amounts secured by
the Financing Documents then due and payable as determined by Administrative Agent in its sole discretion. Notwithstanding one or more partial foreclosures, any unforeclosed Collateral shall remain subject to the Financing Documents to secure
payment of sums secured by the Financing Documents and not previously recovered. To the fullest extent permitted by law, each Borrower, for itself and its successors and assigns, waives in the event of foreclosure of any or all of the Collateral any
equitable right otherwise available to any Credit Party which would require the separate sale of any of the Collateral or require Administrative Agent or Lenders to exhaust their remedies against any part of the Collateral before proceeding against
any other part of the Collateral; and further in the event of such foreclosure each Borrower does hereby expressly consent to and authorize, at the option of Administrative Agent, the foreclosure and sale either separately or together of each part
of the Collateral. 
 Section 10.8 Injunctive Relief. The parties acknowledge and agree that, in the event of a breach or
threatened breach of any Credit Party’s obligations under any Financing Documents, Administrative Agent and Lenders may have no adequate remedy in money damages and, accordingly, shall be entitled to an injunction (including, without
limitation, a temporary restraining order, preliminary injunction, writ of attachment, or order compelling an audit) against such breach or threatened breach, including, without limitation, maintaining any cash management and collection procedure
described herein. However, no specification in this Agreement of a specific legal or equitable remedy shall be construed as a waiver or prohibition against any other legal or equitable remedies in the event of a breach or threatened breach of any
provision of this Agreement. Each Credit Party waives, to the fullest extent permitted by law, the requirement of the posting of any bond in connection with such injunctive relief. By joining in the Financing Documents as a Credit Party, each Credit
Party specifically joins in this Section as if this Section were a part of each Financing Document executed by such Credit Party. 
 ARTICLE 11 – ADMINISTRATIVE AGENT 
 Section 11.1 Appointment and Authorization. Each Lender hereby
irrevocably appoints and authorizes Administrative Agent to be the agent of Lender under and with respect to this Agreement and the other Financing Documents and to enter into each of the Financing Documents to which it is a party (other than this
Agreement) on its behalf and to take such actions as Administrative Agent on its behalf and to exercise such powers under the Financing Documents as are delegated to Administrative Agent by the terms thereof, together with all such powers as are
reasonably incidental thereto. Subject to the terms of Section 12.5 and to the terms of the other 

  

 44 

 
Financing Documents, Administrative Agent is authorized and empowered to amend, modify, or waive any provisions of this Agreement or the other Financing
Documents on behalf of Lenders. The provisions of this Article 11 are solely for the benefit of Administrative Agent and Lenders and neither Borrowers nor any other Credit Party shall have any rights as a third party beneficiary of any of the
provisions hereof. In performing its functions and duties under this Agreement, Administrative Agent shall act solely as agent of Lenders and does not assume and shall not be deemed to have assumed any obligation toward or relationship of agency or
trust with or for Borrowers or any other Credit Party. Administrative Agent may perform any of its duties hereunder, or under the Financing Documents, by or through its own agents or employees. 
 Section 11.2 Administrative Agent and Affiliates. Administrative Agent shall have the same rights and powers under the Financing Documents as
any other Lender and may exercise or refrain from exercising the same as though it were not Administrative Agent, and Administrative Agent and its Affiliates may lend money to, invest in and generally engage in any kind of business with each Credit
Party or Affiliate of any Credit Party as if it were not Administrative Agent hereunder. 
 Section 11.3 Action by Administrative
Agent. The duties of Administrative Agent shall be mechanical and administrative in nature. Administrative Agent shall not have by reason of this Agreement a fiduciary relationship in respect of any Lender. Nothing in this Agreement or any of
the Financing Documents is intended to or shall be construed to impose upon Administrative Agent any obligations in respect of this Agreement or any of the Financing Documents except as expressly set forth herein or therein. 
 Section 11.4 Consultation with Experts. Administrative Agent may consult with legal counsel, independent public accountants and other experts
selected by it and shall not be liable for any action taken or omitted to be taken by it in good faith in accordance with the advice of such counsel, accountants or experts. 
 Section 11.5 Liability of Administrative Agent. Neither Administrative Agent nor any of its directors, officers, agents or employees shall be
liable to any Lender for any action taken or not taken by it in connection with the Financing Documents, except that Administrative Agent shall be liable with respect to its specific duties set forth hereunder, but only to the extent of its own
gross negligence or willful misconduct in the discharge thereof as determined by a final non-appealable judgment of a court of competent jurisdiction. Neither Administrative Agent nor any of its directors, officers, agents or employees shall be
responsible for or have any duty to ascertain, inquire into or verify (i) any statement, warranty or representation made in connection with any Financing Document or any borrowing hereunder; (ii) the performance or observance of any of the
covenants or agreements specified in any Financing Document; (iii) the satisfaction of any condition specified in any Financing Document; (iv) the validity, effectiveness, sufficiency or genuineness of any Financing Document, any Lien
purported to be created or perfected thereby or any other instrument or writing furnished in connection therewith; (v) the existence or non-existence of any Default or Event of Default; or (vi) the financial condition of any Credit Party.
Administrative Agent shall not incur any liability by acting in reliance upon any notice, consent, certificate, statement, or other writing (which may be a bank wire, telex, facsimile or electronic transmission or similar writing) believed by it to
be genuine or to be signed by the proper party or parties. Administrative Agent shall not be liable for any apportionment or distribution of payments made by it in good faith and if any such apportionment or distribution is subsequently determined
to have been made in error the sole recourse of any Lender to whom payment was due but not made, shall be to recover from other Lenders any payment in excess of the amount to which they are determined to be entitled (and such other Lenders hereby
agree to return to such Lender any such erroneous payments received by them). 
 Section 11.6 Indemnification. Each Lender shall,
in accordance with its Pro Rata Share, indemnify Administrative Agent (to the extent not reimbursed by Borrowers) upon demand against any cost, expense (including counsel fees and disbursements), claim, demand, action, loss or liability (except such
as result from Administrative Agent’s gross negligence or willful misconduct as determined by a final non-appealable judgment of a court of competent jurisdiction) that Administrative Agent may suffer or incur in connection with the Financing
Documents or any action taken or omitted by Administrative Agent hereunder or thereunder. If any indemnity furnished to Administrative Agent for any purpose shall, in the opinion of Administrative Agent, be insufficient or become impaired,
Administrative Agent may call for additional indemnity and cease, or not commence, to do the acts indemnified against even if so directed by Required Lenders until such additional indemnity is furnished. 
  

 45 

 Section 11.7 Right to Request and Act on Instructions. Administrative Agent may at any time
request instructions from Lenders with respect to any actions or approvals which by the terms of this Agreement or of any of the Financing Documents Administrative Agent is permitted or desires to take or to grant, and if such instructions are
promptly requested, Administrative Agent shall be absolutely entitled to refrain from taking any action or to withhold any approval and shall not be under any liability whatsoever to any Person for refraining from any action or withholding any
approval under any of the Financing Documents until it shall have received such instructions from Required Lenders or all or such other portion of the Lenders as shall be prescribed by this Agreement. Without limiting the foregoing, no Lender shall
have any right of action whatsoever against Administrative Agent as a result of Administrative Agent acting or refraining from acting under this Agreement or any of the other Financing Documents in accordance with the instructions of Required
Lenders (or all or such other portion of the Lenders as shall be prescribed by this Agreement) and, notwithstanding the instructions of Required Lenders (or such other applicable portion of the Lenders), Administrative Agent shall have no obligation
to take any action if it believes, in good faith, that such action would violate applicable Laws or exposes Administrative Agent to any liability for which it has not received satisfactory indemnification in accordance with the provisions of
Section 11.6. 
 Section 11.8 Credit Decision. Each Lender acknowledges that it has, independently and without reliance upon
Administrative Agent or any other Lender, and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and
without reliance upon Administrative Agent or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking any action under the Financing
Documents. 
 Section 11.9 Collateral Matters. Lenders irrevocably authorize Administrative Agent, at its option and in its
discretion, to (x) release any Lien granted to or held by Administrative Agent under any Security Document (i) upon termination of the Revolving Loan Commitment and payment in full of all Obligations, the expiration, termination or cash
collateralization (to the satisfaction of Administrative Agent) of all Letters of Credit; or (ii) constituting property sold or disposed of as part of or in connection with any disposition permitted under any Financing Document (it being
understood and agreed that Administrative Agent may conclusively rely without further inquiry on a certificate of a Responsible Officer as to the sale or other disposition of property being made in full compliance with the provisions of the
Financing Documents) and (y) release or subordinate any Lien granted to or held by Administrative Agent under any Security Document constituting property which is the subject of a Permitted Asset Disposition (it being understood and agreed that
Administrative Agent may conclusively rely without further inquiry on a certificate of a Responsible Officer as to the identification of any property which is the subject of a Permitted Asset Disposition). Upon request by Administrative Agent at any
time, Lenders will confirm Administrative Agent’s authority to release and/or subordinate particular types or items of Collateral pursuant to this Section. 
 Section 11.10 Agency for Perfection. Administrative Agent and each Lender hereby appoint each other Lender as agent for the purpose of perfecting Administrative Agent’s security interest in assets
which, in accordance with the Uniform Commercial Code in any applicable jurisdiction, can be perfected by possession or control. Should any Lender (other than Administrative Agent) obtain possession or control of any such assets, such Lender shall
notify Administrative Agent thereof, and, promptly upon Administrative Agent’s request therefor, shall deliver such assets to Administrative Agent or in accordance with Administrative Agent’s instructions or transfer control to
Administrative Agent in accordance with Administrative Agent’s instructions. Each Lender agrees that it will not have any right individually to enforce or seek to enforce any Security Document or to realize upon any Collateral for the Loans
unless instructed to do so by Administrative Agent (or consented to by Administrative Agent, as provided in Section 10.5), it being understood and agreed that such rights and remedies may be exercised only by Administrative Agent. 

Section 11.11 Notice of Default. Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or
Event of Default except with respect to defaults in the payment of principal, interest and fees required to be paid to Administrative Agent for the account of Lenders, unless Administrative Agent shall have received written notice from a Lender or
Borrower referring to this Agreement, describing such Default or Event of Default and stating that such notice is a “notice of default”. Administrative 

  

 46 

 
Agent will notify each Lender of its receipt of any such notice. Administrative Agent shall take such action with respect to such Default or Event of Default
as may be requested by Required Lenders (or all or such other portion of the Lenders as shall be prescribed by this Agreement) in accordance with the terms hereof. Unless and until Administrative Agent has received any such request, Administrative
Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Default or Event of Default as it shall deem advisable or in the best interests of Lenders. 
 Section 11.12 Successor Administrative Agent. Administrative Agent may at any time give notice of its resignation to the Lenders and
Borrowers. Upon receipt of any such notice of resignation, Required Lenders shall have the right, without the requirement of any consent of Borrowers, to appoint a successor Administrative Agent. Upon the acceptance of a successor’s appointment
as Administrative Agent hereunder and notice of such acceptance to the retiring Administrative Agent, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Administrative
Agent, the retiring Administrative Agent’s resignation shall become immediately effective and the retiring Administrative Agent shall be discharged from all of its duties and obligations hereunder and under the other Financing Documents (if
such resignation was not already effective and such duties and obligations not already discharged, as provided below in this paragraph). The fees payable by Borrowers to a successor Administrative Agent shall be the same as those payable to its
predecessor unless otherwise agreed between Borrowers and such successor. If no such successor shall have been so appointed by Required Lenders and shall have accepted such appointment within thirty (30) days after the retiring Administrative
Agent gives notice of its resignation, then the retiring Administrative Agent may on behalf of the Lenders (but without any obligation) appoint a successor Administrative Agent. From and following the expiration of such thirty (30) day period,
Administrative Agent shall have the exclusive right, upon one (1) Business Days’ notice to Borrowers and the Lenders, and the delivery to a Lender, for the benefit of all Lenders, of all Collateral in the possession of the retiring
Administrative Agent, to make its resignation effective immediately. From and following the effectiveness of such notice, (i) the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and under the other
Financing Documents and (ii) all payments, communications and determinations provided to be made by, to or through Administrative Agent shall instead be made by or to each Lender directly, until such time as Required Lenders appoint a successor
Administrative Agent as provided for above in this paragraph. The provisions of this Agreement shall continue in effect for the benefit of any retiring Administrative Agent and its sub-agents after the effectiveness of its resignation hereunder and
under the other Financing Documents in respect of any actions taken or omitted to be taken by any of them while the retiring Administrative Agent was acting or was continuing to act as Administrative Agent. 
 Section 11.13 Disbursements of Loans; Payment and Sharing of Payment. 
 (a) Loan Advances, Payments and Settlements; Interest and Fee Payments. 
 (i) Administrative Agent shall have the right, on behalf of Lenders (other than Non-Funding Lenders) to disburse funds to Borrowers for all Loans or
advances thereof requested or deemed requested by Borrowers pursuant to the terms of this Agreement regardless of whether the conditions precedent set forth in Section 7.2 are then satisfied, including the existence of any Default or Event of
Default either before or after giving effect to the making of such Loans or advances; provided, that Administrative Agent shall not advance proceeds of any Revolving Loan pursuant to this clause (i) if, to the knowledge of Administrative Agent,
the Revolving Loan Outstandings exceed the Revolving Loan Limit, either before or after giving effect to the making of any proposed Revolving Loan. Administrative Agent shall be conclusively entitled to assume, for purposes of the preceding
sentence, that each Lender, other than any Non-Funding Lenders, will fund its Pro Rata Share of all Loans and advances thereof requested by Borrowers. Each Lender (other than any Non-Funding Lender) shall reimburse Administrative Agent on demand, in
accordance with the provisions of the immediately following paragraph, for all funds disbursed on its behalf by Administrative Agent pursuant to the first sentence of this clause (i), or if Administrative Agent so requests, each Lender (other than
any Non-Funding Lender) will remit to Administrative Agent its Pro Rata Share of any Loan or advance thereof before Administrative Agent disburses the same to Borrowers. If Administrative Agent elects to require that each Lender (other than any
Non-Funding Lender) make funds available to Administrative Agent, prior to a disbursement by Administrative Agent to Borrowers, Administrative Agent shall advise each Lender by telephone, facsimile or e-mail of the amount of such Lender’s Pro
Rata Share of the Loan or advance thereof requested by Borrowers no later than noon (Chicago time) on the date of 

  

 47 

 
funding of such Loan or advance, and each such Lender shall pay Administrative Agent on such date such Lender’s Pro Rata Share of such requested Loan or
advance, in same day funds, by wire transfer to the Payment Account, or such other account as may be identified by Administrative Agent to Lenders from time to time. If any Lender fails to pay the amount of its Pro Rata Share within one
(1) Business Day after Administrative Agent’s demand, Administrative Agent shall promptly notify Borrowers, and Borrowers shall immediately repay such amount to Administrative Agent. Any repayment required by Borrowers pursuant to this
Section shall be accompanied by accrued interest thereon from and including the date such amount is made available to Borrowers to but excluding the date of payment at the rate of interest then applicable to the applicable Loan under which the
advance is made. Nothing in this Section or elsewhere in this Agreement or the other Financing Documents shall be deemed to require Administrative Agent to advance funds on behalf of any Lender or to relieve any Lender from its obligation to fulfill
its commitments hereunder or to prejudice any rights that Administrative Agent or Borrowers may have against any Lender as a result of any default by such Lender hereunder. 
 (ii) On a Business Day of each week as selected from time to time by Administrative Agent, or more frequently (including daily), if Administrative Agent
so elects (each such day being a “Settlement Date”), Administrative Agent will advise each Lender by telephone, facsimile or e-mail of the amount of each such Lender’s percentage interest of the applicable Loan balance as of
the close of business of the Business Day immediately preceding the Settlement Date. In the event that payments are necessary to adjust the amount of such Lender’s actual percentage interest of the applicable Loan balance to such Lender’s
required percentage interest of the applicable Loan balance as of any Settlement Date, the party from which such payment is due shall pay Administrative Agent, without setoff or discount, to the Payment Account not later than noon (Chicago time) on
the Business Day following the Settlement Date the full amount necessary to make such adjustment. Any obligation arising pursuant to the immediately preceding sentence shall be absolute and unconditional and shall not be affected by any circumstance
whatsoever. In the event settlement shall not have occurred by the date and time specified in the second preceding sentence, interest shall accrue on the unsettled amount at the Federal Funds Rate, for the first three (3) days following the
scheduled date of settlement, and thereafter at the Base Rate plus the Base Rate Margin applicable to the applicable Loan under which the advance is made. 
 (iii) On each Settlement Date, Administrative Agent shall advise each Lender by telephone, facsimile or e-mail of the amount of such Lender’s percentage interest of principal, interest and fees paid for the
benefit of Lenders with respect to each applicable Loan, to the extent of such Lender’s Revolving Loan Exposure with respect thereto, and shall make payment to such Lender not later than noon (Chicago time) on the Business Day following the
Settlement Date of such amounts in accordance with wire instructions delivered by such Lender to Administrative Agent, as the same may be modified from time to time by written notice to Administrative Agent; provided, that, in the case such Lender
is a Defaulted Lender, Administrative Agent shall be entitled to set off the funding short-fall against that Defaulted Lender’s respective share of all payments received from Borrowers. 
 (iv) On the Closing Date, Administrative Agent, on behalf of the Lenders, may elect to advance to Borrowers the full amount of the initial Loans to be
made on the Closing Date prior to receiving funds from the Lenders, in reliance upon each Lender’s commitment to make its Pro Rata Share of such Loans to Borrowers in a timely manner on such date. If Administrative Agent elects to advance the
initial Loans to Borrowers in such manner, Administrative Agent shall be entitled to receive all interest that accrues on the Closing Date on each Lender’s Pro Rata Share of such Loans unless Administrative Agent receives such Lender’s Pro
Rata Share of such Loans by 3:00 p.m. (Chicago time) on the Closing Date. 
 (v) Notwithstanding anything to the contrary in this Agreement,
repayment of Loans by Administrative Agent shall be made first in respect of Loans made at the time any Non-Funding Lenders exist, and second in respect of all other outstanding Loans. 
 (vi) The provisions of this Section 11.13(a) shall be deemed to be binding upon Administrative Agent and Lenders notwithstanding the occurrence of
any Default or Event of Default, or any insolvency or bankruptcy proceeding pertaining to Borrowers or any other Credit Party. 
 (b)
[RESERVED] 
  

 48 

 (c) Return of Payments. 
 (i) If Administrative Agent pays an amount to a Lender under this Agreement in the belief or expectation that a related payment has been or will be
received by Administrative Agent from Borrowers and such related payment is not received by Administrative Agent, then Administrative Agent will be entitled to recover such amount from such Lender on demand without setoff, counterclaim or deduction
of any kind, together with interest accruing on a daily basis at the Federal Funds Rate. 
 (ii) If Administrative Agent determines at any
time that any amount received by Administrative Agent under this Agreement must be returned to Borrowers or paid to any other Person pursuant to any insolvency law or otherwise, then, notwithstanding any other term or condition of this Agreement or
any other Financing Document, Administrative Agent will not be required to distribute any portion thereof to any Lender. In addition, each Lender will repay to Administrative Agent on demand any portion of such amount that Administrative Agent has
distributed to such Lender, together with interest at such rate, if any, as Administrative Agent is required to pay to Borrowers or such other Person, without setoff, counterclaim or deduction of any kind. 
 (d) Defaulted Lenders. The failure of any Defaulted Lender to make any Revolving Loan or any payment required by it hereunder shall not relieve
any other Lender of its obligations to make such Revolving Loan or payment, but neither any other Lender nor Administrative Agent shall be responsible for the failure of any Defaulted Lender to make a Revolving Loan or make any other payment
required hereunder. Notwithstanding anything set forth herein to the contrary, a Defaulted Lender shall not have any voting or consent rights under or with respect to any Financing Document or constitute a “Lender” (or be included in the
calculation of “Required Lenders” hereunder) for any voting or consent rights under or with respect to any Financing Document. 
 (e) Sharing of Payments. If any Lender shall obtain any payment or other recovery (whether voluntary, involuntary, by application of setoff or otherwise) on account of any Loan (other than pursuant to the terms of Sections 2.8(d)) in
excess of its pro rata share of payments entitled pursuant to the other provisions of this Section, such Lender shall purchase from the other Lenders such participations in extensions of credit made by such other Lenders (without recourse,
representation or warranty) as shall be necessary to cause such purchasing Lender to share the excess payment or other recovery ratably with each of them; provided, however, that if all or any portion of the excess payment or other recovery is
thereafter required to be returned or otherwise recovered from such purchasing Lender, such portion of such purchase shall be rescinded and each Lender which has sold a participation to the purchasing Lender shall repay to the purchasing Lender the
purchase price to the ratable extent of such return or recovery, without interest. Borrowers agree that any Lender so purchasing a participation from another Lender pursuant to this clause (e) may, to the fullest extent permitted by law,
exercise all its rights of payment (including pursuant to Section 10.5) with respect to such participation as fully as if such Lender were the direct creditor of Borrowers in the amount of such participation. If under any applicable bankruptcy,
insolvency or other similar law, any Lender receives a secured claim in lieu of a setoff to which this clause (e) applies, such Lender shall, to the extent practicable, exercise its rights in respect of such secured claim in a manner consistent
with the rights of the Lenders entitled under this clause (e) to share in the benefits of any recovery on such secured claim. 
 Section 11.14 Right to Perform, Preserve and Protect. If any Credit Party fails to perform any obligation hereunder or under any other Financing Document, Administrative Agent itself may, but shall not be obligated to, cause
such obligation to be performed at Borrowers’ expense. Administrative Agent is further authorized by Borrowers and the Lenders to make expenditures from time to time which Administrative Agent, in its reasonable business judgment, deems
necessary or desirable to (i) preserve or protect the business conducted by Borrowers, the Collateral, or any portion thereof and/or (ii) enhance the likelihood of, or maximize the amount of, repayment of the Loans and other Obligations.
Borrowers hereby agree to reimburse Administrative Agent on demand for any and all costs, liabilities and obligations incurred by Administrative Agent pursuant to this Section. Each Lender hereby agrees to indemnify Administrative Agent upon demand
for any and all costs, liabilities and obligations incurred by Administrative Agent pursuant to this Section, in accordance with the provisions of Section 11.6. 
  

 49 

 Section 11.15 Additional Titled Agents. Except for rights and powers, if any, expressly
reserved under this Agreement to any bookrunner, arranger or to any titled agent named on the cover page of this Agreement, other than Administrative Agent (collectively, the “Additional Titled Agents”), and except for obligations,
liabilities, duties and responsibilities, if any, expressly assumed under this Agreement by any Additional Titled Agent, no Additional Titled Agent, in such capacity, has any rights, powers, liabilities, duties or responsibilities hereunder or under
any of the other Financing Documents. Without limiting the foregoing, no Additional Titled Agent shall have nor be deemed to have a fiduciary relationship with any Lender. At any time that any Lender serving as an Additional Titled Agent shall have
transferred to any other Person (other than any Affiliates) all of its interests in the Loans and in the Revolving Loan Commitment, such Lender shall be deemed to have concurrently resigned as such Additional Titled Agent. 
 Section 11.16 Definitions. As used in this Article 11, the following terms have the following meanings: 
 “Federal Funds Rate” means, for any day, the rate of interest per annum (rounded upwards, if necessary, to the nearest whole multiple of
1/100 of 1%) equal to the weighted average of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers on such day, as published by the Federal Reserve Bank of New York on the
Business Day next succeeding such day, provided, however, that (a) if such day is not a Business Day, the Federal Funds Rate for such day shall be such rate on such transactions on the next preceding Business Day, and (b) if no such
rate is so published on such next preceding Business Day, the Federal Funds Rate for such day shall be the average rate quoted to Administrative Agent on such day on such transactions as determined by Administrative Agent. 
 “Revolving Loan Exposure” means, with respect to any Lender on any date of determination, the percentage equal to the amount of such
Lender’s Revolving Loan Outstandings on such date divided by the aggregate Revolving Loan Outstandings of all Lenders on such date. 
 ARTICLE 12 – MISCELLANEOUS 
 Section 12.1 Survival. All agreements, representations and warranties made
herein and in every other Financing Document shall survive the execution and delivery of this Agreement and the other Financing Documents. The provisions of Section 2.8 and Articles 11 and 12 shall survive the payment of the Obligations (both
with respect to any Lender and all Lenders collectively) and any termination of this Agreement and any judgment with respect to any Obligations, including any final foreclosure judgment with respect to any Security Document, and no unpaid or
unperformed, current or future, Obligations will merge into any such judgment. 
 Section 12.2 Time. Time is of the essence in
each Borrower’s and each other Credit Party’s performance under this Agreement and all other Financing Documents. 
 Section 12.3 Notices. 
 (a) All notices, requests and other communications to any party hereunder shall be in writing
(including prepaid overnight courier, facsimile transmission or similar writing) and shall be given to such party at its address, facsimile number or e-mail address set forth on the signature pages hereof (or, in the case of any such Lender who
becomes a Lender after the date hereof, in an Assignment Agreement or in a notice delivered to Borrower Representative and Administrative Agent by the assignee Lender forthwith upon such assignment) or at such other address, facsimile number or
e-mail address as such party may hereafter specify for the purpose by notice to Administrative Agent and Borrower Representative; provided, however, that notices, requests or other communications shall be permitted by electronic means
only in accordance with the provisions of Section 12.3(b) and (c). Each such notice, request or other communication shall be effective (i) if given by facsimile, when such notice is transmitted to the facsimile number specified by this
Section and the sender receives a confirmation of transmission from the sending facsimile machine, or (ii) if given by mail, prepaid overnight courier or any other means, when received or when receipt is refused at the applicable address
specified by this Section 12.3(a). 
 (b) Notices and other communications to the parties hereto may be delivered or furnished by

  

 50 

 
electronic communication (including e-mail and Internet or intranet websites) pursuant to procedures approved from time to time by Administrative Agent,
provided, however, that the foregoing shall not apply to notices sent directly to any Lender if such Lender has notified the Administrative Agent that it is incapable of receiving notices by electronic communication. The Administrative
Agent or Borrower Representative may, in their discretion, agree to accept notices and other communications to them hereunder by electronic communications pursuant to procedures approved by it, provided, however, that approval of such
procedures may be limited to particular notices or communications. 
 (c) Unless the Administrative Agent otherwise prescribes,
(i) notices and other communications sent to an e-mail address shall be deemed received upon the sender’s receipt of an acknowledgment from the intended recipient (such as by the “return receipt requested” function, as available,
return e-mail or other written acknowledgment), and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the
foregoing clause (i) of notification that such notice or communication is available and identifying the website address therefor, provided, however, that if any such notice or other communication is not sent or posted during
normal business hours, such notice or communication shall be deemed to have been sent at the opening of business on the next Business Day. 
 Section 12.4 Severability. In case any provision of or obligation under this Agreement or any other Financing Document shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of
the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby. 
 Section 12.5 Amendments and Waivers. 
 (a) No provision of this Agreement or any other Financing
Document may be amended, waived or otherwise modified unless such amendment, waiver or other modification is in writing and is signed or otherwise approved by Borrowers, the Administrative Agent and the Required Lenders; provided that 
 (i) no such amendment, waiver or other modification that would have the effect of increasing or reducing a Lender’s Revolving Loan Commitment Amount
or Revolving Loan Commitment Percentage shall be effective as to such Lender without such Lender’s written consent; 
 (ii) no such
amendment, waiver or modification that would affect the rights and duties of Administrative Agent shall be effective without Administrative Agent’s written consent or signature; 
 (iii) no such amendment, waiver or other modification shall, unless signed by all the Lenders directly affected thereby, (A) reduce the principal
of, rate of interest on or any fees with respect to any Loan or forgive any principal, interest (other than default interest) or fees (other than late charges) with respect to any Loan (B) postpone the date fixed for, or waive, any payment of
principal of any Loan or of interest on any Loan (other than default interest) or any fees provided for hereunder (other than late charges or for any termination of any commitment; (C) change the definition of the term Required Lenders or the
percentage of Lenders which shall be required for Lenders to take any action hereunder; (D) release all or substantially all or any material portion of the Collateral, authorize any Borrower to sell or otherwise dispose of all or substantially
all or any material portion of the Collateral or release any guarantor of all or any portion of the Obligations or its guaranty obligations with respect thereto, except, in each case with respect to this clause (D), as otherwise may be expressly
permitted under this Agreement or the other Financing Documents (including in connection with any disposition permitted hereunder); (E) amend, waive or otherwise modify this Section 12.5 or the definitions of the terms used in this
Section 12.5 insofar as the definitions affect the substance of this Section 12.5; (F) consent to the assignment, delegation or other transfer by any Credit Party of any of its rights and obligations under any Financing Document or
release any Borrower of its payment obligations under any Financing Document, except, in each case with respect to this clause (F), pursuant to a merger or consolidation permitted pursuant to this Agreement or (G) amend any of the provisions of
Section 10.6 or amend any of the definitions Pro Rata Share, Revolving Loan Commitment, Revolving Loan Commitment Amount, Revolving Loan Commitment Percentage or that provide for the Lenders to receive their Pro Rata Shares of any fees,
payments, setoffs or proceeds of Collateral hereunder. It is hereby 

  

 51 

 
understood and agreed that all Lenders shall be deemed directly affected by an amendment, waiver or other modification of the type described in the preceding
clauses (C), (D), (E), (F) and (G) of the preceding sentence; 
 (iv) the provisions of the foregoing clauses (i), (ii) and
(iii) are subject to the provisions of any interlender or agency agreement among the Lenders and Administrative Agent pursuant to which any Lender may agree to give its consent in connection with any amendment, waiver or modification of the
Financing Documents only in the event of the unanimous agreement of all Lenders. 
  

 52 

 Section 12.6 Assignments; Participations; Replacement of Lenders. 
 (a) Assignments. 
 (i) Any Lender may
at any time assign to one or more Eligible Assignees all or any portion of such Lender’s Loans and interest in the Revolving Loan Commitment, together with all related obligations of such Lender hereunder. Except as Administrative Agent may
otherwise agree, the amount of any such assignment (determined as of the date of the applicable Assignment Agreement or, if a “Trade Date” is specified in such Assignment Agreement, as of such Trade Date) shall be in a minimum aggregate
amount equal to One Million Dollars ($1,000,000) or, if less, the assignor’s entire interests in the Revolving Loan Commitment and outstanding Loans; provided, that, in connection with simultaneous assignments to two or more
related Approved Funds, such Approved Funds shall be treated as one assignee for purposes of determining compliance with the minimum assignment size referred to above. Borrowers and Administrative Agent shall be entitled to continue to deal solely
and directly with such Lender in connection with the interests so assigned to an Eligible Assignee until Administrative Agent shall have received and accepted an effective Assignment Agreement executed, delivered and fully completed by the
applicable parties thereto, such other information regarding such Eligible Assignee as Administrative Agent reasonably shall require and a processing fee of Three Thousand Five Hundred Dollars ($3,500); provided, only one processing fee shall
be payable in connection with simultaneous assignments to two or more related Approved Funds. 
 (ii) From and after the date on which the
conditions described above have been met, (i) such Eligible Assignee shall be deemed automatically to have become a party hereto and, to the extent of the interests assigned to such Eligible Assignee pursuant to such Assignment Agreement, shall
have the rights and obligations of a Lender hereunder and (ii) the assigning Lender, to the extent that rights and obligations hereunder have been assigned by it pursuant to such Assignment Agreement, shall be released from its rights and
obligations hereunder (other than those that survive termination pursuant to Section 12.1). Upon the request of the Eligible Assignee (and, as applicable, the assigning Lender) pursuant to an effective Assignment Agreement, Borrowers shall
execute and deliver to Administrative Agent for delivery to the Eligible Assignee (and, as applicable, the assigning Lender) Notes in the aggregate principal amount of the Eligible Assignee’s percentage interest in the Revolving Loan Commitment
(and, as applicable, Notes in the principal amount of that portion of the Revolving Loan Commitment retained by the assigning Lender). Upon receipt by the assigning Lender of such Note, the assigning Lender shall return to Borrowers any prior Note
held by it. 
 (iii) Administrative Agent, acting solely for this purpose as an agent of Borrower, shall maintain at its offices located in
Chicago, Illinois a copy of each Assignment Agreement delivered to it and a register for the recordation of the names and addresses of each Lender, and the commitments of, and principal amount of the Loans owing to, such Lender pursuant to the terms
hereof. The entries in such register shall be conclusive, and Borrower, Administrative Agent and Lenders may treat each Person whose name is recorded therein pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement,
notwithstanding notice to the contrary. Such register shall be available for inspection by Borrowers and any Lender, at any reasonable time upon reasonable prior notice to Administrative Agent. 
 (iv) Notwithstanding the foregoing provisions of this Section 12.6(a) or any other provision of this Agreement, any Lender may at any time pledge or
assign a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank; provided that no such pledge or
assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto. 
 (v) Notwithstanding the foregoing provisions of this Section 12.6(a) or any other provision of this Agreement, Administrative Agent has the right, but not the obligation, to effectuate assignments of Loans and
Revolving Loan Commitments via an electronic settlement system acceptable to Administrative Agent as designated in writing from time to time to the Lenders by Administrative Agent (the “Settlement Service”). At any time when the
Administrative Agent elects, in its sole discretion, to implement such Settlement Service, each such assignment shall be effected by the assigning Lender and proposed assignee pursuant to the procedures then in effect under the Settlement Service,
which procedures shall be consistent with the other provisions of this Section 12.6(a). Each 

  

 53 

 
assigning Lender and proposed Eligible Assignee shall comply with the requirements of the Settlement Service in connection with effecting any assignment of
Loans and Revolving Loan Commitments pursuant to the Settlement Service. With the prior approval of each of Administrative Agent and the Borrower, Administrative Agent’s and the Borrower’s approval of such Eligible Assignee shall be deemed
to have been automatically granted with respect to any transfer effected through the Settlement Service. Assignments and assumptions of the Loans and Revolving Loan Commitments shall be effected by the provisions otherwise set forth herein until
Administrative Agent notifies Lenders of the Settlement Service as set forth herein. 
 (b) Participations. Any Lender may at any
time, without the consent of, or notice to, Borrowers or Administrative Agent, sell to one or more Persons participating interests in its Loans, commitments or other interests hereunder (any such Person, a “Participant”). In the
event of a sale by a Lender of a participating interest to a Participant, (a) such Lender’s obligations hereunder shall remain unchanged for all purposes, (b) Borrowers and Administrative Agent shall continue to deal solely and
directly with such Lender in connection with such Lender’s rights and obligations hereunder and (c) all amounts payable by Borrowers shall be determined as if such Lender had not sold such participation and shall be paid directly to such
Lender. No Participant shall have any direct or indirect voting rights hereunder except with respect to any event described in Section 12.5 expressly requiring the unanimous vote of all Lenders or, as applicable, all affected Lenders. Borrowers
agree that if amounts outstanding under this Agreement are due and payable (as a result of acceleration or otherwise), each Participant shall be deemed to have the right of set-off in respect of its participating interest in amounts owing under this
Agreement and with respect to any Letter of Credit to the same extent as if the amount of its participating interest were owing directly to it as a Lender under this Agreement; provided that such right of set-off shall be subject to the
obligation of each Participant to share with Lenders, and Lenders agree to share with each Participant, as provided in Section 10.5. 
 (c) Replacement of Lenders. Within thirty (30) days after: (i) receipt by Administrative Agent of notice and demand from any Lender for payment of additional costs as provided in Section 2.8(d), which demand shall not
have been revoked, (ii) Borrowers are required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.8(a), (iii) any Lender is a Defaulted Lender, and the
circumstances causing such status shall not have been cured or waived, or (iv) any failure by any Lender to consent to a requested amendment, waiver or modification to any Financing Document in which Required Lenders have already consented to
such amendment, waiver or modification but the consent of each Lender, or each Lender affected thereby, is required with respect thereto (each relevant Lender in the foregoing clauses (i) through (iv) being an “Affected
Lender”), Administrative Agent may, at its option, notify such Affected Lender of such Person’s intention to obtain, at Borrowers’ expense, a replacement Lender (“Replacement Lender”) for such Lender, which
Replacement Lender shall be an Eligible Assignee and, in the event the Replacement Lender is to replace an Affected Lender described in the preceding clause (iv), such Replacement Lender consents to the requested amendment, waiver or modification
making the replaced Lender an Affected Lender. In the event Administrative Agent obtains a Replacement Lender within ninety (90) days following notice of its intention to do so, the Affected Lender shall sell, at par, and assign all of its
Loans and funding commitments hereunder to such Replacement Lender in accordance with the procedures set forth in Section 12.6(a); provided, that (i) Borrowers shall have, as applicable, reimbursed such Lender for its increased
costs and additional payments for which it is entitled to reimbursement under Section 2.8, as applicable, of this Agreement through the date of such sale and assignment and (ii) Borrowers shall pay to Administrative Agent the $3,500
processing fee in respect of such assignment. In the event that a replaced Lender does not execute an Assignment Agreement pursuant to Section 12.6(a) within five (5) Business Days after receipt by such replaced Lender of notice of
replacement pursuant to this Section 12.6(c) and presentation to such replaced Lender of an Assignment Agreement evidencing an assignment pursuant to this Section 12.6(c), such replaced Lender shall be deemed to have consented to the terms
of such Assignment Agreement, and any such Assignment Agreement executed by Administrative Agent, the Replacement Lender and, to the extent required pursuant to Section 12.6(a), Borrower, shall be effective for purposes of this
Section 12.6(c) and Section 12.6(a). Upon any such assignment and payment, such replaced Lender shall no longer constitute a “Lender” for purposes hereof, other than with respect to such rights and obligations that survive
termination as set forth in Section 12.1. 
 (d) Credit Party Assignments. No Credit Party may assign, delegate or otherwise
transfer any of its rights or other obligations hereunder or under any other Financing Document without the prior written consent of Administrative Agent and each Lender. 
  

 54 

 Section 12.7 Confidentiality. Administrative Agent and each Lender shall hold all non-public
information regarding the Credit Parties and their respective businesses identified as such by Borrowers and obtained by Administrative Agent or any Lender pursuant to the requirements hereof in accordance with such Person’s customary
procedures for handling information of such nature, except that disclosure of such information may be made (a) to their respective agents, employees, Subsidiaries, Affiliates, attorneys, auditors, professional consultants, rating agencies,
insurance industry associations and portfolio management services, (b) to prospective transferees or purchasers of any interest in the Loans, provided, however, that any such Persons shall have agreed to be bound by the provisions
of this Section, (c) as required by Law, subpoena, judicial order or similar order and in connection with any litigation, (d) as may be required in connection with the examination, audit or similar investigation of such Person, and
(e) to a Person that is a trustee, investment advisor, collateral manager, servicer, noteholder or secured party in a Securitization (as hereinafter defined) in connection with the administration, servicing and reporting on the assets serving
as collateral for such Securitization. For the purposes of this Section, “Securitization” shall mean a public or private offering by a Lender or any of its Affiliates or their respective successors and assigns, of securities which
represent an interest in, or which are collateralized, in whole or in part, by the Loans. Confidential information shall include only such information identified as such at the time provided to Administrative Agent or Lender, as the case may be, and
shall not include information that either: (i) is in the public domain, or becomes part of the public domain after disclosure to such Person through no fault of such Person, or (ii) is disclosed to such Person by a Person other than a
Credit Party, provided, however, Administrative Agent does not have actual knowledge that such Person is prohibited from disclosing such information. The obligations of Administrative Agent and Lenders under this Section shall
supersede and replace the obligations of Administrative Agent and Lenders under any confidentiality agreement in respect of this financing executed and delivered by Administrative Agent or any Lender prior to the date hereof. 
 Section 12.8 Waiver of Consequential and Other Damages. To the fullest extent permitted by applicable law, no Borrower shall assert, and each
Borrower hereby waives, any claim against any Indemnitee (as defined below), on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a
result of this Agreement, any other Financing Document or any agreement or instrument contemplated hereby or thereby, the transactions contemplated hereby or thereby, any Loan or Letter of Credit or the use of the proceeds thereof. No Indemnitee
shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with this Agreement
or the other Financing Documents or the transactions contemplated hereby or thereby. 
 Section 12.9 GOVERNING LAW; SUBMISSION TO
JURISDICTION. THIS AGREEMENT, EACH NOTE AND EACH OTHER FINANCING DOCUMENT, AND ALL MATTERS RELATING HERETO OR THERETO OR ARISING THEREFROM (WHETHER SOUNDING IN CONTRACT LAW, TORT LAW OR OTHERWISE), SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED
AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES. EACH BORROWER HEREBY CONSENTS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED WITHIN THE STATE OF NEW YORK AND IRREVOCABLY
AGREES THAT, SUBJECT TO ADMINISTRATIVE AGENT’S ELECTION, ALL ACTIONS OR PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE OTHER FINANCING DOCUMENTS SHALL BE LITIGATED IN SUCH COURTS. EACH BORROWER EXPRESSLY SUBMITS AND CONSENTS TO
THE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS. EACH BORROWER HEREBY WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS AND AGREES THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE UPON SUCH BORROWER BY CERTIFIED OR
REGISTERED MAIL, RETURN RECEIPT REQUESTED, ADDRESSED TO SUCH BORROWER AT THE ADDRESS SET FORTH IN THIS AGREEMENT AND SERVICE SO MADE SHALL BE COMPLETE TEN (10) DAYS AFTER THE SAME HAS BEEN POSTED. 
 Section 12.10 WAIVER OF JURY TRIAL. EACH BORROWER, ADMINISTRATIVE AGENT AND THE LENDERS HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL
BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THE FINANCING DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY AND AGREES THAT ANY SUCH ACTION OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. EACH 

  

 55 

 
BORROWER, ADMINISTRATIVE AGENT AND EACH LENDER ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS
RELIED ON THE WAIVER IN ENTERING INTO THIS AGREEMENT AND THE OTHER FINANCING DOCUMENTS, AND THAT EACH WILL CONTINUE TO RELY ON THIS WAIVER IN THEIR RELATED FUTURE DEALINGS. EACH BORROWER, ADMINISTRATIVE AGENT AND EACH LENDER WARRANTS AND REPRESENTS
THAT IT HAS HAD THE OPPORTUNITY OF REVIEWING THIS JURY WAIVER WITH LEGAL COUNSEL, AND THAT IT KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS. 
 Section 12.11 Publication; Advertisement. 
 (a) Publication. No Credit Party will directly
or indirectly publish, disclose or otherwise use in any public disclosure, advertising material, promotional material, press release or interview, any reference to the name, logo or any trademark of Merrill Lynch or any of its Affiliates or any
reference to this Agreement or the financing evidenced hereby, in any case except (i) as required by Law, subpoena or judicial or similar order, in which case the applicable Credit Party shall give Administrative Agent prior written notice of
such publication or other disclosure, or (ii) with Merrill Lynch’s prior written consent. 
 (b) Advertisement. Each Lender
and each Credit Party hereby authorizes Merrill Lynch to publish the name of such Lender and Credit Party, the existence of the financing arrangements referenced under this Agreement, the primary purpose and/or structure of those arrangements, the
amount of credit extended under each facility, the title and role of each party to this Agreement, and the total amount of the financing evidenced hereby in any “tombstone”, comparable advertisement or press release which Merrill Lynch
elects to submit for publication. In addition, each Lender and each Credit Party agrees that Merrill Lynch may provide lending industry trade organizations with information necessary and customary for inclusion in league table measurements after the
Closing Date. With respect to any of the foregoing, Merrill Lynch shall provide Borrowers with an opportunity to review and confer with Merrill Lynch regarding the contents of any such tombstone, advertisement or information, as applicable, prior to
its submission for publication and, following such review period, Merrill Lynch may, from time to time, publish such information in any media form desired by Merrill Lynch, until such time that Borrowers shall have requested Merrill Lynch cease any
such further publication. 
 Section 12.12 Counterparts; Integration. This Agreement and the other Financing Documents may be
signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. Signatures by facsimile or by email delivery of an electronic version of an
executed signature page shall bind the parties hereto. This Agreement and the other Financing Documents constitute the entire agreement and understanding among the parties hereto and supersede any and all prior agreements and understandings, oral or
written, relating to the subject matter hereof. 
 Section 12.13 No Strict Construction. The parties hereto have participated
jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto and no presumption or burden of proof
shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement. 
 Section 12.14
Lender Approvals. Unless expressly provided herein to the contrary, any approval, consent, waiver or satisfaction of Administrative Agent or Lenders with respect to any matter that is the subject of this Agreement, the other Financing Documents
may be granted or withheld by Administrative Agent and Lenders in their sole and absolute discretion and credit judgment. 
 Section 12.15 Expenses; Indemnity 
 (a) Borrowers agree to pay all reasonable legal, audit and appraisal fees and all
other reasonable out-of-pocket charges and expenses incurred by Administrative Agent and Lenders (including the fees and expenses of Administrative Agent’s counsel, advisors and consultants) in connection with the negotiation, preparation,
legal review and execution of each of the Financing Documents, including but not limited to UCC and judgment lien searches and UCC filings and fees for post-closing UCC and judgment lien searches. In addition, Borrowers shall 

  

 56 

 
pay all such fees and expenses associated with any amendments, modifications and terminations to the Financing Documents following closing. If Administrative
Agent or any Lender uses in-house counsel for any of these purposes, Borrowers further agree that the Obligations include reasonable charges for such work commensurate with the fees that would otherwise be charged by outside legal counsel selected
by Administrative Agent or such Lender for the work performed. 
 (b) Borrowers agree to pay all out-of-pocket charges and expenses incurred
by Administrative Agent (including the fees and expenses of Administrative Agent’s counsel, advisers and consultants) in connection with the administration of this Agreement and the other Financing Documents and the credit facilities provided
hereunder and thereunder, the administration, enforcement, protection or preservation of any right or claim of Administrative Agent, the termination of this Agreement, the termination of any Liens of Administrative Agent on the Collateral, or the
collection of any amounts due under the Financing Documents, including any such charges and expenses incurred in connection with any “work-out” or with any proceeding under the Bankruptcy Code with respect to any Credit Party. If
Administrative Agent uses in-house counsel for any of these purposes (i.e., for any task in connection with the enforcement, protection or preservation of any right or claim of Administrative Agent and Lenders and the collection of any amounts due
under the Financing Documents or in connection with any other purpose mentioned in the foregoing sentence), Borrowers further agree that the Obligations include reasonable charges for such work commensurate with the fees that would otherwise be
charged by outside legal counsel selected by Administrative Agent for the work performed. 
 (c) Borrowers hereby indemnify and agree to
defend (with counsel acceptable to Administrative Agent) and hold harmless Administrative Agent, each Lender, and their respective shareholders, directors, partners, officers, agents and employees (collectively in the singular,
“Indemnitee”) from and against any liability, loss, cost, expense (including reasonable attorneys’ fees and expenses for both in-house and outside counsel), claim, damage, suit, action or proceeding ever suffered or incurred by
any Indemnitee or in which an Indemnitee may ever be or become involved (whether as a party, witness or otherwise) (a) arising from any Credit Party’s failure to observe, perform or discharge any of its covenants, obligations, agreements
or duties under the Financing Documents, (b) arising from the breach of any of the representations or warranties contained in any Financing Document, (c) arising by reason of this Agreement, the other Financing Documents or the
transactions contemplated hereby or thereby, or (d) relating to claims of any Person with respect to the Collateral; provided, however, Borrowers shall not be liable under this Section 12.15(c) to the extent such loss is primarily related
to Indemnitee’s gross negligence or willful misconduct. 
 (d) Notwithstanding any contrary provision in this Agreement, the obligations
of Borrowers under this Section shall survive the payment in full of the Obligations and the termination of this Agreement. NO INDEMNITEE SHALL BE RESPONSIBLE OR LIABLE TO THE BORROWERS OR TO ANY OTHER PARTY TO ANY FINANCING DOCUMENT, ANY SUCCESSOR,
ASSIGNEE OR THIRD PARTY BENEFICIARY OR ANY OTHER PERSON ASSERTING CLAIMS DERIVATIVELY THROUGH SUCH PARTY, FOR INDIRECT, PUNITIVE, EXEMPLARY OR CONSEQUENTIAL DAMAGES WHICH MAY BE ALLEGED AS A RESULT OF CREDIT HAVING BEEN EXTENDED, SUSPENDED OR
TERMINATED UNDER THIS AGREEMENT OR ANY OTHER FINANCING DOCUMENT OR AS A RESULT OF ANY OTHER TRANSACTION CONTEMPLATED HEREUNDER OR THEREUNDER. 
  

 57 

 Section 12.16 Reinstatement. This Agreement shall remain in full force and effect and
continue to be effective should any petition or other proceeding be filed by or against any Credit Party for liquidation or reorganization, should any Credit Party become insolvent or make an assignment for the benefit of any creditor or creditors
or should an interim receiver, receiver, receiver and manger or trustee be appointed for all or any significant part of any Credit Party’s assets, and shall continue to be effective or to be reinstated, as the case may be, if at any time
payment and performance of the Obligations, or any part thereof, is, pursuant to applicable law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee of the Obligations, whether as a fraudulent conveyance,
preference or otherwise, all as though such payment or performance had not been made. In the event that any payment, or any part thereof, is rescinded, reduced, restored or returned, the Obligations shall be reinstated and deemed reduced only by
such amount paid and not so rescinded, reduced, restored or returned. 
 [SIGNATURES APPEAR ON FOLLOWING PAGES] 

  

 58 

 IN WITNESS WHEREOF, intending to be legally bound, and intending that this document constitute an
instrument executed and delivered under seal, the parties hereto have caused this Agreement to be duly executed under seal by their respective authorized officers as of the day and year first above written. 
 BORROWER: 
  

					
	BARRIER THERAPEUTICS, INC.
			
	By:	 	 /S/ GEERT CAUWENBERGH
  
	 	[SEAL]
	Name:	 	 GEERT CAUWENBERGH
  
	 	
	Title:	 	 CHIEF EXECUTIVE OFFICER
  
	 	

 Address: 
 Barrier Therapeutics, Inc. 
 600 College Road East 
 Princeton, New Jersey 08540-6697 
 Attn: General
Counsel                             
 Facsimile: (609) 945-1212 
 E-Mail: abristow@barriertherapeutics.com 
 AGENT: 
  

					
	 MERRILL LYNCH CAPITAL,
 a division of Merrill Lynch Business Financial Services Inc.,
 as Administrative Agent and a Lender

			
	By:	 	 /S/ WILLIAM D. GOULD
  
	 	[SEAL]
	Name:	 	 WILLIAM D. GOULD
  
	 	
	Title:	 	 DIRECTOR
  
	 	

 Address: 
 222 N. LaSalle Street, 16th Floor 
 Chicago, Illinois 60601 
 Attn: Account Manager for MLC-HCF Barrier Therapeutics, Inc. transaction 
 Facsimile: (866) 231-8408 
 E-Mail: MLC_HCF_ABL1@ml.com 
 With copies to: 
 Merrill Lynch Capital

 222 N. LaSalle Street, 16th Floor 
 Chicago, Illinois 60601 
 Attn: Group Senior Transaction Attorney, Healthcare Finance 
 Facsimile Number: (312) 499-3245 
 Merrill Lynch Capital 
 7700 Wisconsin Ave., Suite 400 
 Bethesda,
Maryland 20814 
 Attn: Group Senior Transaction Attorney, Healthcare Finance 
 Facsimile Number: (866) 341-9053 

 Payment Account Designation: 
 LaSalle Bank 
 200 West Monroe 
 Chicago, IL 60606 
 ABA #: 071000505 
 Account Name: MLBFS Healthcare Finance 
 Account #: 5800395088 
 Attention: Barrier Therapeutics, Inc. 
 LENDERS: 
  

					
	 MERRILL LYNCH CAPITAL,
 a division of Merrill Lynch Business Financial Services Inc.,
 as Lender

			
	By:	 	 /S/ WILLIAM D. GOULD
  
	 	[SEAL]
	Name:	 	 WILLIAM D. GOULD
  
	 	
	Title:	 	 DIRECTOR
  
	 	

 Address: 
 222 N. LaSalle Street, 16th Floor 
 Chicago, Illinois 60601 
 Attn: Account Manager for MLC-HCF Barrier Therapeutics, Inc. transaction 
 Facsimile: (866) 231-8408 
 E-Mail: MLC_HCF_ABL1@ml.com 
 With copies to: 
 Merrill Lynch Capital

 222 N. LaSalle Street, 16th Floor 
 Chicago, Illinois 60601 
 Attn: Group Senior Transaction Attorney, Healthcare Finance 
 Facsimile Number: (312) 499-3245 
 Merrill Lynch Capital 
 7700 Wisconsin Ave., Suite 400 
 Bethesda,
Maryland 20814 
 Attn: Group Senior Transaction Attorney, Healthcare Finance 
 Facsimile Number: (866) 341-9053 

 ANNEXES, EXHIBITS, RIDERS AND SCHEDULES 
  

			
	 ANNEXES

		
	 Annex A
	  	Commitment Annex
	
	EXHIBITS
		
	 Exhibit A
	  	[Reserved]
	 Exhibit B
	  	Form of Compliance Certificate
	 Exhibit C
	  	Form of Borrowing Base Certificate
	 Exhibit D
	  	Form of Notice of Borrowing
	 Exhibit E
	  	Payment Notification
	 Exhibit F
	  	Products
	
	RIDERS
		
	 Pharma Rider
	  	
	
	SCHEDULES
		
	 Schedule 1.1
	  	List of Products Referenced in “Permitted Asset Dispositions”
	 Schedule 3.1
	  	Existence, Organizational ID Numbers, Foreign Qualification, Prior Names
	 Schedule 3.3
	  	Capitalization
	 Schedule 3.11
	  	Compliance of Products
	 Schedule 4.3
	  	Insurance
	 Schedule 4.4
	  	Material Contracts
	 Schedule 4.8
	  	Notices of Certain Events
	 Schedule 4.9
	  	Intellectual Property
	 Schedule 4.12
	  	Post-Closing Obligations
	 Schedule 5.1
	  	Debt; Contingent Obligations
	 Schedule 5.2
	  	Liens
	 Schedule 5.4
	  	Asset Dispositions
	 Schedule 5.5
	  	Investments; Exceptions to Covenant to Add Subsidiaries as Co-Borrowers
	 Schedule 5.6
	  	Affiliate Transactions
	 Schedule 5.8
	  	Business Description
	 Schedule 5.9
	  	Deposit Accounts and Securities Accounts
	 Schedule 9.1
	  	Collateral Description
	 Schedule 9.2
	  	Location of Collateral

			
	 

  
	  	Annex A to Credit Agreement (Commitment Annex)

  

							
	 Lender
	  	Revolving Loan Commitment
Amount	  	Revolving Loan Commitment
Percentage	 
	 Merrill Lynch Capital
	  	$	12,000,000.00	  	100	%

  

 Exhibit A - Page 1 

			
	 

  
	 	Exhibit A to Credit Agreement – [Reserved]

  

 Exhibit A - Page 2 

			
	 

  
	 	Exhibit B to Credit Agreement (Form of Compliance Certificate)

 COMPLIANCE CERTIFICATE 
 Date:                 ,          
 This certificate is given by
                    , a Responsible Officer of Barrier Therapeutics, Inc. (“Borrower Representative”), pursuant to that
certain Credit and Security Agreement dated as of June 29, 2007 among Borrower Representative and any additional Borrower that may be a party thereto or from time to time be added thereto (collectively, “Borrowers”), Merrill
Lynch Capital, a division of Merrill Lynch Business Financial Services Inc., individually as a Lender and as Administrative Agent, and the financial institutions or other entities from time to time parties thereto, each as a Lender (as such
agreement may have been amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein without definition shall have the meanings set forth in the Credit Agreement.

 The undersigned Responsible Officer hereby certifies to Administrative Agent and Lenders that: 
  

 Exhibit B - Page 1 

 (a) the financial statements delivered with this certificate in accordance with Section 4.1 of the
Credit Agreement fairly present in all material respects the results of operations and financial condition of Borrowers and their Subsidiaries as of the dates and the accounting period covered by such financial statements; 
 (b) I have reviewed the terms of the Credit Agreement and have made, or caused to be made under my supervision, a review in reasonable detail of the
transactions and conditions of Borrowers and their Subsidiaries during the accounting period covered by such financial statements; 
 (c)
such review has not disclosed the existence during or at the end of such accounting period, and I have no knowledge of the existence as of the date hereof, of any condition or event that constitutes a Default or an Event of Default, except as set
forth in Schedule 1 hereto, which includes a description of the nature and period of existence of such Default or an Event of Default and what action Borrowers have taken, are undertaking and propose to take with respect thereto;

 (d) Except as noted on Schedule 2 attached hereto, the Credit Agreement contains a complete and accurate list of all
business locations of Borrowers and guarantors of the Obligations and all names under which Borrowers or such guarantors currently conduct business; Schedule 2 specifically notes any changes in the names under which Borrowers or such
guarantors conduct business; 
 (e) Except as noted on Schedule 3 attached hereto, the undersigned has no knowledge of any
federal or state tax liens having been filed against the Borrowers, any guarantors of the Obligations or any Collateral; 
 (f) Except as
noted on Schedule 3 attached hereto, the undersigned has no knowledge of any failure of the Borrowers or any guarantors of the Obligations to make required payments of withholding or other tax obligations of the Borrowers or any
guarantors of the Obligations during the accounting period to which the attached statements pertain or any subsequent period; 
 (g) If the
Credit Agreement contemplates a lien on the Deposit Accounts and Securities Accounts of the Borrowers and/or guarantors of the Obligations in favor of Administrative Agent, Schedule 4 attached hereto contains a complete and accurate
statement of all Deposit Accounts and Securities Accounts maintained by Borrowers or guarantors of the Obligations; 
 (h) Except as noted on
Schedule 5 attached hereto, the undersigned has no knowledge of any matter for which disclosure or notice is required under Section 4.8 that has not previously been reported to Administrative Agent on Schedule 4.8 to
the Credit Agreement or any Schedule 5 to any previous Compliance Certificate delivered by Borrower Representative to Administrative Agent; 
 (i) Except as noted on Schedule 6 attached hereto, no Borrower has acquired, by purchase, by the approval or granting of any application for registration (whether or not such application was previously
disclosed to Administrative Agent by Borrowers) or otherwise, any Intellectual Property that is registered with any United States or foreign Governmental Authority, or has filed with any such United States or foreign Governmental Authority, any new
application for the registration of any Intellectual Property, or acquired rights under a license as a licensee with respect to any such registered Intellectual Property (or any such application for the registration of Intellectual Property) owned
by another Person, that has not previously been reported to Administrative Agent on Schedule 4.9 to the Credit Agreement or any Schedule 6 to any previous Compliance Certificate delivered by Borrower Representative to
Administrative Agent; and 
 (j) Except as noted in Schedule 7 attached hereto, no Borrower has entered into any contract with
a Governmental Authority pursuant to which payments are to be made by such Governmental Authority to a Borrower. 
  

 Exhibit B - Page 2 

 The foregoing certifications and computations are made as of
                ,         (end of month) and delivered this      day of
            , 20    . 
  

			
	Sincerely,
	By	 	  

	Name	 	  

	Title	 	  

 Schedules to Compliance Certificate 
 Schedule 1 – Non-Compliance with Covenants 
 Schedule 2 – Business Locations and Names of Borrowers and Guarantors 
 Schedule 3 – Tax Liens; Unpaid Tax or Withholding
Obligations 
 Schedule 4 – List of all Deposit Accounts and Securities Accounts of Borrowers and Guarantors 
 Schedule 5 – Notices required under Section 4.8 
 Schedule 6 – Newly Acquired Intellectual Property and Intellectual Property Licenses 
 Schedule 7
– Government Contracts 
  

 Exhibit B - Page 3 

			
	 

  
	 	Exhibit C to Credit Agreement (Form of Borrowing Base Certificate)

 [Underwriter to provide form] 
  

 Exhibit C - Page 1 

			
	 

  
	 	Exhibit D to Credit Agreement (Form of Notice of Borrowing)

 [BORROWER REPRESENTATIVE] 
 Date:                 ,          
 This certificate is given by
                    , a Responsible Officer of Barrier Therapeutics,
Inc.                    (“Borrower Representative”), pursuant to Section 2.1(b)(i) of that certain Credit and Security
Agreement dated as of June 29, 2007 among Borrower Representative and any additional Borrower that may be a party thereto or from time to time be added thereto (collectively, “Borrowers”), the Lenders from time to time party
thereto and Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services Inc., as Administrative Agent for Lenders (as such agreement may have been amended, restated, supplemented or otherwise modified from time to time the
“Credit Agreement”). Capitalized terms used herein without definition shall have the meanings set forth in the Credit Agreement. 
 The undersigned Responsible Officer hereby gives notice to Administrative Agent of Borrower Representative’s request to on [ date ] borrow $[            ]
of Revolving Loans. Attached is a Borrowing Base Certificate complying in all respects with the Credit Agreement and confirming that, after giving effect to the requested advance, the Revolving Loan Outstandings will not exceed the Revolving Loan
Limit. 
 The undersigned officer hereby certifies that, both before and after giving effect to the request above (a) each of the
conditions precedent set forth in Section 7.1 and 7.2 have been satisfied, (b) all of the representations and warranties contained in the Credit Agreement and the other Financing Documents are true, correct and complete as of the date
hereof, except to the extent such representation or warranty relates to a specific date, in which case such representation or warranty is true, correct and complete as of such earlier date, and (c) no Default or Event of Default has occurred
and is continuing on the date hereof. 
 IN WITNESS WHEREOF, the undersigned officer has executed and delivered this certificate this
     day of             ,         . 
  

			
	By:	 	 
	Name:	 	  

	Title:	 	  

  

 Exhibit D - Page 1 

			
	 

  
	 	Exhibit F to Credit Agreement (Products)

 Xolegel 
 Vusion 
 Solage’ 
  

 Exhibit D - Page 1 

			
	 

  
	 	Pharma Rider

 PHARMA RIDER 
 This Pharma Rider is made a part of and is incorporated by reference into that certain Credit and Security Agreement (the “Credit
Agreement”) dated June 29, 2007 by and among Barrier Therapeutics, Inc., a Delaware corporation and any additional Borrower that may hereafter be added to this Agreement (each individually as a Borrower and collectively as Borrowers),
MERRILL LYNCH CAPITAL, a division of Merrill Lynch Business Financial Services Inc., individually as a Lender, and as Administrative Agent, and the financial institutions or other entities from time to time parties hereto, each as a Lender.

 In consideration of the premises and the agreements, provisions and covenants herein contained and in the Credit Agreement, Borrowers,
Lenders and Administrative Agent agree as follows: 
 Section 1 Definitions. All capitalized terms not otherwise defined in this
Rider shall have the meanings given them in the Credit Agreement. 
 Section 1.1 Additional Defined Terms. The following
additional definitions are hereby appended to Section 1.1 of the Credit Agreement: 
 “Correction” means repair,
modification, adjustment, relabeling, destruction or inspection (including patient monitoring) of a product without its physical removal to some other location. 
 “DEA” means the Drug Enforcement Administration of the United States of America and any successor agency thereof. 
 “Drug Application” means a new drug application, an abbreviated drug application, or a product license application for any product, as appropriate, as those terms are defined in the FDCA. 

“FDA” means the Food and Drug Administration of the United States of America or any successor entity thereto. 
 “FDCA” means the Federal Food, Drug and Cosmetic Act, as amended, 21 U.S.C. Section 301 et seq. and all regulations promulgated
thereunder. 
 “Good Manufacturing Practices” means current good manufacturing practices, as set forth in 21 C.F.R. Parts
210 and 211. 
 “Market Withdrawal” means a Person’s Removal or Correction of a distributed product which involves a
minor violation that would not be subject to legal action by the FDA or which involves no violation. 
 “Permits” means
licenses, certificates, accreditations, product clearances or approvals, provider numbers or provider authorizations, marketing authorizations, other authorizations, registrations, permits, consents and approvals required in connection with the
conduct of any Borrower’s or any Subsidiary’s business or to comply with any applicable Laws, including, without limitation, drug listings and drug establishment registrations under 21 U.S.C. Section 510, registrations issued by DEA
under 21 U.S.C. Section 823 (if applicable to any Product), and those issued by State governments for the conduct of any Borrower’s or any Subsidiary’s business. 
 “Products” means any products manufactured, sold or marketed by any Borrower or any of its Subsidiaries for which a Drug Application has
been submitted or approved, including without limitation, those products set forth on Exhibit F (as updated from time to time in accordance with Section 3.11(c)(i) below), provided that, if Borrowers shall fail to comply with their
obligations under Section 3.11(c)(i) to give notice to Agent and update Exhibit F prior to manufacturing, selling or marketing any new Product, any such improperly undisclosed Product shall be deemed to be included in this definition.

 “Recall” means a withdrawal mandated by the FDA or a discretionary withdrawal of a
marketed drug that the FDA considers to be in violation of the laws it administers and against which the FDA would initiate legal action, e.g., seizure. 
 “Removal” means the physical removal of a device from its point of use to some other location for repair, modification, adjustment, relabeling, destruction, or inspection. 
 “Required Permit” means a Permit issued or required under Laws applicable to the business of any Borrower or any of its Subsidiaries or
necessary in the manufacturing, importing, exporting, possession, ownership, warehousing, marketing, promoting, sale, labeling, furnishing, distribution or delivery of goods or services under Laws applicable to the business of any Borrower or any of
its Subsidiaries or any Drug Application (including without limitation, at any point in time, all licenses, approvals and permits issued by the FDA or any other applicable Governmental Entity necessary for the testing, manufacture, marketing or sale
of any Product by any applicable Borrower(s) as such activities are being conducted by such Borrower(s) with respect to such Product at such time). 
 Section 2 Additional Representations and Warranties. The following is hereby appended to the Credit Agreement as new Section 3.11: 
 Section 3.11 Compliance of Products. 
 (a) Each Credit Party: 
 (i) has obtained all Required Permits, or has contracted with third parties holding Required Permits, necessary for compliance with all
Laws and all such Required Permits are current, except where the failure to do so could not reasonably be expected to have a Material Adverse Effect; 
 (ii) has not, to its knowledge, used the services of any Person debarred under the provisions of the Generic Drug Enforcement Act of 1992, 21 U.S.C. Section 335a (a) or (b); 
 (iii) warrants and represents that to its knowledge none of its officers, directors, employees, their agents or affiliates has been
convicted of any crime or engaged in any conduct for which debarment is mandated by 21 U.S.C. Section 335a (a) or authorized by 21 U.S. Section 335a (b); 
 (iv) warrants and represents that to its knowledge none of its officers, directors, employees, their agents or affiliates has made an
untrue statement of material fact or fraudulent statement to the FDA or failed to disclose a material fact required to be disclosed to the FDA, committed an act, made a statement, or failed to make a statement that could reasonably be expected to
provide a basis for the FDA to invoke its policy respecting “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities,” set forth in 56 Fed. Regulation 46191 (September 10, 1991); 
 (v) has not received any written notice that any Governmental Authority, including without limitation the FDA, the DEA, the Office of the
Inspector General of HHS or the United States Department of Justice has commenced or threatened to initiate any action against a Credit Party, any action to enjoin a Credit Party, their officers, directors, or to its knowledge, employees, or their
agents and Affiliates, from conducting their businesses at any facility owned or used by them or for any material civil penalty, injunction, seizure or criminal action; 
 (vi) except as set forth on Schedule 3.11, has not received from the FDA or the DEA, at any time since January 1, 2003,
a Warning Letter, Form FDA-483, “Untitled Letter,” other correspondence or notice setting forth alleged violations of laws and regulations enforced by the FDA or the DEA, or any comparable correspondence from any state or local authority
responsible for regulating drug products and establishments, or any comparable correspondence from any foreign counterpart of the FDA or DEA, or any comparable correspondence from any foreign counterpart of any state or local authority with regard
to any Product or the manufacture, processing, packing, or holding thereof; and 

 (vii) except as set forth on Schedule 3.11, has not engaged in any Recalls
or other forms of product retrieval from the marketplace of any Products since January 1, 2003. 
 (b) None of the Credit
Parties, their Affiliates or any of their respective agents acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement is (i) in violation of any Anti-Terrorism Law, (ii) engages in or conspires
to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law, or (iii) is a Blocked Person. No Credit Party nor, to the
knowledge of any Credit Party, any of its Affiliates or agents acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement, (x) conducts any business or engages in making or receiving any contribution
of funds, goods or services to or for the benefit of any Blocked Person, or (y) deals in, or otherwise engages in any transaction relating to, any property or interest in property blocked pursuant to Executive Order No. 13224, any similar
executive order or other Anti-Terrorism Law. 
 (c) With respect to Products: 
 (i) All Products are listed on Exhibit F; provided, however, that, if after the Closing Date, any Borrower wishes to
sell or market any new Product, Borrowers shall give prior written notice to Administrative Agent of such intention (which shall include a brief description of such Product), along with a copy of an amended and restated Exhibit F; and
provided, further that Borrowers shall promptly (but, in any event within 30 days) provide Administrative Agent with a copy of the FDA’s approval letter for any Product approved after the date hereof; 
 (ii) Each Product is not adulterated or misbranded within the meaning of the FDCA; 
 (iii) Each Product is not an article prohibited from introduction into interstate commerce under the provisions of Sections 404, 505 or
512 of the FDCA; 
 (iv) Each Product that is sold pursuant to a Credit Party’s belief that it is not a “new
drug”, as that term is defined in 21 U.S.C. Section 321(p), is generally recognized by qualified experts as safe and effective for its intended uses as those terms have been interpreted by FDA and the United States Supreme Court, and has
been used for a material extent and for a material time for such uses; 
 (v) Each Product for which a Drug Efficacy Study
Implementation (DESI) Notice has been published in the Federal Register and each Product that is identical to, related to, or similar to such a drug conforms with the requirements set forth in such DESI Notice; 
 (vi) Each Product has been and/or shall be manufactured, imported, possessed, owned, warehoused, marketed, promoted, sold, labeled,
furnished, distributed and marketed in accordance in all material respects with all applicable Permits and Laws; 
 (vii) Each
Product has been and/or shall be manufactured in accordance with Good Manufacturing Practices; 
 (viii) Without limiting the
generality of Section 3.11(a)(i) above, with respect to any Product being tested or manufactured by any Borrower, Borrowers have received, and such Product shall be the subject of, all Required Permits needed in connection with the testing or
manufacture of such Product as such testing is currently being conducted by or on behalf of Borrower, and Borrowers have not received any notice from any applicable Government Authority, specifically including the FDA, that such Government Authority
is conducting an investigation or review of (A) Borrowers’ manufacturing facilities and processes for such Product which have disclosed any material deficiencies or violations of Laws (including Healthcare laws) and/or the Required Permits
related to the manufacture of such Product, or (B) any such Required Permit or that any such Required Permit has been revoked or withdrawn, nor has any such Governmental Authority issued any order or recommendation stating that the development,
testing and/or manufacturing of such Product by Borrower should cease; 

 (ix) Without limiting the generality of Section 3.11(a)(i) above, with respect to
any Product marketed or sold by any Borrower, Borrowers shall have received, and such Product shall be the subject of, all Required Permits needed in connection with the marketing and sales of such Product as currently being marketed or sold by
Borrower, and Borrowers have not received any notice from any applicable Governmental Authority, specifically including the FDA, that such Governmental Authority is conducting an investigation or review of any such Required Permit or approval or
that any such Required Permit has been revoked or withdrawn, nor has any such Governmental Authority issued any order or recommendation stating that such marketing or sales of such Product cease or that such Product be withdrawn from the
marketplace; and 
 (x) Borrowers have not (since the Closing Date) experienced any significant failures in their
manufacturing of any Product such that the amount of such Product successfully manufactured by Borrowers in accordance with all specifications thereof and the Required Payments related thereto in any month shall decrease significantly with respect
to the quantities of such Product produced in the prior month. 
 Section 3 Additional Affirmative Covenants. The following is
hereby appended to the Credit Agreement as new Section 4.13: 
 Section 4.13 Covenants Regarding Products and Compliance with
Required Permits 
 (a) Without limiting the generality of Section 4.4, in connection with the development, testing,
manufacture, marketing or sale of each and any product by any Borrower, Borrowers shall comply in all material respects with all Required Permits at all times issued by any Government Authority, specifically including the FDA, with respect to such
development, testing, manufacture, marketing or sales of such product by Borrowers as such activities are at any such time being conducted by Borrowers. 
 (b) Without limiting the generality of Section 4.13(a), Borrowers shall not permit any event or occurrence to occur or to take or to fail to take any action if the result of any of the forgoing would be that any
of the representations and warranties set forth in Section 3.11 to become untrue in any respect as of any date and Borrowers shall immediately and in any case within three (3) Business Days give written notice to Administrative Agent upon
any Borrower becoming aware that any of the representations and warranties set forth in Section 3.11 with respect to any Product have become incorrect in any respect (provided that, for the avoidance of doubt, the giving of such notice shall
not cure or result in the automatic waiver of any Default or Event of Default that may have resulted from such breach of such representation or warranty under the first part of this sentence). 
 Section 4 Permitted Investments. The definition of Permitted Investments as used in the Credit Agreement is hereby modified to include the
following: purchases by Borrowers of the rights to test, develop, manufacture, sell or market any new pharmaceutical, drug or medical device (and/or any Intellectual Property related thereto) that will upon such purchase become a Product of
Borrowers (provided that, nothing in the foregoing shall be interpreted or construed to contradict or limit any of Borrowers’ obligations under Section 3.11 above, particularly including without limitation the obligations of Borrowers to
give prior written notice to Administrative Agent of Borrowers’ intentions to begin testing, developing, manufacturing, selling or marketing any new Product). 
 Section 5 Events of Default. In addition to the events listed in Section 10.1, the occurrence of any of the following conditions and/or events, whether voluntary or involuntary, by operation of law or
otherwise, shall constitute an “Event of Default” under the Credit Agreement: 
 (a) the institution of any proceeding by FDA or
similar Governmental Authority to order the withdrawal of any Product or Product category from the market or to enjoin Credit Party or any representative of a Credit Party from manufacturing, marketing, selling or distributing any Product or Product
category; 

 (b) the institution of any action or proceeding by any DEA, FDA, or any other Governmental Authority to
revoke, suspend, reject, withdraw, limit, or restrict any Required Permit held by a Credit Party or any representative of a Credit Party; 
 (c) the commencement of any enforcement action against any Credit Party by DEA, FDA, or any other Governmental Authority; 
 (d) the
recall of any Product (other than the Solage product) from the market, the voluntary withdrawal of any Product (other than the Solage product) from the market, or actions to discontinue the sale of any Product (other than the Solage product);

 (e) a change in Law, including a change in FDA or DEA policies or procedures, occurs which could reasonably be expected to have a Material
Adverse Effect; or 
 (f) the termination of any agreements with manufacturers that supply any Products or any components of any Products or
any changes to any agreements with manufacturers that supply any Products or any components of any Products that could reasonably be expected to have a Material Adverse Effect. 
 IN WITNESS WHEREOF, intending to be legally bound, and intending that this document constitute an instrument executed and delivered under seal, the
undersigned have executed this document under seal as of the date of the Credit Agreement. 
 BORROWER: 
 BARRIER THERAPEUTICS, INC. 
  

					
	 By:
	 	 /S/ GEERT CAUWENBERGH
	 	[SEAL]
	 Name:
	 	 GEERT CAUWENBERGH
	 	
	 Title:
	 	 CHIEF EXECUTIVE OFFICER
	 	

 AGENT: 
 MERRILL LYNCH CAPITAL, 
 a division of Merrill Lynch Business Financial Services Inc., 
 as Administrative Agent and a Lender 
  

					
	 By:
	 	 /S/ WILLIAM D. GOULD
	 	[SEAL]
	 Name:
	 	 WILLIAM D. GOULD
	 	
	 Title:
	 	 DIRECTOR
	 	

 LENDERS: 
 MERRILL LYNCH CAPITAL, 
 a division of Merrill Lynch Business Financial Services Inc., 
 as Lender 
  

					
	 By:
	 	 /S/ WILLIAM D. GOULD
	 	[SEAL]
	Name:	 	 WILLIAM D. GOULD
	 	
	 Title:
	 	 DIRECTOR

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]